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A B S T R A C T
Background
Intimate partner violence (IPV) damages individuals, their children, communities, and the wider economic and social fabric of society.
Some governments and professional organisations recommend screening all women for IPV rather than asking only women with
symptoms (case-finding). Here, we examine the evidence for whether screening benefits women and has no deleterious effects.
Objectives
To assess the effectiveness of screening for IPV conducted within healthcare settings on identification, referral, re-exposure to violence,
and health outcomes for women, and to determine if screening causes any harm.
Search methods
On 17 February 2015, we searched CENTRAL, Ovid MEDLINE, Embase, CINAHL, six other databases, and two trial registers. We
also searched the reference lists of included articles and the websites of relevant organisations.
Selection criteria
Randomised or quasi-randomised controlled trials assessing the effectiveness of IPV screening where healthcare professionals either
directly screened women face-to-face or were informed of the results of screening questionnaires, as compared with usual care (which
could include screening that did not involve a healthcare professional).
Data collection and analysis
Two authors independently assessed the risk of bias in the trials and undertook data extraction. For binary outcomes, we calculated a
standardised estimation of the odds ratio (OR). For continuous data, either a mean difference (MD) or standardised mean difference
(SMD) was calculated. All are presented with a 95% confidence interval (CI).
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Main results
We included 13 trials that recruited 14,959 women from diverse healthcare settings (antenatal clinics, women’s health clinics, emergency
departments, primary care) predominantly located in high-income countries and urban settings. The majority of studies minimised
selection bias; performance bias was the greatest threat to validity. The overall quality of the body of evidence was low to moderate,
mainly due to heterogeneity, risk of bias, and imprecision.
We excluded five of 13 studies from the primary analysis as they either did not report identification data, or the way in which they did
was not consistent with clinical identification by healthcare providers. In the remaining eight studies (n = 10,074), screening increased
clinical identification of victims/survivors (OR 2.95, 95% CI 1.79 to 4.87, moderate quality evidence).
Subgroup analyses suggested increases in identification in antenatal care (OR 4.53, 95% CI 1.82 to 11.27, two studies, n = 663,
moderate quality evidence); maternal health services (OR 2.36, 95% CI 1.14 to 4.87, one study, n = 829, moderate quality evidence);
and emergency departments (OR 2.72, 95% CI 1.03 to 7.19, three studies, n = 2608, moderate quality evidence); but not in hospital-
based primary care (OR 1.53, 95% CI 0.79 to 2.94, one study, n = 293, moderate quality evidence).
Only two studies (n = 1298) measured referrals to domestic violence support services following clinical identification. We detected no
evidence of an effect on referrals (OR 2.24, 95% CI 0.64 to 7.86, low quality evidence).
Four of 13 studies (n = 2765) investigated prevalence (excluded from main analysis as rates were not clinically recorded); detection of
IPV did not differ between face-to-face screening and computer/written-based assessment (OR 1.12, 95% CI 0.53 to 2.36, moderate
quality evidence).
Only two studies measured women’s experience of violence (three to 18 months after screening) and found no evidence that screening
decreased IPV.
Only one study reported on women’s health with no differences observable at 18 months.
Although no study reported adverse effects from screening interventions, harm outcomes were only measured immediately afterwards
and only one study reported outcomes at three months.
There was insufficient evidence on which to judge whether screening increases uptake of specialist services, and no studies included an
economic evaluation.
Authors’ conclusions
The evidence shows that screening increases the identification of women experiencing IPV in healthcare settings. Overall, however,
rates were low relative to best estimates of prevalence of IPV in women seeking healthcare. Pregnant women in antenatal settings may
be more likely to disclose IPV when screened, however, rigorous research is needed to confirm this. There was no evidence of an effect
for other outcomes (referral, re-exposure to violence, health measures, lack of harm arising from screening). Thus, while screening
increases identification, there is insufficient evidence to justify screening in healthcare settings. Furthermore, there remains a need for
studies comparing universal screening to case-finding (with or without advocacy or therapeutic interventions) for women’s long-term
wellbeing in order to inform IPV identification policies in healthcare settings.
P L A I N L A N G U A G E S U M M A R Y
Screening women for intimate partner violence in healthcare settings
Background
We carried out this review to find out if asking all women (screening) attending healthcare settings about their experience of domestic
violence from a current or previous partner helps to recognise abused women so that they may be provided with a supportive response
and referred on to support services. We were also interested to know if this would reduce further violence in their lives, improve their
health, and not cause them any harm compared to women’s usual healthcare.
Women who have experienced physical, psychological, or sexual violence from a partner or ex-partner suffer poor health, problems
with pregnancy, and early death. Their children and families can also suffer. Abused women often attend healthcare settings. Some
people have argued that healthcare professionals should routinely ask all women about domestic violence. They argue that ’screening’
might encourage women who would not otherwise do so, to disclose abuse, or to recognise their own experience as ’abuse’. In turn,
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this would enable the healthcare professional to provide immediate support or refer them to specialist help, or both. Some governments
and health organisations recommend screening all women for domestic violence. Others argue that such screening should be targeted
to high-risk groups, such as pregnant women attending antenatal clinics.
Study characteristics
We examined research up to 17 February 2015. We included research studies that had women over 16 years of age attending any
healthcare setting. Our search generated 12,369 studies and we eventually included 13 studies that met the criteria described above. In
all, 14,959 women had agreed to be in those studies. Studies were in different healthcare settings (antenatal clinics, women’s health/
maternity services, emergency departments, and primary care centres). They were conducted in mainly urban settings, in high-income
countries with domestic violence legislation and developed support services to which healthcare professionals could refer. Each of the
included studies was funded by an external source. The majority of the funding came from government departments and research
councils, with a small number of grants/support coming from trusts and universities.
Key results and quality of the evidence
Eight studies with 10,074 women looked at whether healthcare professionals asked about abuse, discussed it, and/or documented
abuse in participating women’s records. There was a twofold increase in the number of women identified in this way compared to the
comparison group. The quality of this evidence was moderate. We looked at smaller groups within the overall group, and found, for
example, that pregnant women were four times as likely to be identified by a screening intervention as pregnant women in a comparison
group. We did not see an increase in referral behaviours of healthcare professionals but only two studies measured referrals in the same
way and there were some shortcomings to these studies. We could not tell if screening increased uptake of specialist services and no
studies examined if it is cost-effective to screen. We also looked to see if different methods were better at picking up abuse, for example,
you might expect that women would be more willing to disclose to a computer, but we did not find one method to be better than
another. We found an absence overall of studies examining the recurrence of violence (only two studies looked at this, and saw no
effect) and women’s health (only one study looked at this, and found no difference 18 months later). Finally, many studies included
some short-term assessment of adverse outcomes, but reported none.
There is a mismatch between the increased numbers of women picked up through screening by healthcare professionals and the
high numbers of women attending healthcare settings actually affected by domestic violence. We would need more evidence to show
screening actually increases referring and women’s engagement with support services, and/or reduces violence and positively impacts
on their health and wellbeing. On this basis, we concluded that there is insufficient evidence to recommend asking all women about
abuse in healthcare settings. It may be more effective at this time to train healthcare professionals to ask women who show signs of
abuse or those in high-risk groups, and provide them with a supportive response and information, and plan with them for their safety.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Screening for intimate partner violence (IPV) compared with usual care or screening without health professional involvement
Patient or population: women attending healthcare settings for any health-related reason
Settings: healthcare
Intervention: face-to-face screening or written/computerised screening with result passed to the healthcare professional
Comparison: non-screened women or those whose screening result was not passed on to the healthcare professional or those screened for issues other than IPV
Outcomes Universal screening for
IPV
Control Effect Number of participants
(studies)
Quality of the evidence
(GRADE)
Relative effect
(95% CI)
Absolute effect
(95% CI)
Identification of IPV by
health professionals (as-
sessed immediately or up
to 1 month)
259/5006 (5.2%) 86/5068 (1.7%) OR 2.95
(1.79 to 4.87)
31 more per 1000 (from 13
more to 61 more)
10,074 (8 studies) ⊕⊕⊕©
Moderate1
1.7% 31 more per 1000 (from 13
more to 60 more)
Identification of IPV by
type of healthcare setting
- Antenatal clinics
24/317 (7.6%) 6/346 (1.7%) OR 4.53
(1.82 to 11.27)
57 more per 1000 (from 14
more to 149 more)
663 (2 studies) ⊕⊕⊕©
Moderate2
1.7% 55 more per 1000 (from 13
more to 145 more)
Identification of IPV by
type of healthcare setting
- Maternal health services
51/594 (8.6%) 9/235 (3.8%) OR 2.36
(1.14 to 4.87)
48 more per 1000 (from 5
more to 124 more)
829 (1 study) ⊕⊕⊕©
Moderate3
3.8% 48 more per 1000 (from 5
more to 124 more)
Identification of IPV by
type of healthcare setting
- Emergency departments
71/1218 (5.8%) 36/1390 (2.6%) OR 2.72
(1.03 to 7.19)
42 more per 1000 (from 1
more to 135 more)
2608 (3 studies) ⊕⊕⊕©
Moderate1
1.2% 20 more per 1000 (from 0
fewer to 67 more)
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Identification of IPV by
type of healthcare setting
- Hospital-based primary
care
25/144 (17.4%) 18/149 (12.1%) OR 1.53
(0.79 to 2.94)
53 more per 1000 (from 23
fewer to 167 more)
293 (1 study) ⊕⊕⊕©
Moderate3
12.1% 53 more per 1000 (from 23
fewer to 167 more)
Referrals (assessed im-
mediately)
7/555 (1.3%) 4/743 (0.5%) OR 2.24
(0.64 to 7.86)
7 more per 1000 (from 2
fewer to 35 more)
1298 (2 studies) ⊕⊕©©
Low4
0.6% 7 more per 1000 (from 2
fewer to 39 more)
CI: confidence interval; GRADE: Grades of Recommendation, Assessment, Development, and Evaluation; IPV: intimate partner violence; OR: odds ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
1Downgraded due to heterogeneity.
2Downgraded due to imprecision.
3Downgraded due to risk of bias.
4Downgraded due to imprecision and risk of bias.
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B A C K G R O U N D
Description of the condition
Intimate partner violence (IPV)
Intimate partner violence (IPV) is a violation of a person’s human
rights and is now recognised as a global public health issue. For
the purpose of this review, we adopt the definition of IPV (of-
ten termed domestic violence) of the World Health Organization
(WHO), that is, any behaviour within an intimate relationship
that causes physical, psychological, or sexual harm to those in the
relationship (Krug 2002;WHO2013a). Intimate partner violence
often involves a combination of abuse behaviours. These include
threats of and actual physical violence, sexual violence, emotion-
ally abusive behaviours, economic restrictions, and other control-
ling behaviours. Many survivors of IPV report that the physical
violence is not the most damaging: it is the relentless psycholog-
ical abuse that leaves the person with long-lasting adverse effects
(Campbell 2002; WHO 2013b).
Intimate partner violence against men is a social problem with
potential adverse outcomes for victims (Coker 2002). Data from
the British Crime Survey suggested that 4.4% of men experienced
IPV in the 2012/13 period compared to 7.1% of women (Office
for National Statistics 2014). In this review, however, we do not
include IPV against men because the majority of abuse with se-
rious health and other consequences is that committed by men
against their female partners (Coker 2002), with women being
three times more likely than men to sustain serious injury and
five times more likely to fear for their lives (CCJS 2005), which
is why most screening interventions target women (Taft 2001).
We also exclude abuse towards women that is perpetrated by other
family members such as in-laws or children. We do include in this
review, women who experience violence by female partners, and
by ex-partners given the increased risks of violence associated with
separation (Wilson 1993; Campbell 2004; WHO 2013a).
Prevalence of IPV
Abuse of women by their partners or ex-partners is a common
worldwide phenomenon (Garcia-Moreno 2006). Latest figures
from the WHO indicate that one in three women globally experi-
ences physical or sexual violence, or both, by a partner, or non-part-
ner sexual violence, in their lifetime (WHO 2013a). Based on 48
population-based surveys across low-, middle-, and high-income
countries, the 2002 World Report on Violence and Health re-
vealed rates of between10%and69%for lifetime physical violence
by a partner (Krug 2002). Definitions used in prevalence studies
ranged from physical abuse in current relationships to the inclu-
sion of physical, emotional, sexual, or a combination of abuses
in past relationships (Hegarty 2006). Estimates of the magnitude
of IPV are obtained from community surveys, clinical samples,
and public records. Discrepancies in prevalence rates arise from
differences in definitions of IPV, sensitivity of tools, modes of data
collection, reporting time frames, and risk variation in the popu-
lations sampled (WHO 2013a).
Impacts of IPV
Intimate partner violence can have short-term and long-term
negative health consequences for survivors, even after the abuse
has ended (Campbell 2002). World Development reports (World
Bank 2006) and statements from the United Nations (Ingram
2005) emphasise that IPV is a significant cause of death and dis-
ability on a worldwide scale (Ellsberg 2008), and theWHO high-
lights violence against women as a priority health issue (WHO
2013a). The high incidence of psychosocial, physical, sexual, and
reproductive health problems in women exposed to IPV leads to
frequent presentations at health services and the need for wide-
ranging health services (Bonomi 2009). In addition, IPV is asso-
ciated with enormous economic and social costs, including those
related to social, criminal justice, housing and health services,
lost productivity, and human suffering (CDC 2003; Walby 2004;
EIGE 2014).
Psychosocial health
The most prevalent mental health sequelae of IPV for female
victims are depression, anxiety, post-traumatic stress disorder
(PTSD), and substance use (Golding 1999; Hegarty 2004; Rees
2011; Trevillion 2012; WHO 2013a), and women often suffer
from low self esteem and hopelessness (Kirkwood 1993; Campbell
2002). Suicide and attempted suicide are also associated with IPV
in both industrialised and non-industrialised countries (Golding
1999; Ellsberg 2008; WHO 2013a). Moreover, these effects im-
pact detrimentally on women’s ability to parent and thus impact
on their children (McCosker-Howard 2006). Exposure to IPV
during childhood has been linked with poor emotional, social,
and attainment outcomes (Kitzmann 2003), with around six in 10
IPV-exposed children exhibiting difficulties. Early exposure to in-
terparental violence has also been associated with increased risk of
IPV perpetration or victimisation during adolescence and adult-
hood (Heyman 2002).
Physical health
Abused women often experience many chronic health problems
(WHO 2013a), including chronic pain and central nervous sys-
tem symptoms (Díaz-Olavarrieta 1999; Campbell 2002), self re-
ported gastrointestinal symptoms, diagnosed functional gastroin-
testinal disorders (Coker 2000), and self reported cardiac symp-
toms (Tollestrup 1999). Intimate partner violence is also one of the
most common causes of injury in women (Stark 1996; Richardson
2002), including oral-maxillofacial trauma treated indental, emer-
gency, and surgical settings (Clark 2014; Ferreira 2014; Wong
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2014). Over 50% of all female murders in the UK and USA are
committed by partners or ex-partners (Brock 1999; Shackelford
2005; Home Office 2010). Worldwide, 38% of female homicides
are perpetrated by partners (WHO 2013a). In Australia, as else-
where, a far higher percentage of indigenous compared with non-
indigenouswomen aremurdered by their partners (Mouzos 2003).
Sexual and reproductive health
Themost consistent and largest physical health difference between
abused and non-abused women is the experience of gynaecological
symptoms (McCauley 1995; Campbell 2002). Women and their
fetuses and babies are also at risk, before, during, and after preg-
nancy (Martin 2001; Silverman 2006). The most serious outcome
is the death of the mother or the fetus (Jejeebhoy 1998; Parsons
1999). Violence by a partner is also associated with high rates of
pregnancy at a young age (Moore 2010), miscarriage and abor-
tion (Taft 2004; Pallitto 2013), low birth weight (Murphy 2001),
and premature birth and fetal injury (Mezey 1997). High rates
of symptoms of antenatal and postnatal depression, anxiety, and
post-traumatic stress disorder (PTSD) are also associated with ex-
posure to IPV during adulthood and pregnancy (Howard 2013).
Description of the intervention
Interventions by healthcare practitioners to improve
the health consequences for women experiencing IPV
Healthcare services play a central role in abused women’s care
(García-Moreno 2014), but the quality of healthcare profession-
als’ responses has been a focus of concern since the 1970s (Stark
1996; Feder 2006). Over the last few decades there has been a
concerted effort by women’s and justice organisations and the vol-
untary sector to respond to the needs of women who have expe-
rienced IPV. In contrast, the response of health services has been
slow (Feder 2009). While most health professionals believe that
IPV is a healthcare issue (Richardson 2001), there are a number of
barriers to identification and response on the part of practitioners
(Hegarty 2001). These include a perceived lack of time and sup-
port resources, fear of offending the woman, a lack of knowledge
and training about what to do for the woman, and a belief that
the woman will not leave the abusive relationship (Waalen 2000).
A further barrier is the lack of evidence for effective interventions
(García-Moreno 2014).
Despite these barriers, there has been progress in the overall re-
sponse of health systems to IPV with many health professional as-
sociations around the world publishing guidelines for clinicians on
how to identify women who have been abused (Davidson 2000;
Family Violence Prevention Fund 2004; Hegarty 2008). Implicit
in many of these recommendations is the assumption that screen-
ing or asking routinely about abuse will increase identification of
women who are experiencing violence, lead to appropriate inter-
ventions and support, and ultimately decrease exposure to vio-
lence and its detrimental health consequences, both physical and
psychological (Taft 2004; WHO 2013b). Screening is predicated
on the assumptions that identifying and responding supportively
to, and referring on, women experiencing IPV is fulfilling health
professionals’ duty of care. However, advocacy or ongoing ther-
apy requires appropriate training and time that clinicians may not
have in routine care. Further, clinicians are part of a wider system
of response and need to be able to identify and refer to domestic
violence services that have more time, and have specialist training
and connections to other community-based services such as hous-
ing. Training and knowledge of referral services should improve
clinicians’ motivation to identify when they are not responsible for
ongoing domestic violence counselling and advocacy. This review,
an update of an earlier review (Taft 2013; O’Doherty 2014a), is
focused on screening with a brief response only; it does not include
advocacy or psychotherapeutic interventions, which are the topics
of separate reviews.
Screening
Screening aims to identify women who have experienced, or are
experiencing, IPV from a partner or ex-partner in order to offer
interventions leading to beneficial outcomes. However, within the
field of domestic/family violence, both the immediate- and longer-
term benefit of screening such women remains unproven (Taket
2004; Spangaro 2009; WHO 2013b), despite some recommen-
dations for screening in particular countries (e.g. USA) (Nelson
2012). Many factors, such as fear or readiness to take action, influ-
ence whether or not women choose to disclose their abuse (Chang
2010), and will affect accurate measurement of screening rates.
Screening for IPV, therefore, is a problematic concept when tra-
ditional screening criteria are applied (Hegarty 2006), as it is a
complex social phenomenon rather than a disease. However, it still
requires rigorous evidence for its effectiveness if it is to be imple-
mented as policy.
It is important to distinguish between universal screening (the ap-
plication of a standardised question to all symptom-free women
according to a procedure that does not vary fromplace to place), se-
lective screening (where high-risk groups, such as pregnant women
or those seeking pregnancy terminations are screened), routine
enquiry (when all women are asked but the method or question
varies according to the healthcare professional or the woman’s situ-
ation), and case-finding (asking questions if certain indicators are
present).
For this review, screening is defined as any method that aims for
every woman patient in a healthcare setting to be asked about her
experiences of IPV, both past and present. Screening may be con-
ducted directly by a healthcare professional or indirectly through a
self completed questionnaire (often by computer) with the health-
care professional informed of the questionnaire results. This may
include the use of screening tools (Rabin 2009), which vary in
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their validity and reliability and therefore in their effectiveness to
accurately detect abuse. These tools are reviewed in CDC 2007
and Feder 2009. Alternatively, clinicians may ask one or a range
of questions related to IPV only at one time point or at several.
It is very unlikely that one single question will address the range
of women’s experiences of IPV. Whether a woman is currently ex-
periencing IPV from a current partner or an ex-partner (e.g. ha-
rassment) or has previously experienced IPV, the goal of screening
is the same - to identify her and offer support appropriate to her
needs that will prevent any further abuse (e.g. advocacy, legal or
police help) and reduce any consequent problems she is experienc-
ing (e.g. offering therapeutic support) or a combination of these.
There has long been debate about the value of screening per se
(Taket 2004; Feder 2009), with some arguing that asking ques-
tions can raise awareness in women experiencing IPV who are con-
templating their situation. Generally,most women are in favour of
universal screening, although this varies with abuse status and age
(Feder 2009). However, studies have found that women’s prefer-
ences vary according to the method of screening used (MacMillan
2006; Feder 2009); readers are referred to several studies that have
examined this question but were excluded from this review (Furbee
1998; Bair-Merritt 2006; Chen 2007; Rickert 2009). Bair-Merritt
2006 found a similar rate of disclosure in audiotaped (11%) com-
pared with written questionnaires (9%) with both methods pre-
ferred to direct physician enquiry. Chen 2007 found that there
was little difference between self completion and healthcare pro-
fessional enquiry in terms of participant comfort, time taken, and
effectiveness, but that women who had experienced IPV were
less comfortable with physician screening. MacMillan and col-
leagues reported thatwomen found self completionmethods easier
and more private and confidential (MacMillan 2006). However,
women’s preferences for how they are asked about IPV needs to be
examined in the context of outcomes beyond disclosure. In other
words, self interview methods may yield higher disclosure rates,
but does this translate into increased awareness about IPV, better
uptake of services, reduced re-exposure to IPV, and improvements
in health?
Identifying IPV is only the first step in intervention. Among
women receiving care in US primary care clinics, Klevens 2012b
tested computer-assisted screening accompanied by a brief video
in which an advocate provided support and information and en-
couraged women to seek help and referral information versus no
screening with referral information only, versus usual care. One
year later they found no difference between the three groups in
physical or mental health status. Women may have experienced
long-standing abuse or it may have commenced recently; theymay
be unaware that the behaviour constitutes abuse or be actively
seeking support for change, and therefore responses to their needs
may need to differ (Chang 2010; Reisenhofer 2013), and may re-
quire involvement of a healthcare professional rather than a list of
resources.
Two reviews of studies addressing the UK National Screening
Committee criteria found that screening by healthcare profession-
als leads to a modest increase in the number of abused women be-
ing identified following screening, but that screening was not ac-
ceptable to the majority of health professionals surveyed (Ramsay
2002; Feder 2009). Hegarty 2006 outlines themany clinician bar-
riers (e.g. time, lack of ongoing or effective training and resources)
and system barriers (e.g. different health priorities, lack of referral
options in the community) that impede effective screening and
routine enquiry, and that need to be addressed before clinicianswill
feel comfortable asking women about their experiences of abuse.
In addition, women experience barriers to disclosure, especially
during pregnancy, with the presence of abusive partners or mon-
itoring of her attendance at healthcare services where she might
disclose. Most reviews to date have concluded that there is no
evidence that women experience better outcomes from screening
interventions (Ramsay 2002; Wathen 2003; Taft 2013). This lack
of evidence has not deterred many governments around the world
implementing universal IPV screening, or selective screening in
high-risk populations. Previous US and Canadian Task Forces on
Preventive Health Care conducted thorough systematic reviews of
the evidence and concluded that there was insufficient evidence to
recommend for or against routine screening for violence against
women (Wathen 2003; Nelson 2004); however, the US Preven-
tive Services Task Force revised their decision (Nelson 2012) and
now recommend screening based on scant evidence from one ef-
fectiveness study (MacMillan 2009). The WHO reviewed the ev-
idence in 2013 and recommended screening women only when
they are pregnant (WHO 2013b). In some countries, screening is
advocated in the absence of sufficient resources or referral options,
and where there is a lack of training and resources, clinicians may
undertake screening inappropriately. Some would further argue
that it is unethical to implement screening for IPV in the absence
of evidence of effectiveness as it may cause harm (Jewkes 2002;
Wathen 2012).
How the intervention might work
Universal screening aims for 100% of women to be asked about
IPV and those experiencing IPV to disclose it. Universal screening
may apply to all women in a healthcare setting, such as a hospi-
tal, while selective screening could be applied to those in high-
risk groups such as those in antenatal or abortion clinics or preg-
nant women attending community-based family practice clinics.
Screening women using face-to-face methods implies the clinician
is directly asking all women who attend for a given consultation
whether they are experiencing or have ever experienced abusive be-
haviours from their partner or ex-partner, providing women with
the choice to disclose or not. Women who disclose abuse may
then be offered a response such as safety assessment and planning,
emotional support, referral to specialist services, or information
on appropriate local/national resources. Another model might of-
fer all women attending a given health service the option of self
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completing screening (through written or computer-based meth-
ods) where a woman can choose whether or not to disclose abu-
sive behaviour from a partner or ex-partner. Positive screen results
would then be assessed by the consulting healthcare professional
who could exercise their own clinical judgement in how to respond
to a positive result. The option of administrative or computerised
follow-up has been explored where the clinician is bypassed, and
instead, for example, a print-out of resources is generated. Klevens
and colleagues found no effect of this type of screening interven-
tion on outcomes for women (Klevens 2012b).
Why it is important to do this review
This review was originally published two years ago (Taft 2013).
However, the international debate on whether or not screening in
healthcare settings is beneficial to women has continued. Given
that the evidence presented in the previous review was appraised
as low to moderate quality and there were few studies that ex-
amined medium- and long-term health and abuse outcomes, it is
important to search for and synthesise new research and, where
possible, combine studies of similar outcomes in a meta-analysis.
We have incorporated another review ’Domestic violence screen-
ing and intervention programmes for adults with dental or facial
injury’ into this update (Coulthard 2010), please see section on
Differences between protocol and review. The reasons for doing
this work have not changed since the original review. There is an
urgent need to assess and identify health sector screening inter-
ventions for IPV (Davidson 2000; Feder 2009), in order to: have
clear evidence about what health professionals can do safely and
effectively to decrease the impact of IPV on women; determine
what is cost-effective; and inform health professionals and policy-
makers about the cost/benefit of screening interventions. In par-
ticular, this systematic review examines themost rigorous evidence
around health service screening interventions for IPV to ascertain
whether the potential benefits of IPV screening for women’s health
and wellbeing outweigh any potential for harm.
O B J E C T I V E S
To assess the effectiveness of screening for IPV conducted within
healthcare settings on identification, referral, re-exposure to vio-
lence, and health outcomes for women, and to determine if screen-
ing causes any harm.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Any study that allocated individual women, or clusters of women,
by a randomor quasi-randommethod (such as alternate allocation,
allocation by birth date, etc.) to a screening intervention compared
with usual care or to a condition where healthcare professionals
were not aware of women’s screening results.
Types of participants
Women (aged 16 years and over) attending a healthcare setting.
We define a ’healthcare setting’ as any health setting where health
services are delivered (such as those listed below), and home visits
by these services.
1. General (family) practice
2. Antenatal and postnatal services
3. Hospital emergency, inpatient or outpatient services
4. Private specialists (e.g. obstetrics and gynaecology,
psychiatry, ophthalmology)
5. Community health services
6. Drug and alcohol services
7. Mental health services
8. Dental services
Types of interventions
Any IPV screening in a healthcare setting as listed above. Screening
is defined as any of a range of methods (face-to-face, survey or
other method, specific to IPV or where IPV was included as part
of general psychosocial screening) that aims for all women patients
in a healthcare setting to be asked about current or past IPV,
including the use of screening tools as well as asking one or a range
of screening questions related to IPV on one ormore occasions.We
only included studies where, in one arm of the trial, the treating
healthcare professional conducted the screening or was informed
of the screening result at the time of the relevant consultation.
We excluded extended interventions that went beyond screening
and an immediate response to disclosure, for example, interven-
tions that include clinical follow-up or offer further counselling
or psychological treatment. We made this an exclusion factor as it
is rarely feasible for health professionals to deliver intensive treat-
ments due to lack of time and skill. Furthermore, we wanted to
isolate the effect of screening in order to provide evidence on the
independent contribution of this particular response to IPV.
Screening was compared to usual care, implying no screening in
the comparative arm. However, we did include studies where an
eligible screening intervention was compared to a condition of
’screening’ that involved no healthcare professionals or face-to-face
interaction.
Types of outcome measures
We did not use outcomes measured by studies as a criterion for
inclusion or exclusion.
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Primary outcomes
A. Identification of IPV by health professionals (data based on
clinical encounter).
Identification was defined as any form of acknowledgement by
a healthcare professional during a consultation that the woman
had experienced exposure to IPV. Identification therefore assumes
communication between healthcare professional and participant
that acknowledges the abuse. Studies use different terms such as
identification, discussion, and patient disclosure of IPV. We care-
fully assessed how stated outcomes were operationalised across
trials in order to determine if they met our definition of iden-
tification. Studies could collect identification data using a vari-
ety of methods (e.g. audio-recordings of encounters, surveying
women and healthcare professionals about what was discussed
during the encounter, and medical record review). Identification
of IPV through face-to-face interviews with researchers was dealt
with separately on the basis that it did not properly represent the
clinical context and may threaten the validity of the primary iden-
tification data.
B. Information-giving and referrals to support agencies by health-
care professionals (including take-up rates when available).
We included in this category any recording, documentation or
organisational validation that women had been given information
about, or referral to, support agencies.
Secondary outcomes
C. Intimate partner violence as measured by:
1. validated instruments (e.g. Composite Abuse Scale (CAS),
Index of Spouse Abuse (ISP); and
2. self reported IPV, even if using a non-validated scale.
D. Women’s perceived and diagnosed physical health outcomes,
using measures of:
1. physical health (e.g. Short-Form health survey - 36 (SF-36)
physical subscale, General Health Questionnaire (GHQ));
2. physical injuries, such as fractures and bruises (self reported
or documented in medical records); and
3. chronic health disorders, such as gynaecological problems,
chronic pain, and gastrointestinal disorders (self reported or
clinical symptoms, or both, documented in medical records).
E. Women’s psychosocial health, using measures of:
1. depression (e.g. Beck Depression Inventory (BDI), Center
for Epidemiologic Studies Depression Scale (CES-D));
2. post-traumatic stress (e.g. Impact of Events Scale (IES),
Post-traumatic Stress Disorder Checklist (PCL));
3. anxiety (e.g. Spielberger’s State-Trait Anxiety Inventory
(STAI), Beck Anxiety Inventory (BAI));
4. self efficacy (e.g. Generalized Perceived Self-Efficacy Scale
(GSE), Sherer’s Self-Efficacy Scale (SES));
5. self esteem (e.g. Rosenberg Self-Esteem Scale (SES),
Coopersmith Self-Esteem Inventory (CSEI));
6. quality of life (e.g. WHO Quality of Life-Bref )
7. perceived social support (e.g. Medical Outcomes Scale
(MOS), Sarason’s Social Support Questionnaire (SSQ)); and
8. alcohol or drug abuse (e.g. Addiction Severity Index (ASI),
Alcohol and Other Drug Abuse (AOD) scale).
F. Occurrence of adverse outcomes such as:
1. increased deaths, all-cause or IPV-related (documented in
medical records or routinely collected data);
2. increase of IPV as measured by any of the above;
3. increase of physical or psychosocial morbidity as listed
above; and
4. false negatives and false positives of screening tests.
G. Services and resource use:
1. family/domestic violence services;
2. police/legal services;
3. counselling or therapeutic services;
4. health service use; and
5. other services.
H. Cost/benefit outcomes, using measures of:
1. health service use;
2. days out-of-role; and
3. medication use.
Timing of outcome assessment
We documented the duration of follow-up in all included studies.
For the purposes of this review, we defined short-term follow-up
as less than six months since baseline or delivery of the screen-
ing intervention, medium-term follow-up as between six and 12
months, and long-term follow-up as more than 12 months.
Selecting outcomes for ’Summary of findings’ table
We included the results of outcomes that could be pooled together
in a meta-analysis in the ’Summary of findings’ tables (Summary
of findings for the main comparison and Summary of findings 2).
These were the primary outcomes of clinical identification of IPV,
and referral. We also included an outcome that was not indicated
a priori, an alternative identification outcome, which we refer to
as non-clinical identification (these data were not drawn from
documentation of abuse; medical records etc. within the clinical
context) (see Differences between protocol and review).
Search methods for identification of studies
We searched the international literature for peer-reviewed and
non-peer-reviewed studies and published and unpublished stud-
ies. We did not apply any date or language restrictions to our
search strategies. We chose not to use a randomised controlled trial
(RCT) filter as we wanted the search to be as inclusive as possible;
an initial check of the differences between using and not using
a RCT filter uncovered a trial not captured when the RCT filter
was applied. Our previous search strategies were not limited to
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any healthcare setting, and so did not require any revisions as they
already captured records relevant to oral and maxillofacial injury
clinics. The previous version of this review included studies up
to July 2012. The searches for this update cover the period from
2012 to 17 February 2015.
Electronic searches
We searched the following databases on 17 February 2015.
1. Cochrane Central Register of Controlled Trials
(CENTRAL 2015, Issue 1), which includes the Specialised
Register of the Cochrane Developmental, Psychosocial and
Learning Problems Group (CDPLPG).
2. Ovid MEDLINE(R) 1946 to February Week 2 2015.
3. Ovid MEDLINE(R) In-process and other non-indexed
citations 13 February 2015.
4. Embase (Ovid) 1980 to 2015 Week 7.
5. CINAHL PLUS (EBSCOhost) 1937 to current.
6. PsycINFO (Ovid) 1806 to February Week 2.
7. Sociological Abstracts (ProQuest) 1952 to current.
8. Conference Proceedings Citation Index - Social Science and
Humanities (CPCI-SS&H; Web of Science) 1990 to 17
February 2015.
9. Database of Abstracts of Reviews for Effectiveness (DARE)
2012, Issue 2, part of the Cochrane Library.
10. Cochrane Database of Systematic Reviews (CDSR) 2015,
Issue 2, part of theCochrane Library.
11. WHO International Clinical Trials Registry Platform
(ICTRP) (who.int/ictrp/en/).
12. ClinicalTrials.gov (clinicaltrials.gov).
The search strategies used for this update are inAppendix 1. Search
strategies used for earlier versions of the review are in Appendix 2.
The searches were originally run by Joanne Abbott, former Trials
Search Co-ordinator (TSC) of CDPLPG. Subsequent searches
were conducted byMargaret Anderson, current TSCofCDPLPG.
We also searched the website of the World Health Organization
(WHO) (who.int/topics/violence/en/) and the Violence Against
Women (VAW) Online Resources (vaw.umn.edu/).
Searching other resources
Handsearching
Due to insufficient resources, wewere unable to undertake planned
handsearching of the Journal of Family Violence, Journal of Inter-
personal Violence, Violence and Victims, Women’s Health, American
Journal of Preventive Medicine, American Journal of Public Health,
Annals of Emergency Medicine, Archives of Internal Medicine, Aus-
tralian & New Zealand Journal of Public Health, and Journal of
the American Medical Association. We are confident that any ma-
jor screening trials involving healthcare professionals would have
been identified through our other search strategies, including our
electronic searches and searches of trials registers, citation tracking,
networks of the review authors, and communication with authors
of included studies.
Citation tracking
We examined the reference lists of acquired papers and tracked
citations forwards and backwards.
Personal communication with the first authors of all
included articles
We emailed the authors of all primary studies included in the re-
view about any omissions (and, in particular omissions of non-
peer-reviewed studies). We contacted theWHO Violence and In-
jury Programme to inquire about any screening studies that might
fit our inclusion criteria of which we were unaware, especially in
low- and middle-income countries (García-Moreno 2015 [pers
comm]).
Data collection and analysis
Selection of studies
We ran searches four times for this review (September 2009,
September 2011, July 2012, and February 2015; see Figure 1). In
the original review, two review author pairs (LOD and AT, LOD
and KH) independently reviewed abstracts. For this update, TL
and EC independently reviewed studies by title and abstract. LOD
and AT reviewed studies independently from the point at which
full-text articles had been retrieved (n = 42 in this update).
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Figure 1. Flow diagram for selection of studies
Where possible, we resolved disagreement about abstract inclusion
between any review authors by reading the full study followed by
discussion. When agreement could not be reached, a third review
author outside that author pairing (GF, LD, JR or KH) assessed
whether or not the study fulfilled the inclusion criteria.
Originally, the complex nature of the ’screening’ definition re-
quired that the entire team met in order to discuss at length and
finalise the revised definition of a screening intervention now gov-
erning criteria for this review. Two review authors (LOD and AT)
independently assessed each study included to this stage against
the inclusion criteria withKHalso assessing the 42 full-text articles
in the 2015 update. As with the earlier stage of the study review
process, we resolved any disagreement by discussing studies in-
depthwith other review authors (GF, LD or JR).Where additional
information was required to adequately understand the nature of
the screening intervention and design, we contacted the first au-
thor of the study in question. This led to all outstanding issues
being resolved. The reasons behind decisions to exclude otherwise
plausible studies are offered in the ’Characteristics of excluded
studies’ table.
Data extraction and management
Two review authors (LOD and AT prior to 2015, or LOD and
TL in 2015) independently extracted the data from the included
studies and entered data into electronic data collection forms. We
requested any missing information or clarification from the first or
corresponding authors of papers, and of the nine authors that we
contacted, eight replied (Rhodes 2002; Carroll 2005; MacMillan
2009; Koziol-McLain 2010; Humphreys 2011; Klevens 2012a;
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Fraga 2014; Fincher 2015). We resolved any disagreements be-
tween the two review authors as regards data extraction through
discussion; no adjudication by a third review author was neces-
sary. We noted all instances where additional statistical data were
provided by study investigators and we distinguished these data
as such in the text (Effects of interventions). Once agreed, we en-
tered all relevant data into Review Manager (RevMan) software,
Version 5.3 (RevMan 2014).
We recorded the following information in the ’Characteristics of
included studies’ table.
1. Method: randomisation or quasi-randomisation method,
intention-to-treat analysis, power calculation, and study dates.
2. Participants: setting, country, inclusion and exclusion
criteria, numbers recruited, numbers dropped out, numbers
analysed, age, marital status, ethnicity, socioeconomic status, and
educational background.
3. Interventions: brief description of intervention, including
screening tool and method, and method of usual care.
4. Outcomes: timing of follow-up events, outcomes assessed,
and scales used.
5. Notes: further information to aid understanding of the
study such as source of funding.
Assessment of risk of bias in included studies
Two review authors (LOD and AT prior to 2015, or LOD, AT,
and TL in 2015) independently assessed the risk of bias of all in-
cluded studies using the criteria outlined below and cross-checked
in accordance with the updated methodological criteria in Section
8 of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). We rated each domain, for each included study,
as either ’high’, ’low’ or ’unclear’ risk of bias.
Sequence generation
Description: the method used to generate the allocation sequence
was described in sufficient detail so as to enable an assessment to be
made as to whether it should have produced comparable groups.
Review authors’ judgement: was there selection bias (biased allo-
cation to interventions) due to inadequate generation of a ran-
domised sequence?
Allocation concealment
Description: the method used to conceal allocation sequences was
described in sufficient detail to assess whether intervention sched-
ules could have been foreseen in advance of, or during, recruit-
ment.
Review authors’ judgement: was there selection bias (biased allo-
cation to interventions) due to inadequate concealment of alloca-
tions prior to assignment?
Blinding
Blinding of participants and personnel
Description: any measures used to blind healthcare professionals
or participants to their randomisation status were described to
enable us to know whether the outcomes may have been affected
by this knowledge.
Review authors’ judgement: was there performance bias due to
knowledge of the allocated interventions by participants and per-
sonnel during the study?
Blinding of outcome assessment
Description: any measures used to blind outcome assessors were
described in sufficient detail so as to enable us to assess possible
knowledge of which intervention a given participant might have
received.
Review authors’ judgement: was there detection bias due to knowl-
edge of the allocated interventions by outcome assessors?
Incomplete outcome data
Description: the study reported data on attrition and the numbers
involved (compared with total randomised) as well as the reasons
for attrition or these were obtained from investigators.
Review authors’ judgement: was there attrition bias due to the
amount, nature, or handling of incomplete outcome data?
Selective outcome reporting
Description: attempts were made to assess the possibility of selec-
tive outcome reporting by authors. Where available, we checked
protocols and trial databases for prior outcome specification.
Where a protocol was not available, we searched the databases of
registered trials to check pre-specified outcome measures. Where
neither were available, we were unable to assess this and therefore
nominated this as ’uncertain’.
Review authors’ judgement: were reports of the study free of sug-
gestion of selective outcome reporting?
Other sources of bias
Description: the study was apparently free of other problems that
could put the outcomes at high risk of bias. In common with our
associated review on advocacy (Ramsay 2009) - update currently
under way and due to be published soon - we specified the follow-
ing three criteria under this heading.
Baseline measurement of outcome measures
Review authors’ judgement: were baseline data (if available) evenly
distributed?
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Reliability of outcome measures
Review authors’ judgement: were outcome measures validated and
referenced?
Protection against contamination
Review authors judgement: was there adequate protection against
the study being contaminated?
Measures of treatment effect
Continuous outcomes
We analysed continuous data if (i) means and standard deviations
(SDs) were available in the report or obtainable from the authors of
studies, and (ii) the datawere said to be normally distributed. If the
second standard was not met then we did not enter such data into
RevMan (RevMan 2014) (as it assumes a normal distribution).
(More detail on the treatment of continuous data is available in
Appendix 3).
Binary outcomes
For binary outcomes (e.g. woman identified/not identified, re-
ferred/not referred), we calculated a standard estimation of the
odds ratio (OR) and 95% confidence intervals (CI) using a ran-
dom-effects model (Higgins 2011). Where data required to calcu-
late the OR were neither reported nor available from the authors
of studies, we did not try to calculate these but have provided the
findings as published by the authors.
Unit of analysis issues
We anticipated both individual- and cluster-randomised con-
trolled trials would be identified. With regard to cluster trials, we
examined studies to assess whether they had accounted for the ef-
fects of clustering using the CONSORT (Consolidated Standards
of Reporting Trials) recommendations (Campbell 2012).We have
archived methods for re-analysing cluster trials in future updates
of this review (Appendix 3).
We did not use indirect comparisons as all included studies com-
pared the intervention to a suitable comparison condition (usual
care or no involvement of healthcare professionals).
Dealing with missing data
We assessed missing data and dropout rates for each of the in-
cluded studies. If studies were required to impute missing data
in published articles, and tables of outcomes with and without
imputation were provided, we used the imputed figures. The
’Characteristics of included studies’ tables specify the number of
women who were included in the final analysis in each group as
a proportion of all women randomised in the study. Where avail-
able, we provided the reasons given for missing data in the nar-
rative summary along with an assessment of the extent to which
the results may have been influenced by missing data. We planned
to use sensitivity analysis to deal with missing data. No study
conformed to all intention-to-treat analysis criteria. We included
those in which all completed cases were analysed in the groups
to which they were randomised (available case analysis, Higgins
2011, Section 16.2), irrespective of whether or not they received
the screening intervention. More detail on the treatment of miss-
ing data is available in Appendix 3.
Assessment of heterogeneity
Weassessed the consistency of results visually andby examining the
I² statistic - a quantity that describes approximately the proportion
of variation in point estimates that is due to heterogeneity rather
than sampling error (Higgins 2002). Where significant statistical
heterogeneity was detected (I² > 50%), we explored differences
in clinical characteristics (participants, interventions, outcomes)
andmethodological characteristics (risk of bias, study design) with
modified analyses. We then summarised any differences in the
narrative synthesis.
Assessment of reporting biases
There were not enough studies to assess reporting biases. Methods
for assessing reporting bias, archived for future updates of this
review, are available in Appendix 3.
Data synthesis
We only performed a meta-analysis where there were sufficient
data and it was appropriate to do so. The decision to pool data in
this way was determined by the compatibility of populations, de-
nominators, and screeningmethods (clinical heterogeneity), dura-
tion of follow-up (methodological heterogeneity), and outcomes.
As fixed-effect models ignore heterogeneity, we have used the ran-
dom-effects models to take account of the identified heterogene-
ity of the screening interventions. The Mantel-Haenszel method,
a default program in RevMan (RevMan 2014), can take account
of few events or small study sizes and can be used with random-
effects models. Where it was inappropriate to combine the data in
a meta-analysis, we provided a narrative description of the effect
sizes as specified in the original study and 95% CIs or SDs for
individual outcomes in individual studies. We did not access in-
dividual patient data (IPD) as we did not encounter unpublished
studies or studies whose data could not be included in our analy-
ses. The main issue with studies included in this review was risk
of bias and the IPD approach cannot, generally, help avoid bias
associated with study design or conduct (Higgins 2011).
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’Summary of findings’ table
We used the online Guideline Development Tool (GDT;
GRADEpro GDT) to develop ’Summary of findings’ tables
(Summary of findings for the main comparison and Summary of
findings 2). These tables summarise the amount of evidence, typi-
cal absolute risks for screened and non-screened women, estimates
of relative effect, and the quality of the body of evidence.
We used the Grades of Recommendation, Assessment, Develop-
ment, and Evaluation (GRADE) approach to classify the review
findings: high quality (further research is unlikely to change our
confidence in the estimate of effect); moderate quality (further
research is likely to have an important impact on our confidence
in the estimate of effect, and might change it), and low or very
low quality (further research is likely to have an important impact
on our confidence in the estimate of effect and is likely to change
it). The quality of a body of evidence involves considering risk
of bias within studies (methodological quality), directness of evi-
dence, heterogeneity, precision of effect estimates, and the risk of
publication bias.
Subgroup analysis and investigation of heterogeneity
We performed subgroup analyses for type of healthcare setting,
and analysed data from a subset of studies that measured preva-
lence (or non-clinically based identification) rather than clinical
identification.
Not enough studies were identified to perform all subgroup analy-
ses planned in the protocol for this review (Taft 2008). Please also
see Appendix 3 for subgroup analyses archived for future updates
of this review.
Sensitivity analysis
We based our primary analyses on available data from all included
studies relevant to the comparison of interest. To assess the robust-
ness of conclusions to quality of data and approaches to analysis,
we conducted the following sensitivity analyses:
1. study quality;
2. differential dropout.
We have archived additional analyses for future updates of this
review. Please see Appendix 3.
R E S U L T S
Description of studies
Results of the search
Our searches of the listed electronic databases (see Figure 1) gen-
erated 12,369 records (including nine records identified from the
reference lists of included studies and from contact with authors)
of which 3533 were duplicates; we therefore screened 8836 ab-
stracts. Authors agreed that 8597 abstracts were irrelevant and that
239 required joint review. Following discussions, we excluded a
further 137. We subsequently retrieved full-text papers for 102
records. We determined that 42 were ineligible. A further 43 ar-
ticles, which appeared as though they could meet inclusion cri-
teria, ultimately did not and we excluded them (reasons for their
exclusion are detailed in the ’Characteristics of excluded studies’
tables). Thirteen studies (that were published in 17 papers) met
the inclusion criteria.
Included studies
Study designs
Thirteen randomised controlled trials (Carroll 2005; MacMillan
2006; Rhodes 2006; Ahmad 2009; MacMillan 2009; Kataoka
2010; Koziol-McLain 2010; Humphreys 2011; Klevens 2012a;
Fraga 2014; Fincher 2015), of which, two were quasi-randomised
controlled trials (Rhodes 2002; Trautman 2007), met the criteria
for inclusion in this review. All 13 studies were reported in peer-
reviewed journals.
Location
Four studies were conducted in Canada (Carroll 2005;MacMillan
2006; Ahmad 2009; MacMillan 2009), six in the USA (Rhodes
2002, Rhodes 2006; Trautman 2007; Humphreys 2011; Klevens
2012a; Fincher 2015), one in Japan (Kataoka 2010), one in Portu-
gal (Fraga 2014), and one inNewZealand (Koziol-McLain 2010).
Several were cluster-randomised trials, which accounted for clus-
tering in their analyses, and were conducted in diverse health-
care settings (Carroll 2005; MacMillan 2006; MacMillan 2009).
Rhodes 2006 stratified by clinic location (inner urban or subur-
ban) and randomised within location.
Healthcare settings
In three studies, women were recruited from antenatal clinics
(Carroll 2005; Kataoka 2010; Humphreys 2011), while Fraga
2014 enrolled women who were one year postpartum at a hospi-
tal obstetrics department and MacMillan 2009 included an ob-
stetrics and gynaecology clinic. Four were located in emergency
departments (EDs) only (Rhodes 2002; Rhodes 2006; Trautman
2007; Koziol-McLain 2010). Ahmad 2009 was conducted in a
hospital-affiliated family practice, and both MacMillan 2006 and
MacMillan 2009 combined primary and tertiary care sites (fam-
ily practices, EDs, and women’s health services). Klevens 2012a
was conducted in assorted women’s health clinics in a hospital.
Fincher 2015 screened women participating in a Special Supple-
mental Nutrition Program at a Women, Infants, and Children’s
15Screening women for intimate partner violence in healthcare settings (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(WIC) service. We identified no eligible trials in dental or oph-
thalmology settings or in maxillofacial injury or fracture clinics.
Characteristics of participants
Both clinicians and their patients participated in all included stud-
ies.
Healthcare professionals
In two studies, the first type of participant to be recruited was the
clinician (Carroll 2005; Ahmad 2009). They were trained prior to
the recruitment of patient participants.
Ahmad 2009 recruited 11/14 eligible family physicians from ur-
ban academic hospital-affiliated family practice clinics. Sevenwere
white female clinicians who had an average age of 46 years and
averaged 16 years in practice. Carroll 2005 recruited 48 family
physicians, obstetricians, andmidwives from four practices diverse
in location and populations, which provided antenatal and post-
partum care. These different clinicians were paired by age, sex,
clinician type, and health service location where possible and then
randomised in pairs. Thirty-six of 48 (75%) were family physi-
cians; the mean age was 42 years and 50% were female. They av-
eraged 13.5 years in practice.
Participants
The 14,959 women recruited to the 13 studies were very diverse
in sociodemographic characteristics, and while some studies de-
scribed the entire screened population, others only described those
whose abuse status was identified through screening. Themajority
of women were Canadian, with over 9000 recruited toMacMillan
2006 and MacMillan 2009.
Pregnant women screened in antenatal settings were aged 30 years
or less (Carroll 2005; Kataoka 2010;Humphreys 2011). InCarroll
2005, among the 253 women, 84% were Canadian born; the ma-
jority were married with an even income spread and no or minor
concerns about their pregnancy. Similarly, although located in an
urban Japanese clinic, the 323 women in Kataoka 2010 were over-
whelmingly married (over 90%); around 60% were having their
first child; and around 80% had post secondary school qualifica-
tions, with 42% having college graduate or postgraduate qualifi-
cations.
In contrast, Humphreys 2011 described only those 50/410 preg-
nant women assessed as ’at risk’ for IPV at five San Francisco
bay antenatal clinics; their profile is consistent with disadvantage.
These 50 women were ethnically diverse: 17 were Hispanic, 11
were black or African-American, 15 were white, and seven were
from other backgrounds. Twenty-three had never married and 29/
50 had only high school education or less. The mean age was
28 years and 38 women had been previously pregnant. Women’s
mean gestational age was 20 weeks and 14 had smoked tobacco in
the past 30 days. Forty-three had been abused in the year before
pregnancy and 19 since pregnancy. Twelve had been abused one to
three times; four had been abused four to six times; and one more
than six times (two had missing data for frequency). Fraga 2014
involved women in amaternity setting who were one year postpar-
tum and had consented to be contacted a year earlier around the
time their baby was born. Although they do not provide sociode-
mographic information for the 915 women in this rapid report,
the sample from which women were drawn involved 2660 white
women, 9.7% of whom had experienced physical abuse during
pregnancy. Women who were abused were more likely to experi-
ence preterm birth compared to non-abused women (21% versus
6.8% respectively), and they were less educated and more likely
to be under 20 years of age, not cohabiting, have lower incomes,
and have received less antenatal care (Rodrigues 2008).
Klevens 2012a recruited 126 predominantly disadvantaged black
women (78.6%) from diverse women’s health clinics (obstetric,
gynaecological, and family planning) of a Chicago public hospital.
The women had a mean age of 35.8 years; either a high school
education or less (42.4%) or vocational/college (41.9%); and were
uninsured (57.1%) or had Medicaid (37.3%).
Women in emergency settings only were recruited fromurban hos-
pitals with ethnically diverse populations (Rhodes 2002; Rhodes
2006; Trautman 2007; Koziol-McLain 2010). These women
tended to be older. In the New Zealand study (Koziol-McLain
2010), 37.6% of 399 women were Maori and their median age
was 40 years. The women’s incomes were evenly spread but tended
to be in a low-income bracket; just under half (45.6%) had com-
pleted a post-school qualification other than a university degree
(8.3%). About 67.4% currently had partners; and 64.9% were
from the main urban area. In a Baltimore Level 1 trauma hos-
pital, the 411 women in Trautman 2007 were overwhelmingly
’non-white’ (83.9%); 41% were aged 35 to 54 years; the major-
ity (50.9%) had children at home; and 34.8% were on Medi-
caid insurance. While 42.3% were high school graduates, 30.5%
had not graduated from high school and 42.4% had an income
in the lowest quintile. Around one-half had physical and mental
health summary scores one or two standard deviations (SDs) be-
low norms. The 323 women recruited in Rhodes 2002 had similar
characteristics to the urban women in Rhodes 2006. The 1281
women in Rhodes 2006 were very diverse according to whether
they were recruited in an urban or suburban ED setting. In the
urban ED, 86% of 883 women were African-American (90% in
2002); had a mean age of 32 years (37 years in 2002); 35% had
a high-school diploma or less and 38% qualifications after high
school, but 53% had an income in the lowest quartile; 46% relied
onMedicaid (39% in 2002); and 51% were single (59% in 2002).
By contrast, in the suburban ED clinic, the median age of the 398
women was 36 years; 80% were white; 71% had post high-school
qualifications; the income spread was more even; 65% had private
insurance; and 43% were married with only 31% single.
Ahmad 2009 was the only study to be based solely in a family prac-
tice clinic affiliated with an urban academic hospital in Toronto,
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Canada. The mean age of the 293 women was 44 years; 34.5%
of women were born outside Canada; over half were married with
29% having children under 15 years of age living at home. Two-
thirds were employed full- or part-time with an even spread of
income, although just under one-third were in the lowest quintile.
MacMillan 2006 recruited 2461 women frommixed settings: two
family practices, two EDs, and two women’s health clinics. The
women’smean age was 37.1 years; 87%were born inCanada; 55%
were married; 46.6% had children at home; 52.2% were educated
for more than 14 years; 46.9% were working full- or part-time;
and 17.6% had incomes in the lowest quintile.
In the MacMillan 2009 study, 6743 women were also recruited
from mixed settings: 12 primary care clinics, 11 EDs, and three
obstetric/gynaecology clinics. Characteristics were only described
for the 411 women retained and 296 women lost to follow-up
(LTFU) since recruitment, but there was a clear trend to greater
abuse and disadvantage among those LTFU compared with those
retained. Compared to those LTFU, women retained were more
educated, less likely to be single, and had lower scores on the
Women Abuse Screen Tool (WAST) and Composite Abuse Scale
(CAS).
Fincher 2015 recruited 402 African-American women, with a
mean age of 27 years, who were attending aWomen, Infants, Chil-
dren’s (WIC) clinic in Atlanta, Georgia USA. This is an area of
high disadvantage with 19% of families living below the federal
poverty line and one in four of these families has a child under five
years of age. Nearly half of families receive food stamps; the ma-
jority are African-American households. The majority of respon-
dents were single (40%) or in an unmarried relationship (45%).
Fourteen per cent of respondents completed some high school ed-
ucation, and 30% had received a high school degree.
Screening intervention
Screening tools
The screening tools applied in these studies as part of the in-
tervention were very heterogeneous. The majority employed an
IPV-specific validated screening instrument, with some studies
using more than one tool. Included interventions always con-
sisted of face-to-face or healthcare professional-involved screening.
Ideally this was compared to usual care (with no enquiry about
IPV). However, there were instances of a screening instrument
being applied in the control arm through, for example, comput-
erised or written enquiry, which was tolerated providing those re-
sults were not processed by any clinical staff. The tools used in
one or more arms of trials were: Woman Abuse Screening Tool
(WAST) (MacMillan 2006; MacMillan 2009); Abuse Assessment
Screen (AAS) (Rhodes 2006; Ahmad 2009; Koziol-McLain 2010;
Humphreys 2011; Fraga 2014); Partner Violence Screen (PVS)
(MacMillan 2006; Trautman 2007; Ahmad 2009; Koziol-McLain
2010; Klevens 2012a); Violence Against Women Screen (VAWS)
(Kataoka 2010); and Revised Conflict Tactics Scale (CTS) - Short
Form (Fincher 2015). Rhodes 2002 adapted questions from the
AAS and PVS and others. In several cases, omnibus screening
aimed to assess a range of psychosocial problems (e.g. to assess a
range of health issues in pregnancy or to diminish stigma around
the true purpose of the study), of which IPV was only one (e.g.
Ahmad 2009; Humphreys 2011). In Carroll 2005, the Antenatal
Psychosocial Health Assessment (ALPHA) tool assessed a range of
psychosocial issues such as child abuse and depression; the IPV
questions contained in the ALPHA are derived from the WAST
(Carroll 2005). The validity of these tools is also heterogeneous
and thoroughly reviewed in Feder 2009 (p 29). Often, data col-
lected through the screening intervention fed into the primary
identification outcome data.
Screening methods and strategies
Studies used different modes of applying the screening tools in-
dicated above in intervention and comparison groups. Five inter-
ventions involved a computer-assisted self completion screening
process with positive results being conveyed to providers (Rhodes
2002; Rhodes 2006; Trautman 2007; Ahmad 2009; Humphreys
2011). MacMillan 2009 used written methods in their inter-
vention arm before conveying results to healthcare professionals.
Carroll 2005, MacMillan 2006, Kataoka 2010, Koziol-McLain
2010, and Fraga 2014 included face-to-face screening where the
healthcare professionals themselves screened the women. Kataoka
2010 selected a written enquiry method as the comparison com-
pared with face-to-face screening, but since it was face-to-face, this
method guaranteed the result was processed by a healthcare profes-
sional; in this study we treated face-to-face screening as the inter-
vention. Klevens 2012a compared healthcare professional screen-
ing with audio computer-assisted self interviews (A-CASI) screen-
ing. Fraga 2014 had three groups, but we combined the two arms
that involved social worker screening (face-to-face and telephone)
and compared it to a group that received a questionnaire by post. In
Fincher 2015, women attending a community health programme
(WIC services) received face-to-face screening by trained health-
care professional researchers who provided information and re-
sources on issues, including healthy relationships. As this was the
only included study that had researchers, as opposed to health-
care professionals, deliver the face-to-face screening, we excluded
it from our primary analysis as, ultimately, the data were not part
of the clinical context.
Comparisons
Six studies compared IPV screening with usual care (Rhodes 2002;
Carroll 2005; Rhodes 2006; Ahmad 2009; MacMillan 2009;
Koziol-McLain 2010). Humphreys 2011 compared IPV screen-
ing and clinician follow-up with researcher-based IPV screening
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where results were not provided to the clinician. Written self com-
pletion was used in one arm of MacMillan 2006 (which we used
as a comparison arm) and they used computerised self comple-
tion in another (which we also treated as comparison). Trautman
2007 compared screening that included questions about IPV with
screening for other issues that did not include IPV, and both sets
of results were passed on to clinicians. Kataoka 2010 compared
face-to-face screening interview by a healthcare professional with
a self administered questionnaire and Klevens 2012a compared A-
CASI screening with the same screen administered by the clini-
cian. Fraga 2014 compared screening by social workers to a group
that received a questionnaire by post.
We treated groups where women self completed IPV questions but
with no follow-up or involvement of clinicians, and screening for
health issues without reference to IPV, as ’usual care’ conditions.
Outcomes and outcome measures
Identification (including discussion or detection)
All but one study, Koziol-McLain 2010, in some way measured
the identification of IPV using various screening modes and tools.
However, this was not always a form of clinical identification,
with some studies gathering what was more akin to prevalence
data according to different modes of screening (MacMillan 2006;
Kataoka 2010; Fincher 2015), rather than information for use in
the clinical domain. There were instances where clinical identifi-
cation data were recorded but did not lend themselves to meta-
analysis because they were not measured consistently across arms
of the trial (Klevens 2012a). Thus, we combined these four studies
in a meta-analysis of non-clinically based identification based on
face-to-face screening versus other screening techniques.
Eight studies measured identification such that it could be defined
as clinical identification of IPV from screening and we used this in
our primary analyses (Rhodes 2002; Carroll 2005; Rhodes 2006;
Trautman 2007; Ahmad 2009; MacMillan 2009; Humphreys
2011; Fraga 2014). These data were gathered through providers’
and women’s self report about what had occurred during the con-
sultation, chart review/clinical documentation, and audio-record-
ings of clinical encounters.
Information-giving, referral, and uptake of services
While most studies included some assessment of the provision of
information, referral, and women’s service use, measurement of
these outcomes varied enormously. First, the provision of infor-
mation or resources was already linked to the majority of inter-
ventions and received by women who took up the intervention.
For example, a computer print-out of resources or information
pamphlets commonly occurred as part of the intervention. Thus,
it was not appropriate for us to treat it as an outcome of screening
interventions. Another example can be found in Rhodes 2006,
where provision of services was defined as safety assessment, coun-
selling by the healthcare providers, and provision of information
on resources; to measure these would be more in keeping with an
assessment of fidelity since these are features of the intervention,
rather than outcomes of a screening intervention.
Studies also varied greatly in how they defined referral. For ex-
ample, Klevens 2012a made reference to three types of ’referral’
- healthcare professional, A-CASI plus provider support, and A-
CASI alone, but this was more about how women in the different
arms self referred based on the list of resources provided to them in
each trial arm. We were interested to know if screening interven-
tions increased women’s formal referral to other internal and ex-
ternal support services, with this information being derived from
medical records or self report by participants or even data from ser-
vices to indicate the number of women referred to them.However,
only two studies treated referral in this way and were included in
a meta-analysis (Trautman 2007; Ahmad 2009). Trautman 2007
examined differences in the numbers referred to social work by the
treating staff at the ED and Ahmad 2009 used audio-recordings
of consultations to determine if women were referred. Ahmad also
checked if any arrangements were made for follow-up appoint-
ments but this was not included in the referral data.
Uptake of services suffered similar difficulties, encompassing dif-
ferent variables for different studies where some looked at specific
uptake based on the resources that were flagged (Trautman 2007;
Klevens 2012a), and others look at a more general uptake of com-
munity services (Koziol-McLain 2010). Consequently, we were
unable to include data on uptake of services in a meta-analysis.
Intimate partner violence
MacMillan 2009 and Koziol-McLain 2010 included level of expo-
sure to IPV (using the CAS, Hegarty 2005) as a primary outcome.
Women’s health and quality of life
MacMillan 2009 included quality of life as a primary outcome (as-
sessed with the WHOQuality of Life-Bref ), but included in their
secondary outcomes: general health (Short Formhealth survey - 12
(SF-12)), depressive symptoms (Center for Epidemiologic Studies
- Depression Scale (CES-D)), post-traumatic stress disorder (Star-
tle, Physiological arousal, Anger, and Numbness (SPAN)), alcohol
use or dependency (Tolerance, Worried, Eye-opener, Amnesia, K/
Cut Down (TWEAK), and Drug Abuse Screening Test (DAST)).
Adverse and other outcomes
Ahmad 2009 included advice for follow-up and patient comfort
with screening, and need to consult with the nurse after screening.
Carroll 2005,MacMillan 2006, Kataoka 2010, andKlevens 2012a
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measured comfort and preference for mode or satisfaction with
the screening process.
Koziol-McLain 2010measured safety behaviours and resource use.
Rhodes 2006 measured provision of domestic violence services,
and Trautman 2007, MacMillan 2009 and Klevens 2012a mea-
sured services usage rates.
MacMillan 2009 measured potential harms using the Conse-
quences of Screening Tool (COST) (MacMillan 2009).
Excluded studies
We excluded 43 studies for the following reasons.
1. Fifteen studies because screening was accompanied by an
intervention that exceeded our criteria for a ’brief intervention’
(Duggan 2004; Green 2005; Curry 2006; Jewkes 2008; Gillum
2009; Cripe 2010; Kiely 2010; Tiwari 2010; Florsheim 2011;
Taft 2011; Subramanian 2012; Hegarty 2013; Kiely 2013;
Saftlas 2014; Wagman 2015).
2. Seven studies because they were not randomised or quasi-
randomised controlled trials (Furbee 1998; Larkin 1999; Knight
2000; Bonds 2006; Halpern 2009; Hewitt 2011; Kapur 2011).
3. Five studies because the results were not passed on to the
healthcare professional according to our criteria (Bair-Merritt
2006; Houry 2011; Klevens 2012b; Beatty 2014; Hoelle 2014).
4. Three studies because they tested educational interventions
and did not supply data on women (Coonrod 2000; Brienza
2005; Fernández Alonso 2006).
5. Three studies because they targeted children and clinicians
(Dubowitz 2011; Feigelman 2011; Dubowitz 2012).
6. Three studies because there was no usual care comparison
(Chen 2007; Ernst 2007; Rickert 2009).
7. Three studies because they were case-finding not screening
trials (Thompson 2000; Campbell 2001; Feder 2011).
8. Two studies because screening results were passed on to the
healthcare professional in both usual care and intervention
groups (Hollander 2001; Taft 2012).
9. One study because it was not conducted in a healthcare
setting (Robinson-Whelen 2010).
10. One study because the population were parents and data
could not be disaggregated (Garg 2007).
Risk of bias in included studies
Our risk of bias judgements are summarised below and in Figure
2 and Figure 3. Further detail can also be found in the ’Risk of
bias’ tables beneath the Characteristics of included studies tables.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Random sequence generation
Nine studies described reliable low-risk random sampling strate-
gies (Carroll 2005; MacMillan 2006; Rhodes 2006; Ahmad
2009; MacMillan 2009; Kataoka 2010; Koziol-McLain 2010;
Humphreys 2011; Klevens 2012a), but two used methods with a
high likelihood of systematic bias: Trautman 2007 used consec-
utive enrolment periods and Rhodes 2002 used alternate alloca-
tion. Fincher 2015 and Fraga 2014 provided no description of
the sequence generation in their report so we contacted them for
information but were unable to gain a comprehensive account of
the procedures.
Allocation concealment
Rhodes 2006, Ahmad 2009, Koziol-McLain 2010, Humphreys
2011, Kataoka 2010, and Klevens 2012a described reliable pro-
cedures to conceal the allocation of participant status. In Carroll
2005, Fraga 2014, and Rhodes 2002, there was inadequate in-
formation to judge whether or not bias could have been intro-
duced. In MacMillan 2006 and MacMillan 2009, monthly calen-
dars showing shift allocation for site co-ordinators was the chosen
method. Recruiters with knowledge of this allocation could have
introduced bias with selective recruitment. A process with simi-
lar potential for bias was used in Trautman 2007. Fincher 2015
was also considered at high risk of bias because there was no de-
scription of how the assignment was managed/concealed, and re-
cruiters were also the interviewers for the face-to-face group so it
is possible that they knew the allocation at the time of recruiting
women.
Blinding
Blinding of participants and personnel (performance bias)
It is very difficult to blind healthcare professionals in a screening
trial, especially when IPV screening results are attached to the pa-
tients’ files. All studies suffered from high risk of performance bias
with the exception of Kataoka 2010 and Fraga 2014, where we
judged that it was unclear whether bias could have affected out-
comes. Protocols to minimise performance bias (Koziol-McLain
2010) and blinding clinicians to the overall purpose of the study
(Ahmad 2009) were stated strategies to minimise this type of bias,
but similar to the remaining studies, knowledge that theywere in a
trial, and patients’ screening results attached to their files increased
the possibility of performance bias. The problem of performance
bias differentially affecting outcomes in the women participants
was likely greater where an intervention was compared to standard
or usual care (Ahmad 2009; Koziol-McLain 2010), as opposed to
using an alternative screening approach.
Blinding of outcome assessment (detection bias)
We judged detection bias to be low in four trials where steps
had been taken to actively blind: interviewers (MacMillan 2009;
Koziol-McLain 2010), chart reviewers (Rhodes 2002), and those
coding audio-recordings (Ahmad 2009). In Kataoka 2010, the
likelihood of detection bias was reduced as there was no clear in-
tervention or comparison group (it was questionnaire versus face-
to-face screening) or study hypothesis, and we only used data from
the first screening (there had been three in total). The risk of detec-
tion bias was unclear in Rhodes 2006, Fincher 2015, Fraga 2014,
and Trautman 2007.Healthcare professionals aware of participant
IPV status gave estimates of their levels of concern in Carroll 2005
andmay have overestimated their levels of concern. InHumphreys
2011 and Klevens 2012a, research staff collecting outcome data
may have been able to detect which study arm a woman was in
(as there was no indication that they were blinded) and this may
have biased outcome detection.
Incomplete outcome data
Three studies were at high risk for attrition differentially affect-
ing groups (Carroll 2005; Ahmad 2009; Fraga 2014). In Ahmad
2009, LTFU was low, but sensitivity analyses suggest missing data
potentially affected the results; this was further confirmed by im-
putation in an intention-to-treat analysis. Unbalanced provider
attrition (nine in the intervention group versus three in the control
group) in Carroll 2005 risks bias, even though participant data
loss was low and evenly spread (7.5%). In Fraga 2014, the postal
questionnaire group suffered from high attrition (70/305; 23%).
Trautman 2007 attained 100% retention as data were collected
immediately. Kataoka 2010 had no more than 10% LTFU across
both intervention and control groups but this was across all three
screenings, and there was no attrition when data were collected for
the first screening (the data used in the review). MacMillan 2006
had approximately 5% attrition depending on the screening tool
used. We judged these studies, along with Klevens 2012a, to be at
low risk of bias from LTFU. The study conducted by MacMillan
2009 resulted in 42% attrition overall, with participants missing
not at random (more severely abused women likely to be lost)
suggesting the observed effect may be biased. Multiple imputation
in MacMillan 2009 for missing data did reduce the effect size and
given that the study accounted for missing data, we judged it to
be low risk.
Humphreys 2011, while making conservative assumptions about
missing data, did not give the reasons for attrition making it dif-
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ficult to judge whether assumptions were appropriate. Koziol-
McLain 2010 reported 13.8% LTFU missing at random but did
not provide reasons for LTFU, making it difficult to judge. Rhodes
2002 gave an inadequate account of the reasons for the 20%miss-
ing chart reviews and the 32%patient attrition, and 21%providers
refusing recording probably biased the effects found in Rhodes
2006. In Fincher 2015, 12% of women dropped out of the com-
puter group compared to 4% in the face-to-face group but we
were unable to obtain any information on these women and it
is unclear at what stage that occurred. At two weeks, 31.8% of
women completed a follow-up suggesting high attrition but we
do not know if there was differential dropout and, in any case,
we were unable to incorporate the two-week data as they were not
reported.
Selective reporting
Publication of protocols and trial registration reduce the risk of se-
lective reporting. MacMillan 2006, Ahmad 2009, Kataoka 2010,
Koziol-McLain 2010, Humphreys 2011, and MacMillan 2009
were registered, but the lack of study protocols across studies made
the analysis and primary outcomes difficult to access. Registered
trials were considered low risk if there was no indication of se-
lective reporting in the report (e.g. we checked that all outcomes
were reported at all time points). These included Ahmad 2009,
Kataoka 2010, MacMillan 2006, and MacMillan 2009. There
was indication of selective reporting in Koziol-McLain 2010 based
on an inconsistency between the outcomes as registered and re-
ported. In three additional studies, certain outcomes were omit-
ted (Carroll 2005; Humphreys 2011; Fincher 2015), and the risk
was unclear in five studies (Rhodes 2002; Rhodes 2006; Trautman
2007; Klevens 2012a; Fraga 2014).
Other potential sources of bias
We judged the potential for contamination in comparison groups
of women to be high across a large proportion of studies
(Rhodes 2002; Rhodes 2006; Trautman 2007; Ahmad 2009;
MacMillan 2009; Humphreys 2011; Klevens 2012a), and low in
Koziol-McLain 2010. A high proportion (21.5% compared to
15.7%) of low-income women in the computer-based group may
have biased screening results in MacMillan 2006, and Kataoka
2010 acknowledges her measurement had psychometric property
limitations with low specificity. The extent of bias from other
sources was unclear in Carroll 2005, Fincher 2015, and in Fraga
2014, where there were imbalances at baseline and we found no
reference to account for these in analyses. Also, there had been
prior research involvement of the cohort of women in a study
about IPV during pregnancy 12 months earlier (Rodrigues 2008),
but this was not addressed.
Effects of interventions
See: Summary of findings for the main comparison; Summary
of findings 2
Screening versus control (no screening/usual care;
clinician not notified of screening results)
Primary outcomes
A. Identification of intimate partner violence (IPV) by health
professionals
Eight of 13 included studies measured identification of female pa-
tients experiencing IPV in ways that could be combined (Rhodes
2002; Carroll 2005; Rhodes 2006; Trautman 2007; Ahmad 2009;
MacMillan 2009; Humphreys 2011; Fraga 2014). In most stud-
ies, the proportion of women identified was small, and ranged
from 3% to 17%. With the exception of Fraga 2014 (where 9%
(n = 86) of women were lost to follow-up between recruitment/
randomisation and delivery of the intervention a year later), we
used the number of women randomised as the denominator to
establish identification rates, rather than the number of women
who received the intervention or the number with abuse at base-
line. We also made conservative assumptions about identification
in four cases. In Ahmad 2009, we have taken cases as detected,
rather than the broader ’discussion opportunity’ as the measure of
identification. In Trautman 2007, we were not able to distinguish
identification by healthcare professionals from those detected by
research staff in the study report, and therefore have only included
the numbers of cases documented in patient records, as these were
entered by healthcare professionals only. While MacMillan 2009
did not specify identification as an outcome, we were able to es-
timate figures using the reported proportions of women who dis-
cussed IPV with their clinicians, based on self report following
clinical encounters (88/199 screened women (44%) compared to
17/212 (8%) of non-screened women). To allow the data to be
comparable to other studies in the meta-analysis, we expressed the
cases of women that discussed abuse as a proportion of all women
randomised to the screened or non-screened groups. However, it is
important to point out that these denominators included women
with negative and mixed results on the Women’s Abuse Screen-
ing Tool and we do not know how many of these women had
discussions about abuse with clinicians. In Rhodes 2002, we have
only included those detected by chart review. We confirmed our
calculations of the women included in the study with the author.
On average, screening interventions more than doubled the iden-
tification of women experiencing abuse compared with control
groups (odds ratio (OR) 2.95, 95% confidence interval (CI) 1.79
to 4.87, eight studies, n (number of women) = 10,074, I² = 66%;
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Analysis 1.1).We downgraded the quality of the evidence to mod-
erate due to heterogeneity. This moderate level of (methodologi-
cal) heterogeneity owed to the MacMillan 2009 study being very
large relative to other studies in the analysis. Removing it in sen-
sitivity analysis, the OR was 2.35 (95% CI 1.53 to 3.59, seven
studies, n = 4393, I² = 38%; analysis not shown).
Rates of missing data were low for the identification outcome
among studies included in the meta-analysis, with nearly all ran-
domised women being included in the analysis (see Characteristics
of included studies). There was one exception where just 66%
of women in the intervention group and 70% of women in the
control group were successfully audiotaped (Rhodes 2006). Thus,
there may have been participation bias with women who found
the recording uncomfortable declining it. Removing this study
in a sensitivity analysis slightly increased the odds of identifying
abusedwomen through screening (OR2.74, 95%CI 1.65 to 4.53,
six studies, n = 3112, I² = 33%; analysis not shown).
Subgroup analyses: type of healthcare setting
We excluded one of the eight studies that reported clinical iden-
tification data from the analysis by setting - MacMillan 2009 in-
cluded multiple healthcare settings and we did not have access to
the disaggregated data.
Antenatal clinics
Two studies tested screening in antenatal settings (Carroll 2005;
Humphreys 2011). The OR for screening to identify victims of
abuse compared to no screening was 4.53 (95% CI 1.82 to 11.27,
two studies, n = 663, I² = 0%; Analysis 1.2). In this setting, we esti-
mated that there could be over 300% likelihood of increased iden-
tification by healthcare professionals in screened pregnant popula-
tions. However, the studies were small and therefore more subject
to sampling variation. We downgraded the quality of the evidence
to moderate on account of imprecision.
Maternal health services
In one study, based in an obstetrics department with women who
were one year postpartum (Fraga 2014), the OR for screening
to identify victims of abuse compared to no screening was 2.36
(95% CI 1.14 to 4.87, n = 829; Analysis 1.2). We downgraded
the quality of this evidence to moderate on the basis of risk of bias
(see ’Characteristics of included studies’).
Emergency departments (EDs)
Three studies evaluated identification from screening in emer-
gency department (ED) settings (Rhodes 2002; Rhodes 2006;
Trautman 2007). In this setting, the OR was 2.72 (95% CI 1.03
to 7.19, three studies, n = 2608, I² = 65%; Analysis 1.2). We
downgraded the quality of the evidence to moderate due to statis-
tical heterogeneity (I² > 50%). With regards to the source of this
heterogeneity, there was clinical diversity in Rhodes 2002 as the
intervention had also targeted men and a notably high proportion
(> 90%) of participants were African-American. Further, it was a
relatively small study, highlighting its methodological diversity. In
a sensitivity analysis, we removed Rhodes 2002, which reduced
the odds that screening identifies women in this setting, but im-
proved the precision of effect estimates and reduced heterogeneity
(OR 1.72, 95% CI 1.11 to 2.66, two studies, n = 2286, I² = 0%;
analysis not shown).
Hospital-based primary care
One moderate quality study evaluated identification from screen-
ing in primary care (Ahmad 2009). In this setting, screening did
not increase identification (OR 1.53, 95% CI 0.79 to 2.94, n =
293; Analysis 1.2).
Subgroup differences
Results were fairly consistent across location subgroups, suggesting
that screeningwas similarly effective in all of the healthcare settings
studied (Chi² = 3.74, df = 3 (P value = 0.29), I² = 19.7%; Analysis
1.2).
Individual studies not included in the meta-analysis
We excluded five studies from the primary meta-analysis of iden-
tification of exposure to IPV. Koziol-McLain 2010 did not as-
sess it. Kataoka 2010 reported prevalence (as opposed to data on
the clinical encounter) for written (29%, 48/163) versus face-
to-face (19%, 32/165) enquiry. We excluded Fincher 2015 from
the meta-analysis for similar reasons. However, in contrast with
Kataoka 2010, they found that face-to-face screening in women
one year postpartum increased disclosure of prior-year IPV (44%,
84/191 versus 28%, 50/177) and lifetime exposure (54%, 103/
191 versus 44%, 76/177) compared to computer-assisted screen-
ing. MacMillan 2006 also used this design, although their study
contained many more possible interactions as they used different
tools, settings, and methods. They reported 12-month prevalence
rates that ranged from 4% to 18% across primary care, emergency
departments, and women’s clinics. The highest proportions were
identified in emergency settings (n = 768), ranging from 10.9% of
women when the Partner Violence Screen (PVS) was used in face-
to-face interviews up to 17.7% for the computerised version of the
PVS. In primary care (n = 814), proportions ranged from 5.4% on
the paper-based Women’s Abuse Screen Tool (WAST) to 11.6%
on the face-to-face PVS.Women’s health clinics (n = 879) reported
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the lowest prevalence, from 4.1% (face-to-face PVS) to 10.0%
(face-to-face WAST). In Klevens 2012a, disclosure to healthcare
professionals (8.7%, 4/46) was compared to CASI (21.3%, 17/
80). Although three women (of 80) in the CASI group later dis-
cussed abuse with the healthcare professional, we excluded it as
identification was not consistently measured as clinical data across
groups.
Given that there were four studies that investigated the identifi-
cation of abused women using a non-clinically based approach
(more consistent with investigating prevalence rates), we com-
pared face-to-face enquiry with computer-based (Klevens 2012a;
Fincher 2015), or written assessment of IPV (Kataoka 2010), or
both (MacMillan 2006). For Kataoka 2010, we used data from the
first screening only (it was followed up by two additional screening
interventions). ForMacMillan 2006, we used the data reported on
the PVS only (the computer and paper-based groups completed
both the PVS and WAST with the face-to-face consisting of one
or the other) as it was more conservative estimate than the data
derived from the WAST. We combined the two groups of women
that had computer- or paper-based screening and compared them
to the women who had the face-to-face screening on the PVS.
Neither face-to-face screening nor written/computer-based tech-
niques were favoured for identifying abused women (OR 1.12,
95% CI 0.53 to 2.36, four studies, n = 2765, I² = 83%; Analysis
2.1). We downgraded this evidence to moderate quality due to
statistical heterogeneity. One study favoured face-to-face screen-
ing (Fincher 2015). The other three suggested no difference be-
tween face-to-face and written/computer techniques for identi-
fying women (MacMillan 2006; Kataoka 2010; Klevens 2012a).
The risk of bias was greatest for the Fincher 2015 study. In re-
moving this study in a sensitivity analysis, heterogeneity remained
high and one technique was not favoured above the other (OR
0.88, 95% CI 0.36 to 2.15, three studies, n = 2397, I² = 73%;
analysis not shown). The heterogeneity in this analysis was likely
due to clinical diversity across studies (different countries, health-
care settings, and participant characteristics) and methodological
differences (large variation in sample sizes and study quality).
B. Information-giving and referrals to support agencies by
healthcare professionals (including uptake rates)
We were able to include two studies in our investigation of health-
care professional referrals (Trautman 2007; Ahmad 2009). In the
case of Trautman 2007, a narrow definition of referral was adopted
(social work assistance only), suggesting that referral to other sup-
port services was not counted. Furthermore, we only included
cases verified by medical records, which may be an underestimate
of the number of women who were referred by healthcare profes-
sionals without verification in charts. Ahmad 2009 audio-recorded
all consultations for women in both arms of the trial. There was
no evidence of an effect of screening interventions on increasing
referrals to supportive services (OR 2.24, 95% CI 0.64 to 7.86, I²
= 0%, n = 1298; Analysis 1.3). We downgraded the evidence to
low quality due to imprecision and risk of bias issues, particularly
in the Trautman 2007 study.
Data on information-giving and uptake of services were too het-
erogeneous to be pooled in a meta-analysis. We treated health-
care professionals discussing safety with abused women as a form
of information-giving. Only Ahmad 2009 reported on the extent
to which physicians assessed patient safety following identifica-
tion, and confirmed that physicians discussed safety with nine of
the 25 women detected in the screened group and with only one
woman in the control group. Ahmad 2009 reported that, of the
25 women detected, 20 (80%) were asked for follow-up appoint-
ments in the intervention arm, whereas only eight (67%) of the 12
women identified in the comparison arm were invited for follow-
up appointments. Klevens 2012a found that, after one week, 4/36
(11%) who were screened by a healthcare professional had taken
up services from the printout provided to women who screened
positive compared to 2/66 (3%) of women in the computer-based
screening groups. No participant had contacted the domestic vio-
lence advocacy programme in the hospital, but the study was un-
able to investigate the reasons. Rhodes 2006 assessed IPV-related
services provided during the visit (which combined safety assess-
ment, counselling by the healthcare professional provider or social
worker, and referrals to domestic violence resources) to women
in the screened group compared to usual care group, in separate
groups of urban and suburban women. Of screened women, 25/
421 (5.9%) received services compared to 10/443 (2.3%) of un-
screened women. Trautman 2007 found that 18/411 (4.4%) of
screened women received social work assistance for IPV compared
to 2/194 (1%) in the comparison arm.
Secondary outcomes
C. Intimate partner violence
Two studies measured the effect of screening on reduction of IPV
among screened compared to non-screened women and used the
same measure (Composite Abuse Scale; CAS) (MacMillan 2009;
Koziol-McLain 2010). However, the denominators and timelines
were different: Koziol-McLain 2010 measured IPV reduction at
three months post-baseline among all women, while MacMillan
2009 measured reduction of IPV among abused women at six, 12,
and 18 months following screening. Therefore, we have presented
their results separately. Both studies reported point estimates for
ORs that were consistent with a decrease in IPV as a result of
screening, however, results did not reach statistical significance. At
18 months, MacMillan 2009 reported an OR of 0.88 (CI 0.43 to
1.82, n = 707 (multiple imputation used to account for women
lost to follow-up (LTFU))). At threemonths, Koziol-McLain 2010
found an adjusted OR of 0.86 (95% CI 0.39 to 1.92, n = 344).
Koziol-McLain 2010 also assessed whether women reported using
more safety behaviours in the screened versus control group and
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found an OR of 1.41 (CI 0.71 to 2.81), suggesting no significant
difference between groups.
D. Women’s perceived and diagnosed physical health
outcomes
Only one study measured physical health (SF-12) after screening
(MacMillan 2009). At 18 months, self reported physical health
had increased in the screened group, but it was not significant,
with a mean difference (MD) of 1.57 (95% CI -0.59 to 3.73, n =
707).
E. Women’s psychosocial health
MacMillan 2009 is the only study to have measured our other
secondary outcomes in the important area of psychosocial health.
While the study measured most of the factors of interest (depres-
sion and mental health in general, post-traumatic stress disorder
(PTSD), alcohol problems, drug problems, and quality of life) at
each time point, we only report those at 18 months, which was
the study’s final measurement point. We cite the imputed figures
and more conservative figures. The study suffered considerable
attrition (42%). While the complete case (n = 411) effect sizes
are greater than those imputed (n = 707) in the published paper,
the imputation method (requested from the author (MacMillan
2011 [pers comm])) assumed missing-at-random, however those
LTFU had higher scores on the CAS, which suggests a potential
underestimate of effect.
1. Depression - the observed figures found a MD of -2.32
(95% CI -4.61 to -0.03) among screened versus unscreened
abused women, consistent with a decrease in depression as a
result of screening. However, this reduced to -1.97 (95% CI -
4.33 to 0.39) with imputation for LTFU and was no longer
statistically significant.
2. PTSD - the data suggested no difference between screened
and non-screened women for PTSD (OR 0.63, 95% CI 0.36 to
1.10).
3. Mental health in general (as assessed by the SF-12) -
screening did not significantly improve the mental health of
screened abused women as the mean improvement of 1.05 in SF-
12 scores (95% CI -1.70 to 3.79) crossed the line of no
significance in both observed and imputed analyses.
4. Quality of life (as assessed by the WHO Quality of Life-
Bref ) - screened women showed more rapid improvement in
quality of life (3.74 points higher; 95% CI 0.47 to 7.00),
however the imputed data suggested that there was no difference
between screened and non-screened women (MD 2.29, 95% CI
-1.71 to 6.28).
5. Alcohol problems - the data suggested no difference
between screened and non-screened women as regards risk of
alcohol problems (OR 1.23, 95% CI 0.62 to 2.44).
6. Drug problems - the data suggested no difference between
screened and non-screened women as regards risk of drug
problems (OR 0.83, 95% CI 0.41 to 1.71).
F. Occurrence of adverse outcomes
Included studies measured women’s preferences for screening
method (MacMillan 2006), acceptability (Ahmad 2009; Koziol-
McLain 2010), comfort levels (Kataoka 2010), positive and nega-
tive reactions (Klevens 2012a), overall satisfaction (Rhodes 2006),
and harm from screening (MacMillan 2009).Negative reactions to
screening at oneweekwere reported as negligible inKlevens 2012a.
At three months, Koziol-McLain 2010, situated in an emergency
setting, reported that 82% of women agreed that “health care
providers should routinely ask all women about difficulties in
home life and relationships”. They found no adverse effects in
participants, clinicians, or researchers. Rhodes 2006 found that
enquiry about and disclosures of IPV were associated with higher
patient satisfaction with care. Fincher 2015, in seeking to under-
stand contextual issues that enable disclosure, reported that race-
matching of women and interviewers had no impact on disclo-
sure rates of IPV. In the Ahmad 2009 hospital-based primary care
study, acceptance of computer-assisted screeningwasmeasured us-
ing the Computerized Assessment Lifestyle Scale (CLAS) (Ahmad
2008). It examines patient perceptions of screening for a number
of health and lifestyle issues and the quality of the subsequent
medical consultation. Although women had some concerns about
privacy and interruptions to their interaction with the healthcare
professional, on average, women agreed that screening was benefi-
cial (mean CLAS score 3.8, standard deviation (SD) 0.67). Scores
were not influenced by IPV status.
Themost rigorous assessment of harm from IPV screening was un-
dertaken by MacMillan 2009. Across various health settings, they
used a specifically developed tool - the Consequences of Screen-
ing Tool (COST) (MacMillan 2009) - to assess the effects of be-
ing asked IPV screening questions. Among the COST questions,
they analysed the eight-item Effects on Quality of Life subscale
as it applies to women who received the screening intervention
regardless of their abuse status. Items are scaled from two to minus
two (range 16 to -16), with negative scores reflecting harm. The
COST was administered to a subset of 591 women interviewed at
baseline only (within 14 days of the index visit), comprising 227
women who screened positive for abuse, 206 with mixed screen
results, and 158 who screened negative. The mean score of 3.52
(SD 3.24) on the eight-item Effects on Quality of Life subscale
supported the view that being asked IPV screening questions was
not harmful to women, in the short term at least. There was no
variation by abuse group; the mean scores were 3.7 (SD 3.2) for
women who scored negative on both the WAST and CAS, 3.3
(SD 3.3) for those who had mixed results, and 3.5 (SD 3.4) for
those who scored positive on both measures (data obtained from
the authors). No study examined harm or adverse outcomes be-
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yond three months, with the majority of studies measuring these
outcomes on the day that screening took place, and up to two
weeks later.
G. Services and resource use
There was overlap between this set of outcomes and women’s take-
up of services as presented in B above. In B, we described service
use/uptake that was linked to the healthcare visit (e.g. services to
which they were referred or were prompted to access from infor-
mation provided), whereas here we present women’s use of general
services. Koziol-McLain 2010 found no differences in resource use
based on the Community Resource Checklist after three months.
MacMillan 2009 presented women’s self reported use of violence-
related services (“for descriptive purposes only”) using a six-month
time frame at baseline, six-, 12-, and 18-months. Rates for service
use by screened versus non-screened women were not significantly
different: 75% versus 71% at baseline and 65% versus 64% at 18
months.
H. Cost-benefit outcomes
We found no studies that reported any data on cost-benefit or any
other economic evaluation of interventions.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Face-to-face screening compared with written/computer-based screening for IPV
Patient or population: women attending healthcare settings for any health-related reason
Settings: healthcare
Intervention: face-to-face screening for IPV
Comparison: written/computer-based screening
Outcomes Face-to-face screen-
ing for IPV
Written/computer-
based screening
Effect Number of partici-
pants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Relative effect
(95% CI)
Absolute effect (95%
CI)
Identification of IPV
(non-clinically based,
assessed
immediately)
139/806 (17.2%) 247/1959 (12.6%) OR 1.12 (0.53 to 2.
36)
13 more per 1000
(from 55 fewer to 128
more)
2765 (4) ⊕⊕⊕©
Moderate1
24.8% 22 more per 1000
(from 99 fewer to 190
more)
CI: Confidence interval; GRADE: Grades of Recommendation, Assessment, Development, and Evaluation; IPV: intimate partner violence; OR: odds ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded due to heterogeneity.
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D I S C U S S I O N
Summary of main results
We identified 13 controlled studies of screening for intimate part-
ner violence (IPV) in healthcare settings. These recruited 14,959
women. Studies were conducted in diverse healthcare settings (an-
tenatal and women’s health clinics, emergency departments (ED),
primary care centres) in predominantly urban settings, in high-in-
come countries. These were countries with domestic violence leg-
islation and developed support services to which healthcare pro-
fessionals could refer. Follow-up periods also varied, from immedi-
ately to one month post-intervention for identification outcomes,
and up to 18 months post-intervention for violence and health
outcomes. A range of different screening tools and techniques were
applied but the review inclusion criteria stipulated inclusion of
interventions that involved screening by, or notification of posi-
tive results to, healthcare professionals. Five studies involved com-
puter-based screening with positive results conveyed to healthcare
professionals. One study used paper-based screening before noti-
fying treating physicians. Seven involved face-to-face or telephone
screening by the healthcare professional. Of the 13 studies, eight
measured clinical identification in both the intervention and com-
parison arm and four studies compared screening techniques based
on identification rates that were not embedded in the clinical con-
text. In these studies, women’s data were managed by researchers
only, or the clinical encounter/records were not accessible in the
two groups (or both), and therefore we dealt with these studies
separately. Only one study discussed the implications of non-dis-
closure or false measurement on the outcomes.
Screening inhealthcare settings is a complex intervention in a com-
plex context, and an optimal evaluation requires multi-methods to
illuminate the reasons for any successes or failures (Spangaro 2009;
May 2011; Catallo 2013a; Catallo 2013b). Globally, the barriers
to screening by healthcare professionals may reside at the individ-
ual professional level (lack of training and resources, fear of inad-
equate skills to address the problem, lack of time, unfavourable
attitudes to the problem), at the clinic or team level (lack of sys-
tems for safety, supervision, and links with referral agencies), or at
the wider political level (violence-tolerant societies, other health-
care priorities for funding, and services such as lack of funding for
law enforcement or domestic violence services) (Colombini 2008;
García-Moreno 2014). This understanding of an intervention was
not adequately acknowledged in the included studies and is often
overlooked in trial reporting. There was variability in the descrip-
tion provided about the wider organisational contexts and how
healthcare professionals were trained and supported to undertake
screening. Very few conducted or reported process evaluations.
Similarly, the sustainability of healthcare professional screening
behaviours in the future (Taft 2015), and after screening studies
are complete, have been rarely addressed since earlier literature
(McLeer 1989).
In surveys, qualitative studies and the studies reported here,
women report that screening for intimate partner violence (IPV) is
acceptable (Koziol-McLain 2008), although this can vary accord-
ing to their abuse status (Feder 2009). While some governments
and healthcare policymakers are in favour, the majority of health-
care professionals are not as supportive of screening policies, and
many barriers to screening have been identified (Hegarty 2006;
Feder 2009).
Does screening for intimate partner violence
increase identification of victims?
Based on the studies in this review, we found moderate evidence
that screening in high-income countries with developed referral
services increases identification of women exposed to IPV com-
pared to usual care. However, the numbers and proportions of
women identified are modest when considered against the esti-
mated prevalence of IPV among women in healthcare settings.
We are mindful that many women will be not be ready to disclose
(Chang 2010; Reisenhofer 2013), nor perhaps willing to disclose
to that specific provider or in that setting (Catallo 2013a). The
odds of identifying victims/survivors of IPV in antenatal settings
were four times higher in screened women compared to those who
received usual care. However, we downgraded the quality of this
evidence to moderate on account of imprecision, reflected in wide
confidence intervals around intervention effect estimates (likely
due to the small sample sizes of these studies). Clinical identifica-
tion was also increased in maternal health services and emergency
departments but not in hospital-based primary care. Further rigor-
ous studies are needed to test these findings in different settings. A
gap in the identified studies is that only one report (Wathen 2008),
associated with the MacMillan 2006 study, directly addressed the
issue of how false positives and false negatives are managed and
their impact on women and on screening effectiveness.
What kind of screening technique is preferred in
the identification of abused women?
Previous studies have suggested that women have a preference
for screening methods that do not involve healthcare profession-
als, which is understandable given the sensitive nature of IPV
and women’s preferences for privacy to disclose (MacMillan 2006;
Catallo 2013a; Catallo 2013b). A recent Australian trial found,
through process and outcome evidence, that both women (and
nurses) preferred a self completion maternal health checklist that
included IPV screening questions (Hooker 2015; Taft 2015). Al-
though preference for screening technique was not a central ques-
tion in this review, our evaluation of adverse outcomes across stud-
ies suggested that, on the whole, the women included in this review
were strongly in favour of being asked about violence in healthcare
settings, regardless of the technique used.
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An alternative question concerns which techniques and methods
(as distinct from which tools) produce more accurate prevalence
rates. While this was not an a priori review question, a subset of
the included studies did address it. Four studies compared screen-
ing techniques based on prevalence rates (or identification rates
that were not embedded clinically). Findings suggested that nei-
ther health professional/face-to-face screening nor written/com-
puter-based screening is favoured for identifying abused women.
High levels of statistical heterogeneity were observed in this four-
study analysis, suggesting clinical diversity across studies (different
countries, healthcare settings, and participant characteristics such
as education, preferences for privacy, and age) and methodologi-
cal differences (large variation in sample sizes and study quality).
These factors have the potential to moderate the effect of different
techniques on disclosure; indeedMacMillan 2006 has highlighted
the extent of the variability in prevalence rates depending on set-
tings, instruments, and techniques.
The clinical identification rates in this review ranged from 3%
to 17% with a median of just 8%. It would appear that women
and/or the providers remained reluctant to raise IPV. For example,
there was a mismatch between disclosures via computer/written
pre-assessments and discussions about IPV in consultations after-
wards across the studies using this approach. In Rhodes 2002, 58/
170 (34%) women indicated exposure to abuse in the pre-consul-
tation computer self assessment yet just 19/170 (11%) of those
cases were documented in patients’ charts by the providers. In
Trautman 2007, 68/411 women (17%) were detected in the com-
puter pre-screen; just 12 (3%) women had IPV documented in
their charts. We acknowledge that chart documentation may un-
derestimate clinical identification and discussion of abuse. How-
ever, using women’s self reports, MacMillan 2009 found that, in
encounters where physicians had been prompted that abuse was
present, under half involved a discussion about violence between
the woman and her doctor. This was consistent with Rhodes 2006,
where just 48% of health provider prompts that abuse had been
reported led to a discussion about IPV. There was more consis-
tency between the disclosure rate in pre-screening and with the
healthcare professional in Ahmad 2009 and Humphreys 2011. In
Ahmad 2009, prevalence was reported in exit surveys as 20% (29/
144) among screened women with 17% (25/144) having had a
discussion during the consultation. In Humphreys 2011, 25/205
(12%) were identified as at-risk in computer pre-screening, with
18/205 (9%) indicating in an interview afterwards that they had
talked about domestic violence with their doctor. Thus, future
studies need to look at how interventions can be enhanced to in-
crease the rate of discussion about IPV (e.g. greater emphasis on
training health care professionals).
The relative success of computerised and other distal techniques
for eliciting disclosures from women has led to studies that by-
pass healthcare professionals altogether and instead assess a partic-
ipant’s risk by computer and then provide support and links to ser-
vices, via a printout for instance. However, when looking beyond
the rate of disclosure, these methods appear to have little impact.
For example, Klevens 2012b found no evidence of effect of com-
puter-only screening and a list of resources on women’s mental
and physical health status at 12 months. Thus, while provider and
patient preferences for screening techniques must be understood
as yet another potential barrier (or facilitator) to implementation
of screening interventions, it remains important to examine prag-
matic screening interventions that will offer abused women the
best chance of finding a pathway to increased safety and better
health.
Does screening increase referral to support
services?
Based on the studies that assessed formal referral following clin-
ically-based identification, screening did not increase referral to
support services compared to usual care. However, to date, we
only found and included two studies (one from primary care and
one from emergency departments) and the assessment of referral
was unreliable, for example, referral rates may have been underes-
timated in Trautman 2007 as they only included referrals to social
work. Thus, we judged the evidence on the effect of screening on
referrals as low quality and further research is likely to have an
important impact on our confidence in the effect estimate. In fact,
in the Ahmad 2009 study, where only three women were reported
as having received referrals, 20 women were asked to make follow-
up appointments with same provider. In the comparison group,
follow-up appointments were made with eight women. It sup-
ports the notion that referring women, particularly in certain set-
tings like primary care, may not be the optimal response as abused
women may not yet be ready to take up a referral at the time of
immediate disclosure (Chang 2010; Reisenhofer 2013). Alterna-
tive provider practices, such as safety-planning and arranging for
follow-up, may be more appropriate, with measurement of safety
behaviours and take-up of subsequent appointments in follow-
up (Wathen 2012; Taft 2015). An important distinction needs to
be made between provider behaviours that occur as part of the
consultation (i.e. ’process’ variables of referring, safety-planning,
providing emotional support, making follow-up appointments),
and women’s later uptake of the specific referrals and follow-up
appointments along with their more general service use. Poor def-
inition of these various processes and outcomes was a key obstacle
to the synthesis of evidence in the current review.
Does screening reduce intimate partner
violence?
The only two studies that measured the impact of screening on a
reduction of partner violence over time did not report an effect.
The studies used different time frames for the outcome. More
studies would be required to reach a conclusion on the impact of
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screening on recurrence of violence. Also, further work is neces-
sary to evaluate the effectiveness of screening linked with a range
of interventions, advocacy (Ramsay 2009), social support (Taft
2011), and healthcare professional interventions (Hegarty 2013),
for impacting on IPV recurrence.
Is screening beneficial for women’s health?
One study assessed mental and physical health outcomes and re-
ported no impact of screening at 18 months (MacMillan 2009).
Given that there was only one study, we are unable to conclude
if screening interventions lead to improvements in women’s psy-
chosocial health. Future studies need to incorporate a broader
range of health outcomes (including general health and pregnancy
outcomes) as part of the evaluation of screening interventions in
healthcare settings.
Does screening harm women?
One of the criticisms commonly raised against the implementa-
tion of screening is that we do not know whether or not it is
harmful (Jewkes 2002). Most studies in this review incorporated
a non-validated set of questions related to women’s experiences
of participating in a screening programme, with none reporting
adverse effects. MacMillan 2009 conducted the most comprehen-
sive assessment of harm from screening and found no evidence of
harm. However, it was undertaken immediately after the health
visit only. Three months was the longest follow-up of possible ad-
verse outcomes (Koziol-McLain 2010), with no evidence of harm-
ful effects in the 86% of women interviewed from both arms of
the trial. Two recent Australian primary care trials, which used
the same tool as in the MacMillan 2009 trial (Valpied 2014; Taft
2015), also found no evidence of harms over a more extended pe-
riod of follow-up. Comprehensive assessment of harm needs to be
incorporated into future trials, with greater focus on the weeks and
months following delivery of the screening intervention. It needs
to be borne in mind that the studies in this review have been un-
dertaken in high-income countries, which may offer women more
legal and social protections in the event that a woman chooses to
disclose. Screening interventions may pose a more substantial risk
to women’s safety and wellbeing in other settings, such as those
that are resource-poor and lack comprehensive training for health-
care professionals, and in environments characterised by higher
levels of gender inequality.
Overall completeness and applicability of
evidence
The studies in this review are from high-income countries and the
conclusions cannot be generalised to medium- and low-income
settings where the care context and culture may be very differ-
ent. For example, support services for healthcare professional re-
ferrals may be absent or underdeveloped, and the problem of vio-
lence in women’s lives may be much less visible where legal rights
for women and criminal sanctions against perpetrators are lack-
ing (Garcia-Moreno 2006). In such settings, without appropriate
safeguards, screening may confer significant harm on women.
There is a need for studies that can investigate the differential
impact of screening on women experiencing different severity or
types of abuse. Also, the evidence for the effectiveness of screening
in specific healthcare settings is scant andmore studies are required
to confirm whether there is a differential effect (e.g. the finding
in antenatal care, which was compatible with an increase in iden-
tification following screening). Having incorporated a review on
’Domestic violence screening and intervention programmes for
adults with dental or facial injury’ (Coulthard 2010), we identified
no studies in oral and maxillofacial injury settings, an area that
warrants attention in future studies.
Given the costs to healthcare systems to provide support for sus-
tainable and effective screening programmes, it would be helpful
to have studies that compared screening to case-finding strategies
(such as Feder 2011), including economic analyses and longer-
term outcomes. Nevertheless, there are sufficient studies to suggest
that screening is effective in raising identification rates. It must be
acknowledged that the actual number of eligible women in any
healthcare setting who are screened has been found to be well be-
low 50% (Stayton 2005) (although the number of eligible women
screened across the trials included in this review ranged from 41%
to 94% with a median of 69%). The proportions of women asked,
those choosing not to disclose, and the impact of false identifi-
cation on women’s lives need further investigation before we can
fully understand the effectiveness of screening.
To date, the evidence reviewed here cannot demonstrate that
screening involving clinical assessment and referral alone reduces
violence, improves health, and does not cause harm. However, we
acknowledge that reported outcomes were in the desired direction
(less violence, less depression, more referrals), suggesting that link-
ing screening interventions with support, advocacy, or psycholog-
ical therapies may achieve positive outcomes with significant pub-
lic health implications. We need larger studies to investigate these
outcomes. While the increased rate of identification from screen-
ing is encouraging, it is unclear whether the healthcare profession-
als would continue to screen if they were not part of a study and
for how long. The question of sustainability of screening for IPV
as in other healthcare behaviour change interventions is a vexed
one and calls for greater understanding if we hope to implement
such programmes effectively at a state or national level (Colombini
2008;May 2011). A study aimed at improving maternal and child
health care for vulnerable mothers provides some evidence that a
nurse-designed, systems approach to screening was sustained with
the outcome of safety planning increasing at two years follow-up
(Taft 2015).
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Quality of the evidence
Overall in this review, studies performed random sequence gener-
ation effectively. Allocation concealment was more open to bias.
Steps taken to conceal the sequence prior to assignment of inter-
ventions was generally poorly described, and the risk of selection
bias could have been reduced by adopting CONSORT guidance.
A further difficulty was identified. Ideally all provider-level (e.g.
training interventions) and patient interventions are delivered af-
ter baseline assessment and randomisation has occurred. How-
ever, with a screening intervention, it is unlikely to be feasible to
assign patients and providers simultaneously as the patient-level
intervention needs to be delivered immediately so training needs
to have already occurred. Achieving full allocation concealment
is made difficult where there is a two-stage allocation process as
knowledge about provider training activities among personnel re-
sponsible for recruiting patient participants could influence the
enrolment process.
In regards to post-assignment, it is widely accepted that blinding
of staff and participants to minimise performance bias is hard to
achieve with complex interventions. This was the greatest threat
to validity across studies. Screening women for a range of health
issues or withholding full information about the trial aims until a
debriefing afterwards, or both, could help to reduce performance
bias among patient participants (e.g. Ahmad 2009). However, the
challenge of non-blinding providers remains, which may lead to
an overestimate of effect (e.g. due to inappropriate administration
of another ’co-intervention’ and other differential behaviours) or
underestimate of effect (e.g. due to contamination bias in compar-
ison arms). Cluster trials were uncommon in the studies, however
this design may offer some solution to issues of allocation con-
cealment and performance bias. Blinding of outcome assessment
was very complex, given that for our primary outcomes - iden-
tification and referral - we mainly used clinical documentation
and self report. Thus, we may have underestimated the levels of
these outcomes. Selecting a reliable measure of identification of
IPV is a persistent challenge in screening trials and warrants much
planning. In regards to selective reporting, around half of trials
had been registered, but protocols were uncommon and there was
widespread indication that not all outcomes listed a priori were
addressed in trial reports.
Wemade 91 judgements about the quality of evidence using seven
domains across 13 studies. We considered less than one-third of
domains at low risk of bias, whereas we judged 40% to be at
high risk and the remainder to be at unclear risk. Therefore, most
information is from studies at high or unclear risk of bias. We
downgraded evidence quality in response to risk of bias in studies
and imprecision arising mainly from small studies/sample sizes.
We observed high levels of statistical heterogeneity in some anal-
yses (though not in the main identification analysis). Although
interventions were similar, clinical diversity across studies arose
from factors such as studies being set in different countries and
healthcare settings and variability in participant characteristics. It
is likely that the large variation in sample sizes and study quality
contributed to methodological heterogeneity. Where possible, we
used sensitivity analyses to assess the robustness of the findings.
We considered the evidence on identification to be of moderate
quality suggesting further research is likely to have an important
impact on our confidence in the estimate of effect (andmay change
it). While we detected no evidence of an effect on referrals, this
evidence was of low quality; further research is very likely to have
an important impact on our confidence in the estimate of effect
and is likely to change it.
Undertaking trials of complex interventions in a sensitive area is
challenging not least because there is a constant need to balance
ethical concerns against methodological and practical issues. For
example, ensuring the safety of the comparison armdemands some
basic training for providers, however, this may lead to an under-
estimate of a true effect. Future studies need to incorporate guid-
ance, such as that supplied by CONSORT, in designing, imple-
menting, and evaluating their trials. Understanding the context of
a complex intervention, such as screening, requires better theoret-
ical underpinning. It also requires detailing (in process evaluation
(Moore 2015) and protocols) of the steps leading to the establish-
ment, implementation, and evaluation of a screening programme,
so that those wishing to replicate or scale-up a given intervention
have adequate information.
Potential biases in the review process
We believe that our review process allowed us to identify all pub-
lished randomised or quasi-randomised controlled trials of screen-
ing interventions, as defined in the review and published up to
the most recent search date (February 2015). All of the authors
included in the review and other experts in the field responded
to our requests for knowledge of other trials, which we may have
missed, but they did not identify any further trials that met our
inclusion criteria. We scoured all trial databases for those that may
be about to be published. At least two review authors made de-
cisions about inclusion or exclusion of studies and we made any
changes to the protocol with all authors’ involvement. Two review
authors also independently assessed study quality.
Agreements and disagreements with other
studies or reviews
This review reinforces the findings of our original review, Taft
2013, and is consistent with other major systematic reviews
(Wathen 2003; U.S. Preventive Services Task Force 2004; Feder
2009), and guidance from the UK National Institute for Health
and Care Excellence (NICE 2014) and from the WHO (Feder
2013), which state that insufficient evidence exists to justify uni-
versal screening for IPV in healthcare settings on the basis of
demonstrated benefit to women. We do not agree with the Nelson
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2012 update on U.S. Preventive Services Task Force 2004, which
concluded, mainly from MacMillan 2009, that screening is effec-
tive; the evidence does not yet warrant this conclusion. The earlier
reviews of screening for IPV found no evidence of either direct
harm or benefit to women, despite evidence that it may increase
identification and referral. By conducting more recent searches
and combining the results of those few studies where feasible, this
review has confirmed themodest effects of screening on increasing
identification of IPV, though there remains limited evidence of a
positive impact of screening on referral by healthcare professionals,
on other key outcomes related to women’s health and wellbeing,
and on any possible harm to women from the screening process.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In this update of our review, our conclusions remain that there is
insufficient evidence to justify implementation of intimate partner
violence (IPV) screening for all women in healthcare settings. It
would be equally or more effective to train healthcare profession-
als in effective case-finding for IPV as part of the routine social
history, to ask women who show signs of abuse or those in high-
risk groups, and provide them with a supportive response, safety-
planning, and information. This review cannot reach any conclu-
sions about the benefits of screening combined with advocacy or
other interventions by healthcare professionals. Further trials are
required to test these hypotheses.
Implications for research
Further research is required to extend the limited evidence iden-
tified in this review. More studies that examine the complexities
of screening in diverse settings (including low- or middle-income
countries), with diverse populations, and that examine the social,
health, and economic benefits for the differing strategies of identi-
fying women are needed.We need further pragmatic trials of what
proportion of women are successfully screened in real-world set-
tings and over what period can they be sustained as well as systems-
levels interventions to address the manifold barriers that exist to
enquiry about IPV by healthcare professionals and disclosure by
victims. The question of which subgroups of women, at which
stage of their journeys, may benefit from screening programmes
also remains.
In addition to emphasising trial registration, publication of proto-
cols, and parallel process evaluation studies, we make a number of
recommendations for future studies. We recommend trials com-
pare:
• screening all women in particular health settings or from
high-risk groups (e.g. mental health services, antenatal clinics)
versus a comparison intervention that also includes basic training
for all healthcare providers in asking about and responding to
IPV (it would be unethical to conduct such a trial using a usual
care arm where the health practitioners have not received basic
education/training) (the extent and nature of the training should
be clearly stated or available online);
• screening plus intensive support intervention in any
healthcare setting versus comparison (as described above);
• case-finding plus intensive support intervention versus
comparison (as described above);
• screening plus intensive support intervention in any
healthcare setting versus case-finding plus intensive support
intervention; and
• the above applied in low- and middle-resource settings.
Outcome selection and measurement recommendations include:
• improving the clarity around definition, operationalisation,
and data collection methods for clinical identification and formal
referral (short-term, ’process’ outcomes);
• explicit timelines to improve the comparability of data
across studies (e.g. three months, six months, one year, two
years);
• measurement of take-up of referrals and follow-up
appointments (specific) and health service use (general) (short-
to medium-term);
• assessment of violence and health and wellbeing outcomes
(medium- to long-term);
• outcomes for children;
• economic evaluation; and
• systematic harm assessment.
Although the number of eligible women randomised across stud-
ies was acceptable and there was little dropout prior to the de-
livery of interventions, studies that featured follow-up beyond
the day of screening were affected by the loss of more vulnerable
women. Given our recommendation for assessing important out-
comes such as violence, women’s health, and quality of life over the
long term, studies will need to develop recruitment and follow-up
protocols that maximise the retention of disadvantaged women as
part of further testing of identification programmes in conjunc-
tion with other interventions for IPV.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmad 2009
Methods Study design: randomised controlled trial
Randomisation method: random-number sampling scheme stratified by participating
physicians. Before recruitment, the randomisation assignment was computer-generated
using varying block sizes of 2 and 4. Women were individually randomised
Power calculation: reported
Study dates: March to September 2005
Participants Setting: urban, hospital-affiliated, academic, family practice clinic
Country: Canada
Inclusion criteria: women, 18 years and over, in relationship in last 12 months, able to
read and write English
Exclusion criteria: none stated
Number (%) of eligible recruited: 314/586 (53.6%)
Numbers recruited: 314; intervention group 156, control group 158
Number of dropouts: 34; intervention group 17, control group 17
Numbers analysed (% of recruited): 280; intervention group 139 (89%), control group
141 (89%)
Numbers analysed (sensitivity analysis): 293; intervention group 144, control group 149
Age: mean 44 years (SD 14 years)
Marital status: married/living with a partner 74%, single 21%, separated/divorced/wid-
owed 5%
Ethnicity: outside Canada 34%
Socioeconomic status:≤USD 40,000 28%, USD 40,001 to 60,000 18%, USD 60,001
to 80,001 14%, USD 80,001 to 100,001 16%, > USD 100,000 24%
Education background: 18% ≤ high school, 33% ≤ college, 34% ≤ university, 15% ≤
postgraduate
Children: children at home aged < 15 years 58%
Positive IPV result exit survey 62/286; intervention group 28/140, control group 34/
146
Interventions Intervention group
• Computer-assisted screening for IPV and control, which included items from the
Abuse Assessment Screen and Partner Violence Screen embedded among items
assessing a range of health issues. A ’yes’ response to any IPV items was reported on a
one-page risk report ’Possible partner abuse-assess for victimisation’ that was provided
to physicians. Relevant community referrals were printed at the end of the report
Control group
• Standard medical care
Outcomes Primary outcomes
• Initiation of discussion about risk for IPV by either participant or provider
(discussion opportunity)
• Detection of women at risk
Secondary outcomes
• Provider assessment of participant safety
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• Referrals
• Advice for follow-up
• Participant acceptance (collected in exit survey)
Discussion and detection of other health risks were also measured but not relevant to
this study
Data collected through audio-recording (short-term)
Notes Funding: Canadian Institutes of Health Research (grants IGF 63976 and FOW 68219),
Institute ofGender andHealth,OntarioWomen’sHealthCouncil, and StrategicTraining
on Health Care, Place and Technology Program
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random-number sampling scheme for
eligible women stratified by participating
physician was used. The randomisation as-
signment was computer-generated by an
off-site biostatistician using varying block
sizes of 2 and 4
Allocation concealment (selection bias) Low risk Women who had provided informed con-
sent were randomly assigned to the in-
tervention group or control group: “Pa-
tient assignments were sealed in opaque
envelopes that were marked on the out-
side with a physician number and sequence
number. The envelopes were opened by the
recruiter after patients’ written consent”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk All physicians initially received study infor-
mation and thosewilling to participate pro-
vided written consent. Training was pro-
vided during clinical team meetings at the
time of consent. Although “Physician par-
ticipants were blinded to the study’s pri-
mary purpose throughout the trial by em-
phasizing all health risks included in the
multirisk computer survey and by using
a nonspecific study title”, they would not
have been entirely blinded to the inter-
vention. For example, the prompt in the
women’s records of the intervention group
would have alerted providers to who was
in the intervention group and conceiv-
ably have influenced their performance.
Womenwere blinded to the study’s primary
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purpose by using strategies similar to those
used for physician participants and embed-
ding questions about women’s risk for IPV
allowed the authors to conceal the study
focus from both physician and patient par-
ticipants. However, the patients were still
aware that the computer survey was part of
the intervention that could have influenced
their behaviour. Awareness of being a con-
trol group participant (i.e. not doing the
computer survey)may have altered the con-
trol group participants’ behaviour in some
way that related to the outcome
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk 2 people undertook primary outcome as-
sessment, working independently to code
the audio-recordings of the clinical en-
counters. Although efforts were made to
blind coders to the patients’ group assign-
ments, this may have been compromised
by what they heard (i.e. some information
during the consultation that revealed the
patient’s allocation). However, this was un-
likely to have affected their observation of
the primary outcomes (initiation of discus-
sions on IPV and detection of IPV). After
their visit, women completed a pencil-and-
paper exit survey and received brochures
on cancer screening, cardiac and mental
health, and IPV, at which time the re-
search staff disclosed the purpose of the
study to women. Although women were
not blinded in answering the exit surveys,
the outcomes measured via the exit survey
were not primary to this study or our re-
view
Incomplete outcome data (attrition bias)
All outcomes
High risk Immediately following randomisation, 12/
156 women in the intervention group
and 9/158 women in the control group
were excluded/withdrew. In the interven-
tion group, 9 did not complete the com-
puter assessment; 2 had their visits can-
celled and1withdrew. In the control group,
2 women had their visit cancelled, and 6
women withdrew and 1 physician with-
drew 1 woman who had mental health is-
sues. The authors observed that women
generally showed interest in the computer
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screening, and some expressed disappoint-
ment when they were not assigned to
the computer-screened group, which may
have explained the higher number of with-
drawals in the control group. It is un-
clear what the actual level of attrition
was, given that individual participant num-
bers for analyses are inconsistent across
the flowchart depiction (intervention 141,
control 144), and the results text (inter-
vention 143, control 144). Numbers in Ta-
ble 3 (RR analyses: intervention 139, con-
trol 141) also differed but this was due to
missing data (missing covariate values for
three visits and outcomes coded as “other”
in 2 cases). In the final analysis, reasons for
exclusions of participants appear balanced
across the 2 groups occurring due to miss-
ing data, recording failures, and language
barriers. Overall the attrition rate was low
at 10.8% (34/314). The sensitivity analyses
suggest that the missing data were enough
to potentially affect the results: “Sensitivity
analyses were conducted to gauge the po-
tential effect of missing values. 2 extreme
situations were considered in which each
missing value was replaced with an extreme
value of the variable that was most likely to
diminish the observed RR toward the null
value or most likely to accentuate the ob-
served RR away from the null. These 2 ex-
tremes provide a range of likely values for
each effect.” Other imputed missing data
were accounted for in the appendicised re-
analysed outcome data, which was under-
taken by ITT
Selective reporting (reporting bias) Low risk None noted. Trial regis-
tered (NCT00385034) but study protocol
not available
Other bias High risk Protection against contamination: there
was a high risk of bias in terms of what
the participants in the control group re-
ceived.Given that the same providers deliv-
ered both conditions to different women,
this suggests the way in which they inter-
acted with women from the control group
may have been influenced by their experi-
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ence of delivering the intervention and thus
underestimated the effect
Carroll 2005
Methods Study design: cluster-randomised controlled trial
Randomisation method: to obtain a balanced sample, each participating provider was
paired to the greatest extent possible with another provider by practice location, type of
provider, sex, and age. 1member of each pair was randomly assigned to the ALPHAgroup
(intervention group) or control group by a biostatistician using computer-generated
random numbers
Power calculation: reported
Study dates: from 1998 to 2002
Participants Setting: 4 communities in Ontario, including urban, suburban, and rural practices with
women from diverse socioeconomic and ethnic backgrounds
Country: Canada
Inclusion criteria (providers): any HCP (e.g. physicians, obstetricians, midwives) who
practised antenatal and intrapartum care, or antenatal plus transfer at 28 weeks, saw at
least 10 antenatal women a year, and were not using any antenatal psychosocial screening
tool other than the standard Ontario Antenatal Record
Inclusion criteria (individuals): female; 12 to 30 weeks’ gestation; able to read and write
English; able to provide informed consent
Exclusion criteria: high obstetric risk as defined by Ontario Antenatal Record
Numbers recruited (providers): 60; intervention group 30, control group 30
Number of dropouts (providers): 12; intervention group 9, control group 3
Numbers (%) of eligible individuals recruited: 253/273 (92.7%)
Numbers recruited (individuals): 253; intervention group 112, control group 141
Number of dropouts (individuals): 26; intervention group 14, control group 12
Numbers analysed (% of recruited): 227; intervention group 98 (88%), control group
129 (91%)
Age: intervention group mean 29.1 (range 17 to 47 years), control group mean 29.4
(range 17 to 44 years)
Ethnicity: born in Canada; intervention group 85.7%, control group 84.5%
Socioeconomic status
• < USD 25,000; intervention group 10.3%, control group 4.7%
• USD 25,000 to 49,999; intervention and control group 22.7%
• USD 50,000 to 74,999; intervention group 29.9%, control group 32.8%
• USD 75,000 to 99,999; intervention group 19.6%, control group 24.2%
• > USD 100,000; intervention group 17.5%, control group 15.6%
Education background: high school or less intervention group 19.4%, control group 26.
6%; some college or university intervention group 25.5%, control group 20.3%; degree
intervention group 55.1%, control group 53.1%
Pregnancy problems: no concerns intervention group 55.1%, control group 50%; minor
concerns intervention group 39.8%, control group 46.9%; major concerns intervention
group 5.1%, control group 3.1%
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Interventions Intervention group
• Providers administered the ALPHA tool face-to-face, which screened for 15 risk
factors, including IPV
Control group
• Usual antenatal care
Outcomes • Providers were followed up 1 month postpartum to determine whether antenatal
risks were considered ’present’ for participants on the basis of providers having ’some’
or ’high’ concern about the risk factor. This included family violence, which had been
assessed in the ALPHA tool using 5 items, one of which directly assessed concern with
current or past woman abuse
• At 4 months’ postpartum, the study nurse contacted all women in the trial to
again complete a number of psychosocial instruments. Women with providers in the
ALPHA group were asked to give feedback about the ALPHA form
Notes Data on psychosocial outcomes at 4 months’ postpartum were not reported. Data on
sample characteristics only reported for the people who completed
Funding: Ontario Ministry of Health and Long Term Care and the Ontario Women’s
Health Council
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk To obtain a balanced sample, each partic-
ipating provider was paired to the greatest
extent possible with another provider by
practice location, type of provider, sex, and
age. 1 member of each pair was randomly
assigned to the ALPHA group (interven-
tion group) or control group by a biostatis-
tician using computer-generated random
numbers
Allocation concealment (selection bias) Unclear risk There is a lack of information about the
level of allocation knowledge of those
who enrolled the provider. Presumably
providers recruited women after their ran-
domisation had occurred. If providers
knew their status, this could have influ-
enced how and which women were re-
cruited based on their own allocation status
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Provider participantswere aware of the pur-
pose of the study and their status as inter-
vention or control group, which may have
influenced their performance. Providers
were also responsible for first tellingwomen
about the study. Interested women received
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an explanatory brochure and consent form
from their provider and a telephone call
from the study nurse to further explain the
study and secure consent.We are not told in
the report what level of awareness women
had about the purpose of the trial. Know-
ing that the trial included a focus on IPV
could have influenced how they responded
to their treatment or non-treatment. How-
ever, IPV was just 1 of 15 psychosocial is-
sues and therefore may have not been sin-
gled out. Individual women in the inter-
vention group may have been aware that
theywere in a treatment group based on the
introduction of the ALPHA tool into the
consultation, which may have influenced
their responses to the ALPHA tool. There
is no mention about the blinding of other
study personnel
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Healthcare professional participants pro-
vided the primary outcome data in that
they reported back on their level of con-
cern with their participating patients. Both
intervention and control group providers
may have overestimated their level of con-
cern as they would have been prompted by
the questions asked in the data collection
form. We are told a nurse undertook a fol-
low-up of women but are not given infor-
mation on level of awareness of women’s
allocations. The women themselves would
not have been blinded in outcome report-
ing
Incomplete outcome data (attrition bias)
All outcomes
High risk 9/30 (30%) intervention group providers
compared to 3/30 (10%) control group
providers withdrew from the study. Inter-
vention group: withdrawn because of ill-
ness,maternity leave or ineligibility because
of language barrier (n = 5); no reason given
for withdrawal (n = 4); control group: with-
drawn because of illness (n = 1); no rea-
son given for withdrawal (n = 2). 6 fam-
ily physicians withdrew from the interven-
tion group compared to 1 in the control
group. There were no data reported on par-
ticipants of the 12 providers that withdrew.
This high level of attrition in the interven-
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tion group provider could indicate delib-
erate withdrawal associated with the out-
come (creating high risk of bias). Among
providerswho remained in the study, and in
terms of the primary outcome, attrition of
individual women was low - providers did
not complete/return data collection forms
on 7.5% of participants. No data were re-
ported on the numbers of womenwhowere
assessed at the 4-month postpartum point
to allow us to evaluate bias at the partici-
pant reporting level. Only 14/21 interven-
tion group providers gave feedback on ex-
perience of using the ALPHA tool. Analysis
included sensitivity analysis to accommo-
date loss of provider participants. Results
were not robust enough to withstand the
loss of providers
Selective reporting (reporting bias) High risk Importantly, there is an absence of informa-
tion on the postpartum psychosocial out-
comes of women.Data on characteristics of
the sample are only reported on those who
were included in the final analysis. The re-
porting of results highlighted the one sig-
nificant finding (family violence, including
child abuse) as the great majority of others
were non-significant
Other bias Unclear risk Protection against contamination: women
in the control group may have seen inter-
vention group providers during subsequent
consultations, which may have contami-
nated women’s psychosocial outcome data.
There is a lack of information about how
the situation of the control group using the
ALPHA tool was avoided
Reliability of outcome measures: while
the primary outcome (akin to identifica-
tion/detection) was adequately measured
as ’some’ or ’high’ concern about a par-
ticular psychosocial issue, the time lapse
between the delivery of the intervention
and the data collection may have intro-
duced bias through recall bias. Intervention
groupmight have hadmore notes onwhich
to base recall than that the control group
providers
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Methods Study design: randomised controlled trial
Randomisation method: computer-generated
Power calculation: reported. However, it was based on combining data from 2 clinics.
We report on just 1 clinic here
Study dates: from 17 July 2012 to 21 September 2012
Participants Setting: Women, Infants, Children’s (WIC) clinic in the large metropolitan city of At-
lanta. WIC clinics provide supplemental food, healthcare referrals and nutrition educa-
tion to low-income women and their children up to five years of age
Country: USA
Inclusion criteria: females, at least 18 years of age, eligible for WIC services, English-
speaking and literate. Only African-American women were included in analyses
Exclusion criteria: none stated
Number (%) of eligible recruited at ’Clinic 2’: 402/648 (61.9%; this percentage was
based on overall participation rate reported across the 2 clinics)
Numbers randomised: 402; face-to-face interview 200, CASI 202
Number of dropouts: 34; face-to-face interview 9, CASI 25
Numbers analysed (% recruited): 368; face-to-face interview 191 (95.5%), CASI 177
(87.6%)
Age: mean 27.4 years (SD 7.8)
Ethnic background: all African-American women in this analysis
Marital status: unmarried relationship 45%, single 40%, married 15%
Education: up to high school 44%, some college 33%, completed college 22%
Employment: working outside the home 45%
Experience of IPV: lifetime experience of any IPV 49%, prior-year experience of any
IPV 36%
Interventions Intervention group
• Face-to-face interview screening (FTFI) using the CTS2S by researchers who were
trainee health professionals or health researchers had been trained in survey
administration and provided with sensitivity training. All participants received
brochure with resources related to WIC services, child health insurance, healthy
relationships, and contact information for local domestic violence agencies and hotlines
Control group
• Women completed the CTS2S via computer and received a printed list of
resources for any health risk behaviours they disclosed (computer-assisted screening
interview; CASI)
Outcomes Primary outcomes
• Lifetime and prior-year IPV data collected through the face-to-face or
computerised screening
Other variables measured were health behaviours, including smoking, alcohol and sub-
stance use, and contraceptive use (data not reported)
Timing of measurement
117 women (31.8%) completed the 2-week follow-up but no data are reported here
Notes We were unable to obtain the follow-up data from the authors (Fincher 2015 [pers
comm])
Funding: the Georgia Department of Public Health, Maternal and Child Health Pro-
gram; Emory Center for Injury Control (Grant - R49 CE001494 and PH2011120G);
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and the Hubert Department of Global Health, Rollins School of Public Health, Emory
University
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk We were informed directly by authors that
there was “computer generated randomiza-
tion to FTFI or CASI within clinic strata.
” (Fincher 2015 [pers comm]). No fur-
ther detail was supplied in the report or
personal communications. There were a
number of differences between the groups
on sociodemographic characteristics, call-
ing into question the success of the ran-
domisation process
Allocation concealment (selection bias) High risk We were unable to obtain information on
the steps taken to conceal the allocation or
on how the personnel/interviewers moved
from the recruitment/consenting stage to
allocating women and delivering the face-
to-face screening or CASI. 34/402 cases
were omitted from the analysis due to in-
complete data and it is unclear at what stage
they dropped out. We were informed that
those recruiting women also did interviews
and recruiterswould likely have had knowl-
edge of the allocation prior to inviting indi-
viduals into the study, which could have in-
fluenced their behaviours differentially sug-
gesting the potential for selection bias
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Personnel conducting the face-to-face in-
terview were not blinded to the purpose of
the study, were aware that they were deliv-
ering the intervention condition, and had a
high level of interaction with women from
recruitment through to follow-up. Partici-
pants were not blinded: “Potential partici-
pants were informed that the survey asked
questions about their general health and
about their relationship with their partner,
” however women in both arms received
this information making it less likely to in-
fluence the outcomes differentially in the
groups. However, we judge that the lack
of blinding for personnel could have inter-
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acted with outcomes differentially
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Women’s disclosure data were used as the
primary outcomedata and it is unlikely that
the 2 arms behaved differently in this re-
gard. The follow-up at 2 weeks was con-
ducted by the same interviewers, which
could have led to detection bias, however it
appears the 2-week data were not reported
here. The latter could have differentially af-
fected outcomes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 34/402 cases were omitted and the rate was
higher in the CASI group (12%) compared
to face-to-face group (4%) as pointed out
above, but is unclear at what stage that oc-
curred. At 2 weeks, 117/368 (31.8%) of
women completed a follow-up suggesting
high attrition but we do not know if there
was differential dropout and, in any case,
we were unable to incorporate the 2-week
data as they were not reported
Selective reporting (reporting bias) High risk No protocol available. The second clinic’s
data are being reported elsewhere. Data on
the 2-week outcomes for women were not
reported. “Telephone follow-up interviews
were conducted with study participants at
2 weeks to ask about their experience with
and preference for screening method.”
Other bias Unclear risk The authors were contacted for additional
information on how randomisation was
conducted and on flow of participants in
the study. However, we were not able to ob-
tain clarity on a number of methodological
queries. It is unclear if steps were taken to
protect against contamination/cross-over
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Fraga 2014
Methods Study design: 3-arm, randomised controlled trial
Randomisation method: not described
Power calculation: used EpiInfo software with 95% confidence interval level and 80%
power, assuming prevalence of 7% in control
Study dates: reported in Rodrigues 2008 that women were recruited over a 10-month
period during 1999 and 2000. Women were contacted again 1 year postpartum, and
although specific dates have not been reported in Fraga 2014, authors confirmed that
between 2000 and 2001 women were re-contacted and received the screening interven-
tion Fraga 2015 [pers comm].
Participants Setting: maternity/maternal health services at a university hospital
Country: Portugal
Inclusion criteria: consenting women who had delivered a baby at the hospital 1 year
prior
Exclusion criteria: not reported
Numbers recruited (12 months prior): 915 women
Numbers randomised: intervention group one 305, intervention group two 305, control
group 305
Number dropouts (lost since recruitment): intervention group one 13, intervention
group two 3, control group 70
Numbers analysed (% of recruited): 829; intervention group one 292 (96%), interven-
tion group two 302 (99%), control group 235 (77%)
Age: not reported for the subset in this study
Marital status: not reported
Ethnicity: not reported
Education: reported as “did not differ between randomization groups”
Interventions Intervention groups
• Group one: face-to-face screening using Abuse Assessment Screen by social worker
• Group two: telephone screening using Abuse Assessment Screen by social worker
We combined the 2 conditions involving the social worker and compared them to postal
screening
Control group
• Screening by postal questionnaire using Abuse Assessment Screen
Timing of measurement: interventions were conducted at 1 year postpartum
Outcomes Primary outcome
• IPV for the 1 year postpartum period was assessed using the validated Abuse
Assessment Screen
Referral rates were not reported
Notes This was a brief report. Women who did not respond to the postal questionnaire were
followed up using one of the other screening methods (face-to-face or telephone), which
increased the IPV detection rate from 9/235 (3.8%) to 19/235 (8.1%) in this group.
Similarly, alternative methods were used for women in the face-to-face and telephone
groups if they did not respond. We only used the initial screening data from this study,
which may have underestimated detection rates for the postal group (as the one with the
low participation rate)
Funding: Fundacao para a Ciencia e a Tecnologia Fundação para a Ciência e a Tecnologia
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(FCOMP-01-0124-FEDER-021439)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation was performed in the ratio
1:1:1 but method was unclear
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described and not likely due to the
nature of the intervention but potentially
high risk for interviewers/outcome asses-
sors as it seems that data were collected on
antenatal abuse at enrolment. It is not clear
whether the interviewers/outcome asses-
sors had access to this information, which
could have biased the outcome assessor
to conduct more rigorous follow-up inter-
views of women identified at enrolment as
’at risk’ due to abuse in the prenatal phase
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described but potentially high risk for
interviewers/outcome assessors as it seems
that data were collected on antenatal abuse
at enrolment. It is not clear whether the in-
terviewers/outcome assessors had access to
this information, which could have biased
the outcome assessor to conduct more rig-
orous follow-up interviews of women iden-
tified at enrolment as ’at risk’ due to ante-
natal abuse
Incomplete outcome data (attrition bias)
All outcomes
High risk The postal questionnaire group suffered
from high attrition (70/305; 23%) and 81
women (27%) received alternative screen-
ing interventions (protocol deviations),
which increased the IPV detection rate in
the ITT analysis. We excluded these pro-
tocol deviations from the ITT data for our
meta-analyses
Selective reporting (reporting bias) Unclear risk The protocol for this study was not avail-
able and therefore we were not able to
determine whether selective reporting was
present. Results were reported by ITT and
per protocol but as percentages only
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Other bias Unclear risk This was a brief report and the authors were
contacted for additional information;miss-
ing data for the primary outcome were ob-
tained, however we were not able to obtain
clarity on most methodological queries
Baseline data were reported to be simi-
lar between groups, however the numeri-
cal data were not published. It was sim-
ply stated that “Age, education, income,
smoking, prenatal visits and abuse during
pregnancy did not differ across the three
randomised groups”. “Abuse during preg-
nancy” was measured using the Abuse As-
sessment Screen as part of a hospital survey
preceding this RCT, and this may have af-
fected the collection and interpretation of
outcome data
Humphreys 2011
Methods Study design: randomised controlled trial
Randomisation method: women reporting risks for smoking, alcohol, drug use, and IPV
were stratified by risk combination and randomly assigned by the computer (on which
they completed a risk assessment) to intervention or usual care
Power calculation: none reported
Study dates: from June 2006 to June 2007
Participants Setting: 5 antenatal clinics in San Francisco
Country: USA
Inclusion criteria: females aged 18 years and over, English speaking, < 26 weeks pregnant,
receiving antenatal care at one of the participating clinics, and not presenting for first
antenatal visit
Exclusion criteria: none stated
Numbers recruited/assessed for IPV risk: 410
Numbers randomised: 50; intervention group 25, control group 25
Number dropouts at exit interview: intervention group 3, control group 1
Numbers analysed (% recruited) at exit interview: intervention group 22 (88%), control
group 24 (96%)
Number dropouts at second interview: intervention group 5, control group 8
Numbers analysed (and % recruited) at second interview: 20 intervention group (80%)
, control group 17 (68%)
Numbers analysed (sensitivity analysis): 50; intervention group 25, control group 25
Age: mean 27.7 years (SD 7.1), range 18 to 43 years
Marital status: married/living with partner 38%, never married 46%, divorced/separated
16%
Ethnicity: Latino 34%, Black 22%, White 30%, Other 14%
Education: < high school 22%, high school 36%, some college 28%, college degree 12%
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Interventions Intervention group
• Computer-based assessment (to check eligibility based on Abuse Assessment
Screen and randomise women) was followed by video doctor plus provider cueing prior
to antenatal consultation
Control group
• Computer-based assessment (to check eligibility based on Abuse Assessment
Screen and randomise women) was not followed by the video doctor/provider cueing
sheet; women simply proceeded to their antenatal appointment
Outcomes Primary outcomes
• Patient-provider discussion of IPV
• Helpfulness of IPV discussion
Timing of measurement: short-term assessment of outcomes (immediately after the in-
tervention and again following antenatal visit 1 month later; data collected fromwomen)
Notes Analysis: no adjustment for clustering
Funding: US Department of Health and Human Services National Institute on Drug
Abuse (R01 DA 15597). The preparation of this manuscript was supported, in part, by
a NIDA Center grant (P50 DA 009253)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women were randomly assigned by the
computer (on which they completed a risk
assessment) to the intervention or control
group: “Women reporting risks were strati-
fied by risk combination and randomly as-
signed by the computer to intervention or
usual care groups”
Allocation concealment (selection bias) Low risk Allocation was adequately concealed as
only the computer had knowledge of the
assignment and there was no opportunity
to influence what groups women went into
as the computer did the allocation imme-
diately
Blinding of participants and personnel
(performance bias)
All outcomes
High risk While some personnel may have become
aware of the participant allocation (e.g. in
order to place computer reports in medical
records), the review authors judged that the
outcome is not likely to be influenced by
this lack of blinding. However, the printed
report would have alerted physicians to
the status of the woman in the interven-
tion group and may have enhanced perfor-
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mance above and beyond how they might
otherwise perform if they were to observe
such a report but not be part of a research
study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk During post-visit interviews at baseline
and 1-month follow-up, participants were
asked “Did you talk about domestic vio-
lence with your doctor today?” which was
used to indicate that a patient-provider dis-
cussion of IPV occurred.Wewere not given
information on the level of blinding of the
research assistant and, in any case, the allo-
cation of the woman could very easily have
been revealed during the outcome evalua-
tion potentially biasing the research assis-
tant’s observations
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of the 25 women in the intervention
group, 3 (12%) did not provide baseline
data and 5 (20%) did not provide data at
1-month follow-up. Of the 25 women in
the control group, 1 (4%) did not provide
baseline data and 8 (32%) did not provide
data at 1-month follow-up. The sensitiv-
ity of the results to LTFU was assessed “by
making the assumption that in the absence
of outcome data, no discussion occurred.”
Reasons for dropout were not provided and
it is therefore difficult to judge if there was
a differential dropout across the groups
Selective reporting (reporting bias) High risk There were differences between the out-
comes as reported in the trial registry
(NCT00540319) and those reported here
Other bias High risk Protection against contamination: women
assigned to the control group could have
received an ’enhanced’ usual care given
that providers were consultingwith women
from both the intervention and control
groups
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Methods Study design: randomised controlled trial
Randomisation method: random numbers table
Power calculation: none reported
Study dates: from February to November 2003
Participants Setting: antenatal clinic of an urban general hospital
Country: Japan
Inclusion criteria: women < 25 weeks pregnant
Exclusion criteria: none stated
Number (%) of eligible recruited: 328/355 (92.4%)
Numbers randomised 328: interview 165, questionnaire 163
Numbers analysed (% recruited) at first time point 328: interview 165 (100%), ques-
tionnaire 163 (100%)
Number of dropouts at second time point: interview 10, questionnaire 3
Numbers analysed (% recruited) at second time point: 315; interview 155 (93.9%),
questionnaire 160 (98.2%)
Number of dropouts at third time point: interview 7, questionnaire 11
Numbers analysed (% recruited) at third time point: 297; interview 148 (89.7%), ques-
tionnaire 149 (91.4%)
Age: 20 to 29 years 30.5%, 30 to 39 years 66.2%, ≥ 40 years 3%
Marital status: married 96.3%, single 2.1%
Education: high school 13.4%, junior college 43.6%, university degree 41.8%
Employment: full-time 33.8%, part-time 17.7%, not working 46.9%
Lifetime experience of physical violence by male partner: 20 (5.8%); interview 8 (4.8%)
; questionnaire 11 (6.8%)
Interventions Intervention group
• Face-to-face screening using the 7-item Japanese VAWS with brief counselling
and a community resource card on 3 occasions
Control group
• Women in the questionnaire group self completed the VAWS in an antenatal clinic
interview room where the community resource cards were available on 3 occasions
Outcomes Primary outcome
• Identification (from screen questionnaires)
Secondary outcomes
• Comfort level
• Need to consult with the nurse after screening (all participants completed a
questionnaire immediately after the intervention)
Notes Funding: Grant-in-Aid for COE (Centre of Excellence) Research, provided by the Min-
istry of Education, Culture, Sports, Science and Technology of Japan
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Researchers “used a random number table
in blocks of four to ensure that approxi-
mately equal numbers of women were al-
located to each group”
Allocation concealment (selection bias) Low risk Although it was indicated that numbered,
sealed envelopes were used, it was un-
clear whether opaque envelopes were used.
However, since there was no clear interven-
tion/comparison group, the likelihood that
selection bias was introduced is low
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The researchers indicate “because of the na-
ture of the screening methods, participants
could not be blinded to the group assign-
ment.” However any such bias was likely
distributed equally across the 2 groups. Al-
though the extent of the knowledge about
participants’ assignment, especially given
the repeat visits among personnel, is un-
clear it is unlikely to have influenced the
outcomes differentially in the groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk There was no blinding of outcome assess-
ment; however, the outcome measurement
is not likely to be differentially influenced
in the 2 groups by lack of blinding as there
was not a clear intervention or comparison
group. Also the “same researcher performed
the allocation procedure and data analysis”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rates were low and balanced in the
2 groups (intervention group 10.3%; con-
trol group 8.6%). 2 people in the interview
group refused to continue compared to 0
in the questionnaire group
Selective reporting (reporting bias) Low risk Primary and secondary outcomes reported
as specified in protocol. The trial was reg-
istered (UMIN-CTRC000000353)
Other bias High risk “Measurements of primary and secondary
outcomes had psychometric property lim-
itations”
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Methods Study design: randomised controlled trial
Randomisation method: the audio computer-assisted self interview computer program
applied simple randomisation (simple randomisation was written into the code of the
software program), which facilitated individual randomisation of women to 1 of 3 trial
arms
Power calculation: none provided
Study dates: from 22 April 2008 to 26 September 2008
Participants Setting: women’s health clinics (obstetrical, gynaecological, and family planning clinics)
at a public hospital
Country: USA
Inclusion criteria: females, at least 18 years of age
Exclusion criteria: womenwho did not speak English; were accompanied by their partner
or a child over 3 years of age; who were visually, hearing, or mentally impaired; women
who had no access to a telephone or were over 36 weeks pregnant
Number (%) of eligible recruited: 126/228 (55%)
Numbers recruited 126: intervention group 46, control group 80
Number of dropouts: 24; intervention group 10, control group 14
Numbers analysed (% recruited): 102; intervention group 36 (78%), control group 66
(83%)
Age: mean 35.8 years (SD 14.4 years)
Ethnicity: 6.3% White, 78.6% Black, 11.9% Latino, 3.2% Asian
Education background: ≤ high school 42.4%, ≤ college/vocational training 41.9%
Insurance status: Medicaid/care 37.3%, private insurance 5.6%, uninsured 57.1%
Interventions Intervention group
• IPV screening by HCP using the PVS, and if positive, HCP support
Control group
The study authors combined the 2 A-CASI arms
• A-CASI IPV screening (PVS), and if positive, a computer printout of locally
available resources for her referral, A-CASI encouragement to show HCP her results
and HCP encouragement to contact IPV services if the woman shared her results
• A-CASI IPV screening (PVS), if positive for IPV, a short video clip provided
support and encouraged help seeking, and the computer printed a list of available IPV
resources for self referral
Outcomes Primary outcomes
3 screening outcomes:
• Rates of IPV disclosure based on PVS
• Screening mode preference
• Impact of IPV screening (positive and negative reactions)
Referral outcomes:
• At 1-week follow-up telephone call, women were asked to report:
◦ Recall of receiving list of services that provide help to women
◦ If women recalled receiving the list, did they share it with anyone
◦ Contact with services
• At 3 months, the local IPV advocacy staff were asked to report records of any
telephone or face-to-face contact from study participants who screened positive
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Notes Funding: Centers for Disease Control and Prevention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Simple randomisation was written into the
code of the computer program used to
screen women and individually assigned
participants to 1 of the 3 trial arms
Allocation concealment (selection bias) Low risk Research assistants obtained informed con-
sent from participants prior to any knowl-
edge of the allocation. The allocation was
revealed to the participant directly via the
computer program used to conduct the
health interview
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blinded. While any
impact of non-blinding on performance
was likely to have been low in the pure A-
CASI condition, the potential for involve-
ment ofHCPs in the other 2 armsmay have
influenced the performance of participants
especially in the face-to-face arm
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Except for data on women’s contact with
local advocacy services, whichwas provided
by blinded advocacy staff, assessment of
outcomes was not blinded. The research
assistant collecting the data was aware of
the assignment of individuals and there-
fore there was potential for introducing a
bias into the assessment of outcomes. Also
“HCPs were asked to respond to a checklist
for compliance with the screening and re-
ferral protocol, HCPs were not actually ob-
served to establish the validity of this check-
list and the accuracy of their reporting”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Participants lost to follow-up were similar
in level of education and insurance status,
but were significantly younger. However,
there were no differences between assigned
study groups for demographic characteris-
tics among the 24 women lost to follow-
up”
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Selective reporting (reporting bias) Unclear risk None noted but study protocol not avail-
able. Study was not registered
Other bias High risk Protection against contamination: there
was a high risk of potential for contamina-
tion across conditions given that all 3 con-
ditions were delivered in the same clinics.
Also, a decision was made to combine data
from the 2A-CASI (A-CASIwithHCP en-
dorsement and A-CASI alone) arms in the
analysis; it is unclear if this was a decision
made a priori. It is possible that such amea-
sure could have led to contamination given
the similarities between A-CASI withHCP
endorsement and the HCP alone condi-
tions
Koziol-McLain 2010
Methods Study design: randomised controlled trial
Randomisation method: randomly assigned individually 1:1 to intervention or control
group
Power calculation: sample size was calculated to detect a 50% treatment effect for 1 or
more physically abusive events occurring in the follow-up period
Study dates: from 16 April 2007 to not reported
Participants Setting: North Island New Zealand hospital ED
Inclusion criteria: women aged 16 years and over, presenting to the ED for care during
selected shifts were eligible
Exclusion criteria: acute presentations precluding informed consent, functional or or-
ganic impairment based on clinician assessment, emergency health needs, non-English
speaking or entered study during previous visit
Number (%) of eligible recruited: 399/983 (40.6%)
Numbers randomised: 399; intervention group 199, control group 200
Number of dropouts at exit interview: intervention group 32, control group 23
Numbers analysed (% of randomised): 344; intervention group 167 (84%), control
group 177 (88.5%)
Age: median 40 years, range 16 to 94 years, interquartile range 27 to 59 years
Relationship status: current relationship 67.4%, relationship within past year 8.3%, no
relationship in past year 22.3%, never had a partner 2%
Ethnicity: Maori 37.6%, New Zealand European 60.4%, other 2%
Socioeconomic status (annual individual income): NZD 0 to 10,000 15.2%, NZD 10,
001 to 20,000 32.1%, NZD 20,001 to 35,001 26.1%, > NZD 35,000 20.3%, do not
know 5.8%
Employed: yes 49.1%, no 31.6%, retired 19.3%
Education: < high school 23.3%, high school 22.8%, other completed qualification 45.
6%, college degree 8.3%
Depression (CES-D): mean 14.0
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Mental health (SF-12): mean 64.8 (SD 24.6)
General health (SF-12): mean 61.9 (SD 30.9)
Acute injury: 79 (19.9%); intervention group 34 (17.3%), control group 45 (22.9%)
One or more children in household: 73.4%
Level of violence (treatment group only): 18% screen result positive, 51% lifetime result
positive
Interventions Intervention group
• Standardised 3-item IPV screen incorporating the Partner Violence Screen and
the Abuse Assessment Screen, statements about the unacceptability of violence, risk
assessment, and referral by a health professional (e.g. nurse, midwife, social worker)
research assistants
Control group
• Usual emergency care
Outcomes Primary outcome
• Violence exposure by a current or past partner in the last 3 months on the
Composite Abuse Scale (CAS)
Secondary outcomes
• Safety behaviours (9-item Safety Behaviors Checklist)
• Resource use - informal (9-item) and formal (7-item) resource use (Community
Resources Checklist)
Other outcomes
• Medical ED charts of all presumed eligible participants were abstracted to collect
data including documentation of IPV; however, these data were not reported as a
comparison
Timing of measurement/follow-up: 3 months after index ED visit women had a face-
to-face structured follow-up interview
Notes Analysis: by ITT
Funding: Health Research Council of New Zealand
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The biostatistician i) computer-generated
a series of randomly selected shifts across
7 days of the week and times of the day
during which recruitment was to be un-
dertaken and ii) provided a computer-gen-
erated randomised sequence for group as-
signment within those periods
Allocation concealment (selection bias) Low risk The concealment of allocation followed
strict protocols. The randomisation sched-
ule was not available to anyone other than
the biostatistician. The biostatistician over-
saw the preparation of sealed, opaque,
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tamper-proof, sequentially numbered en-
velopes containing the randomised treat-
ment allocation. Research log sheets were
used for the real-time documentation of re-
cruitment and the use of envelopes to pro-
vide a clear audit trail that was closelymon-
itored by the site project leader
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to blind participants in
the intervention group from the purpose of
the intervention. Also, personnel may have
become aware of the participant’s allocation
(e.g. through medical record), which may
have influenced their treatment of that par-
ticipant. The study did employ strict proto-
cols in order to attempt to reduce the risk of
differential behaviour by participants and
personnel
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All follow-up staff were blinded to group
assignment” at 3 months in collecting
the primary and secondary outcome data.
Medical records were abstracted by a nurse
blinded to group assignment to determine
if it was documented that there was an IPV
screen or diagnosis
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 32/199 (16.1%) LTFU in the interven-
tion group; 23/200 (11.5%) LTFU in the
control group. There is a lack of informa-
tion about whether or not reasons for with-
drawal/loss to follow-up differed between
the groups. However, the researchers indi-
cate “logistic regression of missing data be-
cause of attrition demonstrated no signif-
icant associations with variables associated
with the primary outcome measure, sup-
porting their being missing completely at
random”
Selective reporting (reporting bias) High risk There is no reference to a trial proto-
col. However, the trial was registered (AC-
TRN12607000210471) and some pre-se-
lected outcomes (e.g. SF-12) were not re-
ported here
Other bias Low risk No evidence of contamination, measures
are valid and reliable but some baseline dif-
ferences reported. “There were some po-
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tentially important group differences: com-
pared with women in the usual care group,
women in the treatment group were some-
what older (42 versus 38.5); more likely
to be New Zealand European (63% ver-
sus 58%) and more likely to have been
admitted to hospital (43% versus 36%).”
They were also less likely to be poorly ed-
ucated (with less than secondary school)
(17.1% versus 29.5%) but study analysis
tested and adjusted for baseline differences.
“Age and ethnicity were individually asso-
ciated with violence in the follow-up pe-
riod and included in the final model as de-
sign effects caused by differences at base-
line... the final best subset model included
measures of socioeconomic status... Hos-
mer and Lemeshow test statistic was NS”
MacMillan 2006
Methods Study design: quasi-randomised controlled trial
Randomisation method: randomised clinic days or shifts
Power calculation: yes
Study dates: from May 2004 to January 2005
Participants Setting: 2 EDs, family practices, and women’s health clinics
Country: Canada
Inclusion criteria: women were eligible for participation if they were: (1) 18 to 64 years
old, (2) at the site for their own healthcare visit, (3) able to separate themselves from
individuals who accompanied them, (4) able to speak and read English, (5) able to
provide informed consent
Exclusion criteria: too ill to participate
Number (%) of eligible recruited: 2461/2602 (94.4%)
Numbers assigned: 2461 intervention group 853, control group one 769, control group
two 839
Number of dropouts (varied by screening tool): intervention group 3.7% to 5.2%,
control group one 3.5% to 5.7%, control group two 1.5% to 3.0%
Numbers analysed (varied by screening tool): intervention group 788, control group one
741, control group two 810 (CAS); intervention group 404, control group one 725,
control group two 814 (PVS); intervention group 411, control group one 742, control
group two 826 (WAST)
Marital status: single/never married 41%
Ethnicity: born outside Canada 11%
Employment: working full- or part-time 52%
Income: annual income < CAD 25,000 47%
Education: achieved education > 14 years 52%
Children: ≥ 1 child at home 52%
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Interventions Intervention group
• Face-to-face screening by the HCP using 1 of the 2 screening instruments
randomly determined. Any disclosure became part of the clinical encounter and
women were offered usual care
Control groups
• Control group one: computer-based self completed screening using the PVS and
the WAST randomly ordered
• Control group two: written self completed screening using the PVS and the
WAST randomly ordered
Outcomes Primary outcomes
• Identification (12-month prevalence based on instrument compared to CAS)
• Extent of missing data
• Women’s preference for screening approach
Notes Funding: the Ontario Women’s Health Council (Ontario Ministry of Health and Long-
termCare). AuthorsMacMillan andWathenheldCanadian Institutes ofHealthResearch
grants/fellowships; Dr Boyle held a Canada Research Chair in the Social Determinants
of Child Health
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random number table was used to assign
clinic shifts
Allocation concealment (selection bias) High risk “The research coordinator created calen-
dars that informed site coordinators of the
assignments.”There is, therefore, a risk that
advance awareness of shift/day allocations
may have introduced selection bias in in-
tervention assignment by not protecting
the allocation sequence before and until as-
signment, for example, recruiters appear to
have had knowledge of the allocation prior
to inviting individuals into the study,which
could have influenced their behaviours dif-
ferentially
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The study did not specify a control condi-
tion and it was not feasible to blind partic-
ipants from the method of screening they
would receive. While any impact of non-
blinding on performance was likely to have
beendistributed similarly across thewritten
and computerised groups (who were told
their HCPs would be unaware of their re-
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sponses), it may have influenced the per-
formance of participants in the face-to-face
arm since their providers conducted the
screening and therefore “would necessar-
ily be aware of women’s responses.” In this
arm, it was also not feasible to blind per-
sonnel to the allocation following assign-
ment as they would have been informed by
the recruiter of the woman’s participation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessment was unable to be
blinded and based on women’s responses
to the screening instruments, self comple-
tion of the CAS, and their evaluation of
the method. It was therefore subjective, al-
though the extent of any systematic differ-
ences in responses is likely to be randomly
distributed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data collection was conducted immedi-
ately following the treatment. Although
there was slightly higher attrition (4%) in
the face-to-face arm of the trial, overall at-
trition was low at 5%. Reasons for missing
data were not supplied
Selective reporting (reporting bias) Low risk All specified outcomes reported. Trial was
registered (NCT00336297)
Other bias High risk A higher proportion of women in the com-
puter group were from the lowest income
quintile and may have been more likely to
both be abused and to disclose by computer
MacMillan 2009
Methods Study design: randomised controlled trial
Randomisation method: a table for each day/shift of the week was created for an 8-week
period and a random number table was used to determine the order of weeks 1 through
8 in the cells
Power calculation: yes
Study dates: from July 2005 to December 2006. Individual women were each followed
up for 18 months, starting in July 2005 and ending in July 2008
Participants Setting: 12 primary care sites (family practices and community health centres), 11 acute
care sites (EDs) and 3 speciality care sites (obstetrics/gynaecology)
Country: Canada
Inclusion criteria: women aged 18 to 64 years, had a male partner at some time in the
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last 12 months, presented for their own healthcare visit, able to separate themselves from
individuals who accompanied them, were living with 120 km of the site, were able to
speak and read English, and able to provide informed consent
Exclusion criteria: too ill to participate
Number (%) of eligible recruited: 6743/8293 (81.3%)
Numbers assigned: 6743; intervention group 3271, control group 3472
Number (%) of assigned that completed all healthcare visit questionnaires: 5681/6743
(84.3%); intervention group 2733, control group 2948
Number (%) with positive results and followed up: 707 (12.4%); intervention group
347, control group 360
Number of dropouts: intervention group 48, control group 148
Numbers analysed (and % with positive result) 411; intervention group 199 (57%),
control group 212 (59%)
*Age: intervention group mean 33.8 years (SD 10.8), control group mean 33.9 years
(SD 10.7)
Marital status: single/never married 41%
Ethnicity: born outside Canada 11%
Employment: working full- or part-time 52%
Income: annual income < CAD 25,000 47%
Education: intervention group mean 13.7 years (SD 2.8), control group mean 13.5 years
(SD 2.8)
Children: ≥ 1 child at home 52%
Interventions Intervention group
• Women in the screened group self completed the WAST; if a woman screened
positive this information was provided to her clinician before the healthcare visit.
Subsequent discussions or referrals, or both, were at the discretion of the HCP
Control group
• Women in the non-screened group self completed the WAST after their visit
Outcomes Primary outcomes
• Recurrence of IPV (CAS)
• Quality of life (WHO Quality of Life-Bref )
Timing of measurement: followed up baseline (< 14 days), 6, 12, 18 months post-
intervention (collected through self report by women)
We obtained clarification about the number of participants who discussed abuse with
their provider (MacMillan 2015 [pers comm])
Notes *Characteristics of participants are provided for the 707 women who had positive results
for IPV in last 12months. Age and education details for the group were obtained through
personal communication (MacMillan 2011 [pers comm])
Funding: the Ontario Women’s Health Council (Ontario Ministry of Health and Long-
TermCare) with investigator grants fromCanadian Institutes ofHealth Research. Author
Boyle held a Canada Research Chair in the Social Determinants of Child Health
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Randomisation was by day or shift. “A ta-
ble for each day of the week was created
for an 8-week period, and a random num-
ber table was used to determine the order
of weeks 1 through 8 in the cells.” This
suggests there was balance across shifts and
days of the week, and that systematic dif-
ferences in presentation by day or shift were
avoided
Allocation concealment (selection bias) High risk “The research coordinator createdmonthly
calendars showing shift allocations for site
coordinators.” There is, therefore, a risk
that advance awareness of shift/day alloca-
tions may have introduced selection bias
in intervention assignment by not protect-
ing the allocation sequence before and until
assignment. For example, recruiters would
likely have had knowledge of the alloca-
tion prior to inviting individuals into the
study, which could have influenced their
behaviours differentially
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not possible to protect the allocation
sequence after assignment given that partic-
ipants “were told that they might be asked
questions about their relationships by com-
pleting a form thatmay be passed onduring
this visit to the clinician, who might dis-
cuss their situation in more detail.” Thus,
participants may have had awareness that
theywere receiving an intervention (or not)
, which could have affected their perfor-
mance. It was also not feasible to blind per-
sonnel to the allocation following assign-
ment as they would have been prompted
by the questionnaire placed in the patient
record
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Interviewers blinded to group assignment
met with women within 14 days of the in-
dex visit to conduct a baseline interview
and again at 6, 12, and 18 months”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Participant loss to follow-up was high
but evenly balanced: 43% (148/347) in
screened women and 41% (148/360) in
non-screened women” over 18 months
making a true ITT analysis difficult. It
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was noted by authors that women in the
screened group who were LTFU reported
higher scores on theWAST and CAS. Such
differences between retained and lost were
not observed in the non-screened group.
Thus, there is a possibility that the observed
effect estimate is biased. In contrast, there
were no group differences in proportions
lost, or reasons for dropout, although those
LTFU in the intervention group were more
likely to be more severely abused. To deal
withmissing data, average growthmeasures
were estimated from 5 complete files gen-
erated through multiple imputation to test
the robustness of the observed findings for
all enrolled women
Selective reporting (reporting bias) Low risk All outcomes for all time points reported.
Trial was registered (NCT00182468)
Other bias High risk Protection against contamination: sites in-
volved both screening (intervention group)
and non-screening (control group) shifts/
days and therefore there is a risk that those
who were in the control group could have
received care that was influenced by physi-
cians’ prior experience of delivering the in-
tervention
Rhodes 2002
Methods Study design: quasi-randomised controlled trial
Randomisation method: alternate allocation of individual patients
Power calculation: none reported
Study dates: none reported
Participants Setting: 1 urban university hospital emergency department
Country: USA
Inclusion criteria: English-speaking women andmen, aged 18 to 65 years, who presented
for emergency care with a non-urgent complaint, and triaged into lowest 2 categories of
5-level system
Exclusion criteria: those in pain, blind, overtly psychotic, or unable to read
Number (%) of eligible recruited: 470/542 (86.7%) of which 322 (68.5%) were female
Numbers (of women) assigned: intervention group 170, control group 152
Number of dropouts: 20% of charts were missing, differences by arm unspecified
Numbers analysed (by groups into which they were allocated): intervention group 170,
control group 152
Age: mean (women) 33 years (intervention group), 41 years (control group)
Marital status (men and women): married 19% (intervention group), 27% (control
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group); single 60% (intervention group), 58% (control group); widowed/separated or
divorced 21% (intervention group), 15% (control group)
Ethnicity (all patients): Black; intervention group 91%, control group 90%
Insurance status (all patients): Medicaid, intervention group 37%, control group 40%;
Medicare, intervention group 17%, control group 19%; private, intervention group
34%, control group 27%; none, intervention group 12%, control group 14%
Reason for visit (all patients): medical, intervention group 50%, control group 58%; in-
jury, intervention group 27%, control group 23%; gynaecologic or urinary, intervention
group 20%, control group 18%; other, intervention group 3%, control group 1%
Interventions Intervention group
• Women completed a computer-based screen, which included other health lifestyle
and behavioural risks. Patients were then offered a computer printout to take with
them. Results on a one-page computer printout were attached to the patient’s ED
chart. This included a prompt to assess for DV if one or more DV questions were
answered positively. Resources for IPV support in hospital and in the community were
listed on the prompt
Control group
• Usual care
Outcomes • Documentation by physicians was assessed by blinded chart review
• Screen positive data were assessed from computer responses (in the intervention
group only)
This study also examined other psychosocial risks for both victimisation and perpetration
Notes Funding: theChicagoCommunity Trust (#6-35467), the RobertWood JohnsonClinical
Scholars Program, and the Section of Emergency Medicine, University of Chicago
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation method: “Patients were al-
ternately assigned to a computer-based in-
tervention or usual care.” This method is
open to selection bias and there is inade-
quate description of protection from such
bias
Allocation concealment (selection bias) Unclear risk Not all eligible patients were enrolled due
to limited computer availability. Further-
more, “to avoid selection bias, when the
computer was available, the patient to be
recruited was the one most recently arrived
and assigned as non-urgent at triage.” This
method remains fallible to bias, but it is
unclear whether it would have biased selec-
tion
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Results of screening were attached to the
patient file in order to alert the treating
physician to psychosocial issues as part of
the intervention. This meant that the treat-
ing physician was also made aware that
the patient was in the intervention group.
There was therefore a high risk of perfor-
mance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Chart reviewers were blinded to whether
a patient had participated in the computer
screening and whether these results were
shared with the treating physician and were
blinded to the assessment of the other chart
reviewer”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “Findings are based on a review of 80%
of charts. The percentage did not vary by
whether the patient had received computer
screening” - but detailed figures of and rea-
sons for the missing 20% are not given
Selective reporting (reporting bias) Unclear risk The trial was not registered so we were un-
able to check the selected outcomes, but as
it is a screening trial, identification, docu-
mentation and information-giving are ex-
pected outcome measures
Other bias High risk Characteristics of participants both male
and female were evenly distributed across
intervention and control groups, but it is
unclear how this applied to females. There
is a high risk of contamination as the partic-
ipants were screened or not screened alter-
nately and then saw their physician at the
1 clinic visit, with physicians seeing both
intervention and control participants
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Methods Study design: randomised controlled trial
Randomisation method: consenting women were randomly assigned in a 1:1 ratio. Treat-
ment assignment was ascertained by the research assistant by opening sealed randomisa-
tion envelopes in sequential order. The envelopes were prepared from a randomisation
list generated by computer in blocks of size 10 to ensure balance between groups over
short time spans such as shifts and days of the week as well as over the entire course of
the study
Power calculation: no
Study dates: from June 2001 to December 2002
Participants Setting: 2 socio-economically diverse EDs - an urban academic medical centre serving
mainly publicly insured inner city African-American population and a suburban com-
munity hospital serving a privately insured suburban white population
Country: USA
Inclusion criteria: consenting women, aged 18 to 65 years, triaged as medically non-
emergent
Exclusion criteria: none stated
Number (%) of eligible recruited: 1281/2165 (59.2%)
Numbers recruited: 1281; intervention group 637, control group 644
Number of dropouts: intervention group 216, control group 194
Numbers analysed (% recruited): 871; intervention group 421 (66.1%), control group
450 (70%) (based on audio-recording data)
Age: mean 33.3 years (SD 12 years)
Marital status: married 21%, single 45%, divorced/separated/widowed 13%, unknown
21%
Ethnicity: African-American 60%, white 29%, other 7%, unknown 4%
Socioeconomic status: < USD 20,000 40%, USD 20,000 to 39,999 24%, USD 40,000
to 79,999 16%, ≥ USD 80,000 8%
Education: 1 < high school diploma 10%, high school or equivalent 18%, > high school
48%, unknown 24%
Positive IPV screen result on exit questionnaire: 218/903 (24%); urban 151/578 (26%)
, suburban 67/325 (20.6%)
Interventions Intervention group
• Self administered computer-based health risk assessment (Promote Health
Survey), which generated health recommendations for participants and alerted
physicians to various potential health risks, including domestic violence. If the woman
answered ’yes’ to any of the 8 IPV assessment items, then the report generated for the
physician had a prompt ’Possible partner violence: assess for current abuse’ and
suggested referral options
Control group
• Usual ED care
Outcomes Primary outcomes
• Discussion of IPV
• Disclosure of IPV to HCP
• Provision of domestic violence services
Data were collected through audio-recording of consultations (primary method). Data
were also abstracted from medical records and collected directly from participants
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Notes Funding: Grant RO1HS 11096-03 from the Agency for Healthcare Research and Qual-
ity. Dr Rhodes was also supported by grant K23/ MH64572 from the National Institute
of Mental Health
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation for participating pa-
tientswas generated by “computer in blocks
of size 10 to ensure balance between groups
over short time spans, such as shifts and
days of the week, as well as over the entire
course of the study.”
Allocation concealment (selection bias) Low risk Womenwere recruited and consented prior
to the “research assistant opening sealed
randomization envelopes in sequential or-
der.” “Consenting patients were then ran-
domly assigned”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers were not blinded to the purpose
of the study or the intervention: “health
care providers were informed that the study
objective was to study the effect of a com-
puter prompt on IPV communication and
were encouraged to screen all women for
abuse.” However, this was unlikely to have
led to benefits extraneous to the intended
effect of the intervention for women in the
intervention group; the outcome of inter-
est is unlikely to have been influenced by
lack of blinding. Women were blinded to
the purpose of the study being told it was
a “study of physician-patient communica-
tion.” Women in the intervention group
may have realised that the computer-based
health risk assessment was part of the in-
tervention thus influencing how they be-
haved. However, we would not expect that
the outcome would have been influenced
by this incomplete blinding. For example,
changes in women’s behaviour such as be-
ing more encouraged to discuss IPV with
theHCPwouldnot differ fromwhatwould
be expected to arise from the intervention.
Lack of blinding in the situation where
participants in the control group inadver-
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tently became aware of the intervention
through interactions with other women or
staff could conceivably have influenced the
outcome. We are not given sufficient in-
formation about the degree of awareness of
other staff regarding women’s allocations,
which could have influenced their interac-
tions with women and, therefore, the out-
comes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk We are not told about who edited the au-
dio-recordings of the ED visits “a 7-hour
ED visit might be edited to 20 minutes
of actual health care provider-patient in-
teraction”; it would have been important
for them to be blinded as knowing the
allocation could have affected the editing
process. Although research assistants who
were to undertake the primary data col-
lection via coding of audio-recordings of
both intervention and control group con-
sultations were said to be blinded, the al-
location of participants could have been
revealed during the remaining audio data
and thereby influenced coders’ interpre-
tation of what they heard. It is also not
known if the person who edited differed
from the coders. If the coder was also the
editor then it would have increased the like-
lihood that the allocation of the partici-
pant would have become known. “Charts
of all enrolled patients were coded using
a structured chart abstraction form to as-
sess evidence of DV documentation;” how-
ever, there is no indication of blinding of
assessors. It is likely that the allocations
of women in the intervention group were
quite evident by virtue of presence of the
IPV risk report and it is unclear if presence
of a report was considered different to other
documentationof IPV. Finally, both groups
of women self completed an exit survey and
were not blinded; however, any effect was
likely equal in both groups
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 21/101 (21%) providers did not consent
to having their consultations recorded and
thus there was incomplete outcome data
for their participants. However, this lack
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of recording should have been equal in
both groups since providers were seeing
participants in both the intervention and
the control groups. The overall attrition
of participants was 32% and we are not
given clear information about the extent to
which the providers’ refusal to audio-record
sessions accounted for this rate (i.e. what
proportion of patients declined the audio-
recording post-randomisation). While the
attrition levels in audio-recording appear
balanced across the two groups: 216/637
(intervention group 34%), 194/644 (con-
trol group 30.1%), there was no sensitiv-
ity analysis included in the report to ascer-
tain the impact of those missing data on the
robustness of the effect. Attrition rates on
chart review were similarly spread and low
at 8%, and moderately high but spread on
the exit survey. There is a lack of informa-
tion on reasons for these (albeit low) attri-
tion rates in the chart review. There were
four cases in the control group that appear
in the participant flowchart but are absent
from the observed rates in Table 3
Selective reporting (reporting bias) Unclear risk Data onmedical recordswere not furnished
except that it is indicated in the text that
there was no difference between groups on
the documentation of IPV. No reference to
a trial protocol and thus no confirmation
that the original trial aims and primary out-
comes were as reported here
Other bias High risk Protection against contamination: the same
providers delivered the intervention or
usual care to participants. While they
should have remained unaware of who the
participantswere in the control group, their
experience of consulting with participants
in the intervention group could have influ-
enced their performance with the partici-
pants in the control group
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Methods Study design: quasi-experimental control study
Randomisation method: there were 3 distinct consecutive 2-week enrolment periods. In
the second enrolment period all eligible women who presented to the ED were assigned
to the intervention group. During the first and third enrolment periods all eligible
presenting women were allocated to a TCG
Power calculation: yes
Study dates: enrollment occurred between April and May 2003
Participants Setting: adult urban ED of a large university hospital serving a primarily socio-econom-
ically disadvantaged, minority population
Country: USA
Inclusion criteria: women aged≥ 18yearswhopresented to the ED formedical treatment
Exclusion criteria: acute or critically ill presentation, illiteracy, impaired mental status,
disorientation or apparent intoxication, would not separate from their partner; or already
enrolled
Numbers (%) of eligible recruited: 1005/1395 (72%)
Numbers recruited: 1005; intervention group 411, control group 594
Number of dropouts: intervention group 0, control group 0
Numbers analysed (% recruited): 1005; intervention group 411 (100%), control group
594 (100%)
Age range (years): 18 to 24 years 22.9%, 25 to 34 years 23.3%, 35 to 54 years 41.4%,
≥ 55 years 12.4%
Marital status: married/living with partner 20%, never married 53.8%, divorced/sepa-
rated 21%, widowed 5.2%
Ethnicity: White 16.1%, Non-white 83.9%
Socioeconomic status (annual household income): < USD 10,000 42.4%, USD 10,000
to 15,999 20.6%, USD 16,000 to 20,999 12.2%, USD 21,000 to 35,999 14.8%, ≥
USD 36,000 10%
Education: < high school 30.5%, high school or equivalent 42.3%, > high school 27.
2%
Children in household: yes 50.9%
Interventions Intervention group
• Self administered computer-based health survey, including 4 items about IPV. If
the woman answered yes to any of the 4 IPV assessment items, then 2 reports were
generated. One copy was attached to the woman’s medical record to alert treating staff
and the second copy was placed in a box for social work referral
Control group
• Self administered computer-based health survey containing no items about IPV
and usual ED care (consisting of current ED policy that recommended but did not
enforce routine IPV screening)
Outcomes Primary outcomes
• Screening
• Detection
• Referral
• Service rates
Timing of measurement: immediate abstraction of data from medical records
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Notes Funding: no external funding
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk During 3 distinct, consecutive, 2-week en-
rolment periods, all eligible women were
asked to complete a computer-based health
survey. During the first and third enrol-
ment periods, the computer-based health
survey did not include any IPV items. Dur-
ing the second enrolment period, it did in-
clude IPV screening items. It is likely that
this type of allocation process introduced a
high risk of bias due to systematic differ-
ences between the intervention group and
the control group
Allocation concealment (selection bias) High risk Patient service co-ordinators recruited and
obtained consent from participants. There
was no blinding of recruiters to the po-
tential allocation of women as the alloca-
tion for the period during which women
presented to the ED was defined in ad-
vance and not concealed in any way ex-
plained in the report. Therefore, awareness
of the allocation could have influenced how
women were recruited. Furthermore, the
experimental allocation for that periodmay
have become inadvertently known to some
women through interactions with other
participants and staff influencing their de-
cision to participate or not
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women approached were told that this was
a study about women’s health whereby they
would be “asked to answer questions about
themselves on a computer and to allow
theirmedical record to be reviewedby study
personnel.” Thus, there was some blind-
ing of women to the purpose of the study.
However, healthcare personnel were un-
blinded as “the medical records of all sub-
jects were attached by coordinators to par-
ticipants medical records to alert treating
staff ”
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated that research assistant was un-
blinded as “the medical records of all sub-
jects were reviewed by a research assistant
to determine whether there was any docu-
mentation in the record”
Incomplete outcome data (attrition bias)
All outcomes
Low risk There were no dropouts although we ac-
knowledge that it was unclear how trialists
dealt with missing data within variables
Selective reporting (reporting bias) Unclear risk There was no reference to a study proto-
col and therefore insufficient information
to permit a judgement of ’low’ or ’high’ risk
of bias
Other bias High risk Protection against contamination: the pro-
cess of the providers consulting with
women in the control group in the third,
2-week block following the 2-week inter-
vention group block could have contam-
inated their interactions with participants
in the control group. In fact, the authors
state, “Three study periods were used to de-
termine whether usual care related to in-
timate partner violence would return to
baseline (i.e. first enrolment period) in the
third enrolment period when the intimate
partner violence questions were removed
or whether it would be higher as a result
of the computerized intimate partner vio-
lence screening during the second study pe-
riod”. There is some risk that an insensi-
tive instrument was used to measure refer-
rals with referrals applying to social work-
ers only (which could have led to an under-
estimate of physician referring)
A-CASI: audio computer-assisted self interviews; ALPHA: Antenatal Psychosocial Health Assessment; CAS: Composite Abuse Scale;
CASI: computer-assisted screening interview; CES-D: Centre for Epidemiological Studies - Depression; ED: emergency department;
FTFI: face-to-face interview screening; HCP: healthcare professional; IPV: intimate partner violence; ITT: intention-to-treat; LTFU:
loss to follow-up; NS: non-significant; PVS: Partner Violence Screen; CTS2S: Revised Conflict Tactics Scale-Short Form; RCT:
randomised controlled trial; RR: risk ratio; SD: standard deviation; SF: Short Form; TCG: treatment control group; VAWS: Violence
Against Women Scale; WAST: Woman Abuse Screening Tool; WIC: Women, Infants, Children’s (clinic)
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bair-Merritt 2006 Screening results not passed on to healthcare professional
Beatty 2014 Screening results not passed on to healthcare professional
Bonds 2006 Not a randomised or quasi-random method
Brienza 2005 Educational intervention targeted to clinicians with no data on women
Campbell 2001 Case-finding not screening
Chen 2007 No usual care group comparison
Coonrod 2000 Educational intervention targeted to clinicians with no data on women
Cripe 2010 Intervention exceeded ’brief ’ intervention
Curry 2006 Intervention exceeded ’brief ’ intervention
Dubowitz 2011 Intervention targeted to children and clinicians
Dubowitz 2012 Intervention targeted to children and clinicians
Duggan 2004 Intervention exceeded ’brief ’ intervention
Ernst 2007 No usual care group comparison
Feder 2011 Case-finding not screening trial
Feigelman 2011 Intervention targeted to children and clinicians
Fernández Alonso 2006 Educational intervention targeted to clinicians with no data on women
Florsheim 2011 Intervention exceeded ’brief ’ intervention
Furbee 1998 Not a randomised or quasi-random method
Garg 2007 Participant data included both sexes and could not be disaggregated
Gillum 2009 Intervention exceeded ’brief ’ intervention
Green 2005 Intervention exceeded ’brief ’ intervention
Halpern 2009 Not a randomised or quasi-randomised method
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Hegarty 2013 Intervention exceeded ’brief ’ intervention
Hewitt 2011 Not a randomised or quasi-randomised method
Hoelle 2014 Screening results not passed on to healthcare professional
Hollander 2001 Usual care included screening results given to healthcare professional
Houry 2011 Screening results not passed on to healthcare professional
Jewkes 2008 Intervention exceeded ’brief ’ intervention
Kapur 2011 Not a randomised or quasi-randomised method
Kiely 2010 Intervention exceeded ’brief ’ intervention
Kiely 2013 Not a comparison of screening with usual care
Klevens 2012b Screening results not passed on to healthcare professional
Knight 2000 Not a randomised or quasi-randomised method
Larkin 1999 Not a randomised or quasi-randomised method
Rickert 2009 No usual care group comparison
Robinson-Whelen 2010 Not in a healthcare setting
Saftlas 2014 Intervention exceeded ’brief ’ intervention
Subramanian 2012 Intervention exceeded ’brief ’ intervention
Taft 2011 Intervention exceeded ’brief ’ intervention
Taft 2012 Screening result passed on to healthcare professional in both arms
Thompson 2000 Case-finding not screening
Tiwari 2010 Intervention exceeded ’brief ’ intervention
Wagman 2015 Intervention exceeded ’brief ’ intervention
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Characteristics of ongoing studies [ordered by study ID]
NCT01207258
Trial name or title Social Health Intervention Project (SHIP)
Methods Randomised controlled trial
Participants Inclusion criteria
• Female patients
• Aged 18 to 64 years
• Presenting to 1 of 2 urban emergency departments
• Self disclose both problem drinking and intimate partner violence
Exclusion criteria
• Intoxication at the time of screening
• Cognitive impairment or psychosis identified on physical examination or chart review
• Serious current medical illness or injury, defined as respiratory distress, haemodynamic instability,
active vomiting, bleeding, labour, severe pain, or acute need for hospital admission
• Suicidal or homicidal ideation by chart review
• No identifiable residence or contact phone number
• Under arrest at the time of ED visit
• Non-English speaking
• Previously enrolled in the study
Interventions Intervention
• Brief manual-guided motivational intervention and a phone booster at 10 days
Control
• Usual care including an ’assessed’ control group and a no contact control group
Outcomes Primary outcomes
• Episodes of heavy drinking
• Incidents of intimate partner violence
Timing of measurement: assessed weekly by Interactive Voice Response System for 12 weeks, and at 3, 6, and
12 months by interviewers blinded to group assignment
Starting date Trial is complete and under review
Contact information Karin.rhodes@uphs.upenn.edu
Notes Funding: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Award R01-AA018705
NCT01661504
Trial name or title Evaluating a health care provider delivered intervention to reduce intimate partner violence and mitigate
associated health risks: study protocol for a randomized controlled trial in Mexico City
Methods Cluster-randomised controlled trial
Participants Inclusion criteria
• Healthcare professionals (nurses)
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• Women currently experiencing abuse in a heterosexual relationship
◦ 18 to 44 years of age
◦ Non-pregnant or in first trimester
Exclusion criteria: cognitive impairment (e.g. slurred speech), seeking treatment for life-threatening emergency
care, and intending to relocate within 2 years
Interventions Intervention
• Nurses meeting eligibility criteria in treatment groups received an intensive training on screening for
IPV, providing supportive referrals, and assessing for health and safety risks
Control
• Women in the control clinics were given a referral card containing general information on IPV and a
list of resources, which was consistent with the current goal for standard of care in the Mexico City MoH
Outcomes Primary outcomes
• Past-year IPV (physical or sexual, or both)
• Reproductive coercion
• Safety planning
• Use of community resources
• Quality of life.
Timing of measurement: surveys conducted at baseline, 3 months, and 15 months from baseline
Starting date Trial was conducted between 2012 and 2015
Contact information Jhumka Gupta
Yale University
jhumka.gupta@yale.edu
Notes The study is funded by an anonymous donor. This work was supported, in part, by Yale University’s Center
for Interdisciplinary Research on AIDS (CIRA), through grants from the National Institute of Mental Health
(P30MH062294)
ED: emergency department; IPV: intimate partner violence.
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D A T A A N D A N A L Y S E S
Comparison 1. Universal screening for intimate partner violence (IPV) versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Identification of IPV by health
professionals
8 10074 Odds Ratio (M-H, Random, 95% CI) 2.95 [1.79, 4.87]
2 Identification of IPV by type of
healthcare setting
7 4393 Odds Ratio (M-H, Random, 95% CI) 2.35 [1.53, 3.59]
2.1 Antenatal clinics 2 663 Odds Ratio (M-H, Random, 95% CI) 4.53 [1.82, 11.27]
2.2 Maternal health services 1 829 Odds Ratio (M-H, Random, 95% CI) 2.36 [1.14, 4.87]
2.3 Emergency departments
(EDs)
3 2608 Odds Ratio (M-H, Random, 95% CI) 2.72 [1.03, 7.19]
2.4 Hospital-based primary
care
1 293 Odds Ratio (M-H, Random, 95% CI) 1.53 [0.79, 2.94]
3 Referrals 2 1298 Odds Ratio (M-H, Random, 95% CI) 2.24 [0.64, 7.86]
Comparison 2. Face-to-face screening for intimate partner violence (IPV) versus written/computer-based screening
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Identification of IPV 4 2765 Odds Ratio (M-H, Random, 95% CI) 1.12 [0.53, 2.36]
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Analysis 1.1. Comparison 1 Universal screening for intimate partner violence (IPV) versus control,
Outcome 1 Identification of IPV by health professionals.
Review: Screening women for intimate partner violence in healthcare settings
Comparison: 1 Universal screening for intimate partner violence (IPV) versus control
Outcome: 1 Identification of IPV by health professionals
Study or subgroup Screened group Control group Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ahmad 2009 25/144 18/149 15.7 % 1.53 [ 0.79, 2.94 ]
Carroll 2005 6/112 2/141 6.6 % 3.93 [ 0.78, 19.88 ]
Fraga 2014 51/594 9/235 14.8 % 2.36 [ 1.14, 4.87 ]
Humphreys 2011 18/205 4/205 10.6 % 4.84 [ 1.61, 14.55 ]
MacMillan 2009 88/2733 17/2948 17.4 % 5.74 [ 3.40, 9.67 ]
Rhodes 2002 17/170 1/152 4.8 % 16.78 [ 2.21, 127.66 ]
Rhodes 2006 42/637 28/644 17.8 % 1.55 [ 0.95, 2.54 ]
Trautman 2007 12/411 7/594 12.2 % 2.52 [ 0.98, 6.46 ]
Total (95% CI) 5006 5068 100.0 % 2.95 [ 1.79, 4.87 ]
Total events: 259 (Screened group), 86 (Control group)
Heterogeneity: Tau2 = 0.31; Chi2 = 20.82, df = 7 (P = 0.004); I2 =66%
Test for overall effect: Z = 4.22 (P = 0.000024)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours control group Favours screened group
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Analysis 1.2. Comparison 1 Universal screening for intimate partner violence (IPV) versus control,
Outcome 2 Identification of IPV by type of healthcare setting.
Review: Screening women for intimate partner violence in healthcare settings
Comparison: 1 Universal screening for intimate partner violence (IPV) versus control
Outcome: 2 Identification of IPV by type of healthcare setting
Study or subgroup Screened group Control group Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Antenatal clinics
Carroll 2005 6/112 2/141 5.9 % 3.93 [ 0.78, 19.88 ]
Humphreys 2011 18/205 4/205 10.9 % 4.84 [ 1.61, 14.55 ]
Subtotal (95% CI) 317 346 16.8 % 4.53 [ 1.82, 11.27 ]
Total events: 24 (Screened group), 6 (Control group)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 3.25 (P = 0.0012)
2 Maternal health services
Fraga 2014 51/594 9/235 18.6 % 2.36 [ 1.14, 4.87 ]
Subtotal (95% CI) 594 235 18.6 % 2.36 [ 1.14, 4.87 ]
Total events: 51 (Screened group), 9 (Control group)
Heterogeneity: not applicable
Test for overall effect: Z = 2.32 (P = 0.020)
3 Emergency departments (EDs)
Rhodes 2002 17/170 1/152 3.9 % 16.78 [ 2.21, 127.66 ]
Rhodes 2006 42/637 28/644 26.4 % 1.55 [ 0.95, 2.54 ]
Trautman 2007 12/411 7/594 13.6 % 2.52 [ 0.98, 6.46 ]
Subtotal (95% CI) 1218 1390 43.9 % 2.72 [ 1.03, 7.19 ]
Total events: 71 (Screened group), 36 (Control group)
Heterogeneity: Tau2 = 0.45; Chi2 = 5.77, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 2.01 (P = 0.044)
4 Hospital-based primary care
Ahmad 2009 25/144 18/149 20.7 % 1.53 [ 0.79, 2.94 ]
Subtotal (95% CI) 144 149 20.7 % 1.53 [ 0.79, 2.94 ]
Total events: 25 (Screened group), 18 (Control group)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
Total (95% CI) 2273 2120 100.0 % 2.35 [ 1.53, 3.59 ]
Total events: 171 (Screened group), 69 (Control group)
Heterogeneity: Tau2 = 0.11; Chi2 = 9.68, df = 6 (P = 0.14); I2 =38%
Test for overall effect: Z = 3.94 (P = 0.000082)
Test for subgroup differences: Chi2 = 3.74, df = 3 (P = 0.29), I2 =20%
0.01 0.1 1 10 100
Favours control group Favours screened group
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Analysis 1.3. Comparison 1 Universal screening for intimate partner violence (IPV) versus control,
Outcome 3 Referrals.
Review: Screening women for intimate partner violence in healthcare settings
Comparison: 1 Universal screening for intimate partner violence (IPV) versus control
Outcome: 3 Referrals
Study or subgroup Screened group Control group Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ahmad 2009 3/144 1/149 30.4 % 3.15 [ 0.32, 30.63 ]
Trautman 2007 4/411 3/594 69.6 % 1.94 [ 0.43, 8.70 ]
Total (95% CI) 555 743 100.0 % 2.24 [ 0.64, 7.86 ]
Total events: 7 (Screened group), 4 (Control group)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.12, df = 1 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Face-to-face screening for intimate partner violence (IPV) versus
written/computer-based screening, Outcome 1 Identification of IPV.
Review: Screening women for intimate partner violence in healthcare settings
Comparison: 2 Face-to-face screening for intimate partner violence (IPV) versus written/computer-based screening
Outcome: 1 Identification of IPV
Study or subgroup Face-to-face group
Written/computer
group Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Fincher 2015 84/191 50/177 29.5 % 1.99 [ 1.29, 3.08 ]
Kataoka 2010 16/165 7/163 21.9 % 2.39 [ 0.96, 5.98 ]
Klevens 2012a 4/46 17/80 18.3 % 0.35 [ 0.11, 1.12 ]
MacMillan 2006 35/404 173/1539 30.2 % 0.75 [ 0.51, 1.10 ]
Total (95% CI) 806 1959 100.0 % 1.12 [ 0.53, 2.36 ]
Total events: 139 (Face-to-face group), 247 (Written/computer group)
Heterogeneity: Tau2 = 0.44; Chi2 = 17.52, df = 3 (P = 0.00055); I2 =83%
Test for overall effect: Z = 0.31 (P = 0.76)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours written/computer Favours face-to-face
A P P E N D I C E S
Appendix 1. Search strategies used for 2015 update
Cochrane Central Register of Controlled Trials (CENTRAL)
CENTRAL 2015, Issue 1, searched 17 February 2015. Limited to publication year = 2012 to 2015 [41 records]
#1 MeSH descriptor: [Battered Women] explode all trees
#2 MeSH descriptor: [Domestic Violence] this term only
#3 MeSH descriptor: [Spouse Abuse] this term only
#4 “domestic violence”
#5 abuse* near/3 spous*
#6 abuse* near/3 partner*
#7 wife near/3 abuse*
#8 wives near/3 abuse*
#9 wife near/3 batter*
#10 wives near/3 batter*
#11 batter* near/3 wom*n
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#12 partner* near/3 violen*
#13 spous* near/3 violen*
#14 domestic next violence
#15 gender near/3 violenc*
#16 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#17 MeSH descriptor: [Mass Screening] this term only
#18 MeSH descriptor: [Medical History Taking] this term only
#19 screen*
#20 identif*
#21 routine* near/3 ask*
#22 routine* near/3 question*
#23 (medical history) or (history near/1 tak*)
#24 disclos*
#25 detect*
#26 #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
#27 MeSH descriptor: [Women] explode all trees
#28 MeSH descriptor: [Female] explode all trees
#29 MeSH descriptor: [Adolescent] explode all trees
#30 wom*n or female*
#31 adolescen*
#32 teen*
#33 #27 or #28 or #29 or #30 or #31 or #32
#34 #16 and #26 and #33 Publication Year from 2012 to 2015, in Trials
Ovid MEDLINE(R)
OvidMEDLINE(R) 1946 to February Week 2 2015, searched 17 February 2015. Limited to ed=20120601 to 20150205 [777 records]
1 Battered Women/
2 Domestic Violence/
3 Spouse Abuse/
4 (abuse$ adj3 wom#n).tw.
5 (abuse$ adj3 spous$).tw.
6 (abuse$ adj3 partner$).tw.
7 (abuse$ adj3 (wife or wives)).tw.
8 (batter$ adj3 (wife or wives)).tw.
9 (batter$ adj3 wom#n).tw.
10 domestic violence.tw.
11 (partner$ adj3 violen$).tw.
12 (spous$ adj3 violen$).tw.
13 (gender adj3 violen$).tw.
14 or/1-13
15 Mass Screening/
16 Medical History Taking/
17 screen$.tw.
18 identif$.tw.
19 detect$.tw.
20 disclos$.tw.
21 (medical history or (history adj1 tak$)).tw.
22 (routine$ adj3 (ask$ or question$)).tw.
23 or/15-22
24 exp Women/
25 Female/
26 Adolescent/
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27 (wom#n or female$).tw.
28 adolescen$.tw.
29 teen$.tw.
30 or/24-29
31 14 and 23 and 30
32 limit 31 to ed=20120601-20150205
Ovid MEDLINE In-process and other non-indexed citations
Ovid MEDLINE In-process February 13 2015, last searched 17 February 2015 [253 records]
1 (abuse$ adj3 wom#n).tw.
2 (abuse$ adj3 spous$).tw.
3 (abuse$ adj3 partner$).tw.
4 (abuse$ adj3 (wife or wives)).tw.
5 (batter$ adj3 (wife or wives)).tw.
6 (batter$ adj3 wom#n).tw.
7 (partner$ adj3 violen$).tw.
8 (spous$ adj3 violen$).tw.
9 domestic violence.tw.
10 (gender adj3 violen$).tw.
11 or/1-10
12 screen$.tw.
13 identif$.tw.
14 (routine$ adj3 (ask$ or question$)).tw.
15 ((history adj3 tak$) or medical history).tw.
16 detect$.tw.
17 disclos$.tw.
18 or/12-17
19 (wom#n or female$).tw.
20 adolescen$.tw.
21 teen$.tw.
22 or/19-21
23 11 and 18 and 22
Embase (Ovid)
Embase 1980 to 2015 Week 07, searched 17 February 2015. Limited to publication year=2012 to current [1187 records]
1 partner violence/
2 Domestic Violence/
3 marital rape/
4 (abuse$ adj3 wom#n).tw.
5 (abuse$ adj3 spous$).tw.
6 (abuse$ adj3 partner$).tw.
7 (abuse$ adj3 (wife or wives)).tw.
8 (batter$ adj3 (wife or wives)).tw.
9 (batter$ adj3 wom#n).tw.
10 domestic violence.tw.
11 (partner$ adj3 violen$).tw.
12 (spous$ adj3 violen$).tw.
13 (gender adj3 violen$).tw.
14 or/1-13
15 Mass Screening/
16 Screening/
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17 anamnesis/
18 screen$.tw.
19 identif$.tw.
20 (routine$ adj3 (ask$ or question$)).tw.
21 ((medical history or history) adj1 tak$).tw.
22 detect$.tw.
23 disclos$.tw.
24 or/15-23
25 exp Women/
26 Adolescent/
27 (wom#n or female$).tw.
28 adolescen$.tw.
29 teen$.tw.
30 or/25-29
31 14 and 24 and 30
32 limit 31 to yr=“2012 -Current” (1187)
CINAHL Plus (EBSCOhost)
CINAHL Plus 1937 to current searched 17 February 2015. Limited to EM = 20120601 onwards [532 records]
S26 S24 AND S25
S25 EM 20120601-
S24 S8 AND S17 AND S23
S23 S18 OR S19 OR S20 OR S21 OR S22
S22 TI (adolescen* or teen*) OR AB (adolescen* or teen*)
S21 (MH “Adolescence”)
S20 TI(wom?n or female*) OR AB(wom?n or female*)
S19 (MH “Women”)
S18 (MH “Female”)
S17 S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16
S16 TI(routine* N3 (ask* or question*)) OR AB(routine* N3 (ask* or question*))
S15 TI(detect* or identif* or disclos*) OR AB(detect* or identif* or disclos*)
S14 TI(medical history) or AB(medical history)
S13 TI(history N1 tak*) or AB(history N1 tak*)
S12 TI(screen*) or AB(screen*)
S11 (MH “Patient History Taking”)
S10 (MH “Patient Assessment”)
S9 (MH “Health Screening”)
S8 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7
S7 TI(domestic violence) or AB (domestic violence)
S6 TI(partner* or spouse* or gender) N3 (violen*)) or AB(partner* or spouse* or gender) N3 (violen*))
S5 TI(batter* N3 (wom?n or wife or wives)) OR AB(batter* N3 (wom?n or wife or wives))
S4 TI(abuse* N3 (wom?n or spouse* or partner* or wife or wives ))or AB(abuse* N3 (wom?n or spouse* or partner* or wife or wives ))
S3 (MH “Battered Women”)
S2 (MH “Domestic Violence”)
S1 (MH “Intimate Partner Violence”)
PsycINFO (Ovid)
PsycINFO 1806 to February Week 2 2015, searched 17 February 2015. Limited to up=20120604 to 20150209 [726 records]
1 Battered Females/
2 Domestic Violence/
3 Partner Abuse/
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4 Intimate Partner Violence/
5 (abuse$ adj3 wom#n).tw.
6 (abuse$ adj3 spous$).tw.
7 (abuse$ adj3 partner$).tw.
8 (abuse$ adj3 (wife or wives)).tw.
9 (batter$ adj3 wom#n).tw.
10 (batter$ adj3 (wife or wives)).tw.
11 (partner$ adj3 violen$).tw.
12 (spous$ adj3 violen$).tw.
13 domestic violence.tw.
14 (gender adj3 violen$).tw.
15 or/1-14
16 Screening/
17 Patient history/
18 screen$.tw.
19 identif$.tw.
20 detect$.tw.
21 disclos$.tw.
22 (routine$ adj3 (ask$ or question$)).tw.
23 (medical history or (history adj1 tak$)).tw.
24 or/16-23
25 exp Women/
26 (wom#n or female$).tw.
27 adolescen$.tw.
28 teen$.tw.
29 or/25-28
30 15 and 24 and 29
31 limit 30 to up=20120604-20150209
Sociological Abstracts (ProQuest)
Sociological Abstracts 1952 to current, searched 17 February 2015. Limited by year=2012 to 2015 [287 records]
(SU.EXACT(“Females”) OR SU.EXACT(“adolescents”) OR (wom*n OR female*) OR (adolescent* OR teen*)) AND ((screen*) OR
(identif*) OR ((routine* NEAR/3 question*) OR (routine* NEAR/3 ask*)) OR (detect*) OR (disclos*)) AND (SU.EXACT((“Family
violence”)) OR SU.EXACT((“Partner Abuse”) OR (“Battered Women”)) OR (abuse NEAR/3 wom*n) OR (abuse NEAR/3 spouse*)
OR (abuse NEAR/3 partner*) OR (wife NEAR/3 abuse*) OR (wives NEAR/3 abuse*) OR (wife NEAR/3 batter*) OR (wives NEAR/3
batter*) OR (women NEAR/3 batter*) OR (partner* NEAR/3 violen*) OR (spouse* NEAR/3 violen*) OR (gender NEAR/3 violen*)
OR (“domestic violence”)) Limits applied Narrowed by Entered date: 2012 to 2015
Conference Proceedings Citation Index - Social Science and Humanities (CPCI-SS&H; Web of Science)
CPCI-SS&H 1990 to 17 February, searched 17 February 2015. No date limits [73 records]
# 8 #7 AND #6
# 7 TS=(women* or female* or adolescen* or teen*) Indexes=CPCI-SSH Timespan=All years
# 6 #5 AND #4 Indexes=CPCI-SSH Timespan=All years
# 5 TS=(screen* or identif* or disclos* or detect* or (routin* NEAR/3 question*) or ( tak* NEAR/1 history) or “medical history”)
Indexes=CPCI-SSH Timespan=All years
# 4 #3 OR #2 OR #1 Indexes=CPCI-SSH Timespan=All years
# 3 TS=(batter* NEAR/3 ( wife or wives or women )) Indexes=CPCI-SSH Timespan=All years
# 2 TS=(abuse* NEAR/3 ( spous* or partner* or wife or wives )) Indexes=CPCI-SSH Timespan=All years
# 1 TS=(((gender* or spous* or partner*) NEAR/3 violen*) or “domestic violence” ) Indexes=CPCI-SSH Timespan=All years
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Cochrane Database of Systematic Reviews (CDSR), part of the Cochrane Library
CDSR 2015 Issue 2, searched 17 February 2015. No date limits [4 records]
#1 MeSH descriptor: [Battered Women] explode all trees
#2 MeSH descriptor: [Domestic Violence] this term only
#3 MeSH descriptor: [Spouse Abuse] this term only
#4 (abuse* near/3 wom*n):ti,ab
#5 (abuse* near/3 spous*):ti,ab
#6 (abuse* near/3 partner*):ti,ab
#7 (wife near/3 abuse*):ti,ab
#8 (wives near/3 abuse*):ti,ab
#9 (wife near/3 batter*):ti,ab
#10 (wives near/3 batter*):ti,ab
#11 (batter* near/3 wom*n):ti,ab
#12 (partner* near/3 violen*):ti,ab
#13 (spous* near/3 violen*):ti,ab
#14 (domestic next violence):ti,ab
#15 gender near/3 violenc*:ti,ab
#16 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#17 MeSH descriptor: [Mass Screening] this term only
#18 MeSH descriptor: [Medical History Taking] this term only
#19 screen*:ti,ab
#20 identif*:ti,ab
#21 ((medical history) or (history near/1 tak*)):ti,ab
#22 routine* near/3 ask*:ti,ab
#23 routine* near/3 question*:ti,ab
#24 disclos*:ti,ab
#25 detect*:ti,ab
#26 #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
#27 MeSH descriptor: [Women] explode all trees
#28 MeSH descriptor: [Female] explode all trees
#29 MeSH descriptor: [Adolescent] explode all trees
#30 (wom*n or female*):ti,ab
#31 adolescen*:ti,ab
#32 teen*:ti,ab
#33 #27 or #28 or #29 or #30 or #31 or #32
#34 #16 and #26 and #33 in Cochrane Reviews (Reviews and Protocols)
Database of Abstracts of Reviews of Effects (DARE), part of the Cochrane Library
DARE 2015 Issue 1, searched 17 February 2015. Limited to year=2012 to 2015 [3 records]
#1 MeSH descriptor: [Battered Women] explode all trees
#2 MeSH descriptor: [Domestic Violence] this term only
#3 MeSH descriptor: [Spouse Abuse] this term only
#4 (abuse* near/3 wom*n):ti,ab
#5 (abuse* near/3 spous*):ti,ab
#6 (abuse* near/3 partner*):ti,ab
#7 (wife near/3 abuse*):ti,ab
#8 (wives near/3 abuse*):ti,ab
#9 (wife near/3 batter*):ti,ab
#10 (wives near/3 batter*):ti,ab
#11 (batter* near/3 wom*n):ti,ab
#12 (partner* near/3 violen*):ti,ab
#13 (spous* near/3 violen*):ti,ab
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#14 (domestic next violence):ti,ab
#15 gender near/3 violenc*:ti,ab
#16 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#17 MeSH descriptor: [Mass Screening] this term only
#18 MeSH descriptor: [Medical History Taking] this term only
#19 screen*:ti,ab
#20 identif*:ti,ab
#21 ((medical history) or (history near/1 tak*)):ti,ab
#22 routine* near/3 ask*:ti,ab
#23 routine* near/3 question*:ti,ab
#24 disclos*:ti,ab
#25 detect*:ti,ab
#26 #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
#27 MeSH descriptor: [Women] explode all trees
#28 MeSH descriptor: [Female] explode all trees
#29 MeSH descriptor: [Adolescent] explode all trees
#30 (wom*n or female*):ti,ab
#31 adolescen*:ti,ab
#32 teen*:ti,ab
#33 #27 or #28 or #29 or #30 or #31 or #32
#34 #16 and #26 and #33 Publication Year from 2012 to 2015, in Other Reviews
International Clinical Trials Registry Platform (who.int/ictrp/en/)
ICTRP searched 18 February 2015 No date limits applied [34 records]
CONDITION: intimate partner violence Or domestic violence OR battered women AND Intervention: screen OR screening OR
identify OR identification OR detect OR detection OR disclose OR disclosure AND Recruitment status is ALL
ClinicalTrials.gov (clinicaltrials.gov)
ClinicalTrials.gov, searched 18 February 2015. No date limits applied [17 records]
Interventional Studies | intimate partner violence OR domestic violence OR battered women | screen OR screening OR identify OR
identification OR disclose OR disclosure OR detect OR detection | Studies with Female Participants
Appendix 2. Search strategies used for previous version of review
Cochrane Central Register of Controlled Trials (CENTRAL)
Last searched 5 July 2012
#1 MeSH descriptor Battered Women explode all trees
#2 MeSH descriptor Domestic Violence, this term only
#3 MeSH descriptor Spouse Abuse, this term only
#4 abuse* near/3 wom*n
#5 abuse* near/3 spous*
#6 abuse* near/3 partner*
#7 wife near/3 abuse*
#8 wives near/3 abuse*
#9 wife near/3 batter*
#10 wives near/3 batter*
#11 partner* near/3 violen*
#12 spous* near/3 violen*
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#13 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12)
#14 MeSH descriptor Mass Screening, this term only
#15 screen*
#16 identif*
#17 routine* near/3 ask*
#18 routine* near/3 question*
#19 detect*
#20 (#14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 MeSH descriptor Women explode all trees
#22 MeSH descriptor Adolescent explode all trees
#23 wom*n or female*
#24 adolescen*
#25 teen*
#26 (#21 OR #22 OR #23 OR #24 OR #25)
#27 (#13 AND #20 AND #26)
Ovid MEDLINE(R)
Last searched 5 July 2012
1 Battered Women/
2 Domestic Violence/
3 Spouse Abuse/
4 (abuse$ adj3 wom#n).tw.
5 (abuse$ adj3 spous$).tw.
6 (abuse$ adj3 partner$).tw.
7 ((wife or wives) adj3 abuse$).tw.
8 ((wife or wives) adj3 batter$).tw.
9 (partner$ adj3 violen$).tw.
10 (spous$ adj3 violen$).tw.
11 or/1-10
12 Mass Screening/
13 screen$.tw.
14 identif$.tw.
15 detect$.tw.
16 (routine$ adj3 (ask$ or question$)).tw.
17 or/12-16
18 exp Women/
19 Adolescent/
20 (wom#n or female$).tw.
21 adolescen$.tw.
22 teen$.tw.
23 or/18-22
24 11 and 17 and 23
Ovid MEDLINE(R) In-Process and Other Non-Indexed Citations
Last searched 5 July 2012
1 (abuse$ adj3 wom#n).tw.
2 (abuse$ adj3 spous$).tw.
3 (abuse$ adj3 partner$).tw.
4 ((wife or wives) adj3 abuse$).tw.
5 ((wife or wives) adj3 batter$).tw.
6 (partner$ adj3 violen$).tw.
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7 (spous$ adj3 violen$).tw.
8 or/1-7
9 screen$.tw.
10 identif$.tw.
11 (routine$ adj3 (ask$ or question$)).tw.
12 detect$.tw.
13 or/9-12
14 (wom#n or female$).tw.
15 adolescen$.tw.
16 teen$.tw.
17 or/14-16
18 8 and 13 and 17
Embase (Ovid)
Last searched 5 July 2012
1 Battered Women/
2 Domestic Violence/
3 Spouse Abuse/
4 (abuse$ adj3 wom#n).tw.
5 (abuse$ adj3 spous$).tw.
6 (abuse$ adj3 partner$).tw.
7 ((wife or wives) adj3 abuse$).tw.
8 ((wife or wives) adj3 batter$).tw.
9 (partner$ adj3 violen$).tw.
10 (spous$ adj3 violen$).tw.
11 or/1-10
12 Mass Screening/
13 screen$.tw.
14 identif$.tw.
15 (routine$ adj3 (ask$ or question$)).tw.
16 detect$.tw.
17 or/12-16
18 exp Women/
19 Adolescent/
20 (wom#n or female$).tw.
21 adolescen$.tw.
22 teen$.tw.
23 or/18-22
24 11 and 17 and 23
CINAHL Plus (EBSCOhost)
Last searched 5 July 2012
S24 S17 and S23
S23 S18 or S19 or S20 or S21 or S22
S22 adolescen* or teen*
S21 AG adolescent
S20 women or woman or female*
S19 (MH “Women+”)
S18 (MH “Female”)
S17 S9 and S16
S16 S10 or S11 or S12 or S13 or S14 or S15
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S15 (MH “Health Screening”)
S14 identif*
S13 MH “Experimental Studies”
S12 detect*
S11 (routin* N3 ask*) or (routin* N3 question*)
S10 screen*
S9 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8
S8 (partner* N3 violen*) or (spouse* N3 violen*)
S7 (wife N3 batter*) or (wives N3 batter*)
S6 abuse* N3 spouse*
S5 abuse* N3 partner*
S4 abuse* N3 wom?n
S3 MH “Intimate Partner Violence”
S2 MH “Domestic Violence”
S1 MH “Battered Women”
PsycINFO (Ovid)
Last searched 5 July 2012
1 Battered Women/ (2689)
2 Domestic Violence/ (7821)
3 Spouse Abuse/ (4154)
4 (abuse$ adj3 wom#n).tw. (2995)
5 (abuse$ adj3 spous$).tw. (908)
6 (abuse$ adj3 partner$).tw. (1266)
7 ((wife or wives) adj3 abuse$).tw. (570)
8 ((wife or wives) adj3 batter$).tw. (316)
9 (partner$ adj3 violen$).tw. (3626)
10 (spous$ adj3 violen$).tw. (351)
11 or/1-10 (15402)
12 Screening/ (5344)
13 screen$.tw. (48857)
14 identif$.tw. (287698)
15 (routine$ adj3 (ask$ or question$)).tw. (244)
16 detect$.tw. (73953)
17 or/12-16 (383820)
18 exp Women/ (97549)
19 (wom#n or female$).tw. (380933)
20 adolescen$.tw. (157334)
21 teen$.tw. (13531)
22 or/18-21 (535027)
23 11 and 17 and 22 (2087)
Sociological Abstracts (ProQuest)
Last searched 5 July 2012
((SU.EXACT(“Females”) or SU.EXACT(“adolescents”) or (wom*n or female*) or (adolescent*or teen*)) AND ((screen*)or (iden-
tif*) or ((routine* NEAR/3 question*) or (routine* NEAR/3 ask*)) or (detect*))) AND (SU.EXACT((“Familyviolence”)) or
SU.EXACT((“Partner Abuse”) or (“Battered Women”)) or (abuse NEAR/3 wom*n) or (abuse NEAR/3spouse*) or (abuse NEAR/
3 partner*) or (wife NEAR/3 abuse*) or (wives NEAR/3 abuse*) or (wife NEAR/3 batter*) or(wives NEAR/3 batter*) or (partner*
NEAR/3 violent*) or (spouse* NEAR/3 violent*))
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Database of Abstracts of Reviews of Effects (DARE), part of the Cochrane Library
Last searched 5 July 2012
#1 MeSH descriptor Battered Women explode all trees
#2 MeSH descriptor Domestic Violence, this term only
#3 MeSH descriptor Spouse Abuse, this term only
#4 abuse* near/3 wom*n
#5 abuse* near/3 spous*
#6 abuse* near/3 partner*
#7 wife near/3 abuse*
#8 wives near/3 abuse*
#9 wife near/3 batter*
#10 wives near/3 batter*
#11 partner* near/3 violen*
#12 spous* near/3 violen*
#13 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12)
#14 MeSH descriptor Mass Screening, this term only
#15 screen*
#16 identif*
#17 routine* near/3 ask*
#18 routine* near/3 question*
#19 detect*
#20 (#14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 MeSH descriptor Women explode all trees
#22 MeSH descriptor Adolescent explode all trees
#23 wom*n or female*
#24 adolescen*
#25 teen*
#26 (#21 OR #22 OR #23 OR #24 OR #25)
#27 (#13 AND #20 AND #26)
metaRegister of Controlled Trials (mRCT)
Last searched July 2012
Search string: intimate partner violence OR domestic violence
Sociological Abstracts (CSA)
Searched up to 2009
Query: ((DE=“domestic violence”) or(DE=“battered women”) or(abuse* within 3 wom*n) or(abuse* within 3 spous*) or(abuse* within
3 partner*) or((wife within 3 abuse*) or (wives within3 abuse*)) or((wife within 3 batter*) or (wives within 3 batter*)) or(partner*
within 3 violen*) or(spous* within 3 violen*)) and((screen*) or(identif*) or((routine* within 3 question*) or (rountine* within 3 ask*))
or(detect*)) and((DE=“women”) or(DE=“adolescents”) or(wom*n or female*) or(adolescen*) or(teen*))
ASSIA (CSA)
Searched up to 2009 only
Query: ((DE=“domestic violence”) or(DE=“battered women”) or(abuse* within 3 wom*n) or(abuse* within 3 spous*) or(abuse* within
3 partner*) or((wife within 3 abuse*) or (wives within3 abuse*)) or((wife within 3 batter*) or (wives within 3 batter*)) or(partner*
within 3 violen*) or(spous* within 3 violen*)) and((screen*) or(identif*) or((routine* within 3 question*) or (routine* within 3 ask*))
or(detect*)) and((DE=“women”) or(DE=“adolescents”) or(wom*n or female*) or(adolescen*) or(teen*))
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Appendix 3. Additional methods
Analysis Method
Measures of treatment effect Where measurements were comparable and on the same scale, we intended to combine them to
obtain mean differences. Where scales measured the same clinical outcomes in different ways (e.g.
depression, quality of life), mean differences were to be standardised in order to combine results
across scales. There have been insufficient data in studies in the review and update to undertake
these analyses. These methods will be retained for subsequent updates
Unit of analysis issues There was one included cluster-RCT to date, which did account for clustering. For future up-
dates, where studies have not appropriately accounted for clustering, we will re-analyse data using
methods recommended by Donner 1980.
Dealing with missing data Rates of missing data on the primary outcome have not required thus far that we undertake best-
case and worst-case scenario analyses to estimate the effect of the missing data on the results of
pooled studies. Such analyses would enable us to ascertain if observed effect sizes increased or
decreased as a function of the extent of attrition in the two arms of the trial. These methods will
be retained for subsequent updates
Assessment of reporting biases We planned to draw funnel plots to investigate any relationship between effect size and study
precision (closely related to sample size) (Egger 1997) to investigate a relationship that could be
due to publication or related biases or due to systematic differences between small and large studies.
Funnel plots (estimated differences in treatment effects against their standard error)were not drawn
because there was an insufficient number of included studies (more than 10 are recommended),
to identify asymmetry due to publication bias
Subgroup analyses We planned to conduct subgroup analysis for type of healthcare setting (which was done) and
the type of screening intervention (based on types of tools, questions), which could be done in a
future update with more studies. We also stated in the protocol that we would undertake subgroup
analysis based on screening intervention only or where it was embedded as part of a larger multi-
component intervention. However, the implications of our altered criterion for assessing inclusion
of interventions/comparisons, which explicitly excludes interventions that extended beyond an
immediate response and referral phase following screening, meant that this subgroup analysis has
not been relevant to date
Sensitivity analysis Our original protocol stated our intention to use sensitivity analysis to deal with study quality
and differential dropout, which has been undertaken in this review. However, we have not used
sensitivity analysis for intention-to-treat issues and duration of follow-up as neither have applied
to date. These methods will be retained for subsequent updates
RCT: randomised controlled trial.
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WH A T ’ S N E W
Last assessed as up-to-date: 17 February 2015.
Date Event Description
7 May 2015 New citation required but conclusions have not
changed
Two new studies included in the review.
17 February 2015 New search has been performed The review was updated following a new search in
February 2015
H I S T O R Y
Protocol first published: Issue 1, 2008
Review first published: Issue 4, 2013
Date Event Description
16 September 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
AT originally developed the search strategy. AT and LOD selected the studies prior to 2009; AT, LOD and KH selected studies for the
2009 to 2012 period and AT and LOD extracted the data; AT undertook the analysis with the help of LOD and KH and drafted the
original review. All authors provided topic expertise and contributed to writing and editing the original review.
LOD led the 2015 update with guidance from all co-authors. AT, LOD, and KH independently selected studies from the point at
which full-text articles had been retrieved. Extraction and ’Risk of bias’ assessment was done by LOD with Tess Lawrie (not author).
All authors provided topic expertise and contributed to writing and editing the update of the review.
D E C L A R A T I O N S O F I N T E R E S T
Lorna O’Doherty - the La Trobe funding went towards contracting Lorna from the University of Melbourne to work on the original
Cochrane Review. She is responsible for the 2015 update to the review and conducted the 2015 work within the remit of her current
position at Coventry University. TheNational Health andMedical Research Council (NHMRC) funded her former position as research
fellow at the University of Melbourne. She does not have any competing interest to declare. She was first author of an abridged version
of the original review published in the BMJ in 2014.
Kelsey Hegarty* - has been funded through a NHMRC Grant to undertake a randomised controlled trial in the field of intimate
partner violence (IPV) - women’s evaluation of abuse and violence care in general practice (WEAVE) trial (Hegarty 2013), which was
completed by the time of the 2015 update. Angela Taft, Lorna O’Doherty, and Gene Feder were also involved in the trial. The author
team examined the WEAVE trial against inclusion criteria and it was judged as ineligible on the basis that the intervention was too
intensive to be considered a screening-only trial. Kelsey participated in the World Health Organization (WHO) Guideline Group
on health practitioners’ responses to IPV and received payment from the General Practice Victoria for training provided to general
practitioners in how to manage partner violence.
101Screening women for intimate partner violence in healthcare settings (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jean Ramsay - none known.
Leslie Davidson - National Institutes of Health (NIH) Fogarty International Center paid travel, accommodation, and meeting expenses
for Leslie to attend the Society of Neuro Scientists of Africa (SONA) and a NIH workshop in March 2015 in South Africa unrelated
to IPV.
Gene Feder - Gene chaired theWHO IPV and sexual violence guideline development group. Gene’s institution received funds from the
National Institute for Health and Care Excellence (NICE) for him to chair the Domestic Violence and Abuse guidelines development
group. Gene’s institution also receives funds from Safer Lives for his consultancy work and from a National Institute of Health Research
applied research programme grant on domestic violence and abuse.
Angela Taft* - received an Australian Research Council Grant to undertake a screening trial (Taft 2015). Kelsey Hegarty was also
involved in the trial. Its eligibility was considered for the 2015 update. The author team examined the Improving maternal and child
health care for vulnerable mothers (MOVE) trial against inclusion criteria and it was judged as ineligible on the basis that screening
was conducted by healthcare professionals in both arms of the trial.
Kelsey Hegarty* and Angela Taft* were involved in (Taft 2012), which was previously examined by the author team and was judged
ineligible for inclusion in the review as it was case-finding and not a screening trial.
* Kelsey Hegarty and Angela Taft were excluded from making decisions about the trials they led.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• La Trobe University, Australia.
Financial (salary) and technical support
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. Altered objective
We made it explicit in the objective for the review that we would also examine the impact of screening in health settings on women’s
re-exposure to violence and to determine if screening causes any harms.
2. Altered criterion for assessing inclusion of interventions/comparisons
The treating healthcare professional must have been informed of the result of the screening assessment undertaken at the time of the
relevant consultation if they did not conduct the screening themselves face-to-face. Essentially, there must be some involvement of a
healthcare professional in the intervention arm.
The comparison condition was also considered to determine if the overall comparison was valid for inclusion. Originally we defined
the comparison as usual care. We acknowledge, however, that ’treatment-as-usual’ (TAU) arms may involve some kind of screening
technique such as computer or paper-based screening. Providing that there was no healthcare professional involvement, we considered
it to be a comparison consistent with other included studies.
Some studies compared face-to-face screening with other techniques of identification, but the way in which identification was opera-
tionalised differed from the main body of studies, reflecting prevalence rather than clinical identification.
We excluded interventions where the timing of these consultations went beyond an immediate response and referral phase, and included
further counselling or therapeutic sessions as we wanted to isolate the effect of screening only.
3. Amendments to outcomes
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We added the outcome below as it has bearing on the potential for beneficial support to women at a later date
G. Services and resource use:
i. family/domestic violence services;
ii. police/legal services;
iii. counselling or therapeutic services;
iv. other services.
In this update, we conducted a meta-analysis on an outcome that was not pre-specified but represents an alternative definition of
’identification’, which was more research-based than clinical. The methods used to gather data on this outcome were more consistent
with prevalence studies. It was necessary to treat this outcome separately to clinical identification given that womenmay bemore inclined
to disclose abuse when the enquiry occurs outside the clinical encounter and context. Thus, it would be expected that non-clinical
identification rates would exceed rates of clinical identification, and more closely reflect best estimates of IPV in clinical populations.
4. Search strategy amendment
We were unable to complete the planned handsearching of several journals and we were unable to search ’Domestic Violence Data
source’ as the webpage was no longer available. However, given the extent of the alternative searching, we believe the likelihood of
overlooking an eligible trial was low.
5. Incorporation of a separate review
Although the 2015 update incorporates another review (Coulthard 2010), we have only included studies of screening interventions for
women. Screening interventions for men might be addressed in a future review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Efficiency, Organizational; ∗Mass Screening; Randomized Controlled Trials as Topic; Spouse Abuse [∗diagnosis; statistics & numerical
data]
MeSH check words
Female; Humans
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